<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="music/PMC1142204/results/search/drugs/results.xml">
   <result pre="more beneficial treatment for pain than fiber, and the pharmaceuticals" exact="famotidine" post="(H 2-receptor antagonist) and pizotifen (serotonin antagonist) ( 49)."/>
   <result pre="than fiber, and the pharmaceuticals famotidine (H 2-receptor antagonist) and" exact="pizotifen" post="(serotonin antagonist) ( 49). However, until these findings are"/>
   <result pre="Olness K MacDonald JT Uden DL Comparison of self-hypnosis and" exact="propranolol" post="in the treatment of juvenile classic migraine Pediatrics 1987"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC1868723/results/search/drugs/results.xml">
   <result pre="American Psychiatric Association 1 97 McCrory DC Gray RN Oral" exact="sumatriptan" post="for acute migraine Cochrane Database Syst Rev 2003 CD002915"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC2322948/results/search/drugs/results.xml">
   <result pre="which did not receive additional medication (just one with additional" exact="methylphenidate" post="medication). The evaluations of Hamre's group [ 23- 27]"/>
   <result pre="child); no other therapy during study, but 1 child with" exact="methylphenidate" post="medication Positive changes (normalisation) of movement skills (5/5) and"/>
   <result pre="problems (4/5) and slight drop of hyperactivity (4/5); stopping of" exact="methylphenidate" post="medication at the end of the study in 1/1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC2734746/results/search/drugs/results.xml">
   <result pre="= 20) 0.19 § Daily dose of inhaled steroids in" exact="beclomethasone" post="μg equivalents over the past 1-2 wk. These were"/>
   <result pre="past 1-2 wk. These were calculated on the assumption that" exact="beclomethasone" post="2000 μg = budesonide 1600 μg = fluticasone 1000"/>
   <result pre="were calculated on the assumption that beclomethasone 2000 μg =" exact="budesonide" post="1600 μg = fluticasone 1000 μg. ¥ Rescue medication"/>
   <result pre="assumption that beclomethasone 2000 μg = budesonide 1600 μg =" exact="fluticasone" post="1000 μg. ¥ Rescue medication = Inhaled rescue bronchodilator"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC2762955/results/search/drugs/results.xml">
   <result pre="relieves me a bit from the pain...the one with the" exact="codeine" post="[Co-Codamol] I don't take anyway...'(Patient 5) Apart from medication,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3072476/results/search/drugs/results.xml">
   <result pre="? not evaluated * Used as a comparative agent against" exact="prochlorperazine" post="At 1 h acetaminophen tended to be slightly more"/>
   <result pre="Used as a comparative agent against prochlorperazine At 1 h" exact="acetaminophen" post="tended to be slightly more effective (39% of children"/>
   <result pre="to be slightly more effective (39% of children relieved) than" exact="ibuprofen" post="(37% of children relieved), but 2 h after administration"/>
   <result pre="ibuprofen (37% of children relieved), but 2 h after administration" exact="ibuprofen" post="was more effective (68 vs. 54%). Sumatriptan nasal spray"/>
   <result pre="2 h was achieved in significantly more attacks treated with" exact="rizatriptan" post="5-mg tablets (77%) or with rizatriptan 5-mg wafer (77%)"/>
   <result pre="more attacks treated with rizatriptan 5-mg tablets (77%) or with" exact="rizatriptan" post="5-mg wafer (77%) than with standard care (64%). Pain"/>
   <result pre="rates after 2 h were 28% for placebo, 62% for" exact="zolmitriptan" post="and 69% for ibuprofen (placebo vs. zolmitriptan p &amp;lt;"/>
   <result pre="were 28% for placebo, 62% for zolmitriptan and 69% for" exact="ibuprofen" post="(placebo vs. zolmitriptan p &amp;lt; 0.05; placebo vs. ibuprofen"/>
   <result pre="placebo, 62% for zolmitriptan and 69% for ibuprofen (placebo vs." exact="zolmitriptan" post="p &amp;lt; 0.05; placebo vs. ibuprofen p &amp;lt; 0.05)."/>
   <result pre="for ibuprofen (placebo vs. zolmitriptan p &amp;lt; 0.05; placebo vs." exact="ibuprofen" post="p &amp;lt; 0.05). Both drugs are well tolerated with"/>
   <result pre="mild side effects. The Food Drug Administration has recently approved" exact="almotriptan" post="for the acute treatment of migraine headache in adolescents."/>
   <result pre="for the acute treatment of migraine headache in adolescents. Nevertheless," exact="almotriptan" post="is still not approved in Europe. There are limited"/>
   <result pre="is moderate evidence that analgesics (acetaminophen and ibuprofen) and nasal-spray" exact="sumatriptan" post="are more effective than placebo treatment. Based on the"/>
   <result pre="in the emergency department and to confirm the usefulness of" exact="prochlorperazine" post="as treatment for severe attack or status migrainosus. In"/>
   <result pre="migraine prophylaxis in children. The overall positive response rate of" exact="cyproheptadine" post="was 83% and common side effects included sedation and"/>
   <result pre="(5.6%) and sensory (2.8%). There are limited data about levetiracetam," exact="gabapentin" post="and zonisamide. Pharmacological treatment of TTH Most TTH is"/>
   <result pre="if non-pharmacological management is inadequate. For children with frequent headache," exact="amitriptyline" post="might be beneficial, although no placebo-controlled studies have been"/>
   <result pre="the most effective symptomatic treatments are oxygen [ 79– 82]," exact="sumatriptan" post="[ 81, 83] and acetylsalicylic acid [ 80– 84]."/>
   <result pre="are oxygen [ 79– 82], sumatriptan [ 81, 83] and" exact="acetylsalicylic acid" post="[ 80– 84]. Prophylactic treatments reported in literature are"/>
   <result pre="Prophylactic treatments reported in literature are prednisone/prednisolone [ 85, 86]," exact="indomethacin" post="[ 84], pizotifen [ 81], verapamil [ 81, 82,"/>
   <result pre="in literature are prednisone/prednisolone [ 85, 86], indomethacin [ 84]," exact="pizotifen" post="[ 81], verapamil [ 81, 82, 87], methysergide ["/>
   <result pre="prednisone/prednisolone [ 85, 86], indomethacin [ 84], pizotifen [ 81]," exact="verapamil" post="[ 81, 82, 87], methysergide [ 79, 83, 85],"/>
   <result pre="[ 84], pizotifen [ 81], verapamil [ 81, 82, 87]," exact="methysergide" post="[ 79, 83, 85], loratadine [ 88], astemizole ["/>
   <result pre="verapamil [ 81, 82, 87], methysergide [ 79, 83, 85]," exact="loratadine" post="[ 88], astemizole [ 88] and flunarizine [ 89]."/>
   <result pre="82, 87], methysergide [ 79, 83, 85], loratadine [ 88]," exact="astemizole" post="[ 88] and flunarizine [ 89]. No controlled study"/>
   <result pre="79, 83, 85], loratadine [ 88], astemizole [ 88] and" exact="flunarizine" post="[ 89]. No controlled study has been reported. If"/>
   <result pre="85, 90]. Considering the unbearable pain intensity, off-label use of" exact="sumatriptan" post="nasal spray or subcutaneous sumatriptan may be necessary. Ergotamine"/>
   <result pre="pain intensity, off-label use of sumatriptan nasal spray or subcutaneous" exact="sumatriptan" post="may be necessary. Ergotamine has also been used. It"/>
   <result pre="a partial relief in another 12% of patients treated with" exact="prednisone" post="was reported [ 85, 90]. For prophylactic treatment the"/>
   <result pre="reported [ 85, 90]. For prophylactic treatment the efficacy of" exact="verapamil" post="has been attributed to a possible stabilization of vascular"/>
   <result pre="well tolerated and can be used in combination with corticosteroids," exact="sumatriptan" post="and ergotamine [ 91, 92]. Life quality of headaches"/>
   <result pre="and can be used in combination with corticosteroids, sumatriptan and" exact="ergotamine" post="[ 91, 92]. Life quality of headaches Health-related quality"/>
   <result pre="or headache stops after vomiting. If an antiemetic is required," exact="ondansetron" post="may be preferred for its good tolerability. Supplementary measures"/>
   <result pre="Hämäläinen ML Hoppu K Valkeila E Santavuori P Ibuprofen or" exact="acetaminophen" post="for the acute treatment of migraine in children: a"/>
   <result pre="G Burke B Frank LM Toor S et al. Children’s" exact="ibuprofen" post="suspension for the acute treatment of pediatric migraine headache"/>
   <result pre="IW et al. Treatment of childhood migraine attacks with oral" exact="zolmitriptan" post="and ibuprofen Neurology 2006 67 497 499 10.1212/01.wnl.0000231138.18629.d5 16775229"/>
   <result pre="al. Treatment of childhood migraine attacks with oral zolmitriptan and" exact="ibuprofen" post="Neurology 2006 67 497 499 10.1212/01.wnl.0000231138.18629.d5 16775229 34. Hamalainen"/>
   <result pre="16775229 34. Hamalainen Ml, Hoppu K, Santavuori Pr (1997) Oral" exact="dihydroergotamine" post="for therapy-resistant migraine attacks in children. Pediatr Neurol 16:114–117"/>
   <result pre="attacks in children. Pediatr Neurol 16:114–117 35. Uebarall MA Intranasal" exact="sumatriptan" post="for the acute treatment of migraine in children Neurology"/>
   <result pre="Laurenza A et al. A randomized, double-blind, placebo-controlled study of" exact="sumatriptan" post="nasal spray in the treatment of acute migraine in"/>
   <result pre="37. Ahonen K Hämäläinen ML Rantala H Hoppu K Nasal" exact="sumatriptan" post="is effective in the treatment of migraine attacks in"/>
   <result pre="randomized placebo-controlled study. Do children with migraine respond to oral" exact="sumatriptan" post="differently than adults? Neurology 1997 48 1100 1103 9109909"/>
   <result pre="40. Mac Donald JT Treatment of juvenile migraine with subcutaneous" exact="sumatriptan" post="Headache 1994 34 581 582 10.1111/j.1526-4610.1994.hed3410581.x 7843952 41. Linder"/>
   <result pre="1994 34 581 582 10.1111/j.1526-4610.1994.hed3410581.x 7843952 41. Linder SL Subcutaneous" exact="sumatriptan" post="in the clinical setting: the first 50 consecutive patients"/>
   <result pre="Mathew NT Cady RK et al. Efficacy and tolerability of" exact="almotriptan" post="in adolescents: a randomized, double- blind, placebo controlled trial"/>
   <result pre="Olness K Macdonald JT Uden DL Comparison of self-hypnosis and" exact="propranolol" post="in the treatment of juvenile classic migraine Pediatrics 1987"/>
   <result pre="S Antolini A et al. A placebo-controlled crossover trial of" exact="nimodipine" post="in pediatric migraine Headache 1990 30 264 268 10.1111/j.1526-4610.1990.hed3005264.x"/>
   <result pre="L Bertoli S et al. A placebo-controlled crossover trial using" exact="trazodone" post="in pediatric migraine Headache 1993 33 1 36 39"/>
   <result pre="Hershey AD Powers SW Bentti AL Degrauw TJ Effectiveness of" exact="amitriptyline" post="in the prophylactic management of childhood headaches Headache 2000"/>
   <result pre="H Oksel F Erermis S Uyar M et al. Sodium" exact="valproate" post="prophylaxis in childhood migraine Headache 2002 42 819 822"/>
   <result pre="Powers SW Vockell AL LeCates S Kabbouche M Effectiveness of" exact="topiramate" post="in the prevention of childhood headache Headache 2002 42"/>
   <result pre="double-blind, placebo-controlled study to evaluate the efficacy and safety of" exact="topiramate" post="for migraine prevention in pediatric subjects 12 to 17"/>
   <result pre="934 10.1542/peds.2008-0642 19255022 68. Miller GS Efficacy and safety of" exact="levetiracetam" post="in pediatric migraine Headache 2004 44 238 243 10.1111/j.1526-4610.2004.04053.x"/>
   <result pre="Podreka I Dopamine D2 receptor blockade and antimigraine action of" exact="flunarizine" post="Cephalalgia 1994 14 3 235 240 10.1046/j.1468-2982.1994.014003235.x 7954746 73."/>
   <result pre="Koch G Wessely P Long-term results of migraine prophylaxis with" exact="flunarizine" post="and beta-blockers Cephalalgia 1991 11 6 251 256 10.1046/j.1468-2982.1991.1106251.x"/>
   <result pre="M Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with" exact="paracetamol" post="Cephalalgia 2003 23 59 66 10.1046/j.1468-2982.2003.00470.x 12534583 77. Dooley"/>
   <result pre="MP et al. Tolerability and efficacy of a combination of" exact="paracetamol" post="and caffeine in the treatment of tension-type headache: a"/>
   <result pre="headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and" exact="naproxen" post="sodium J Headache Pain 2008 9 6 367 373"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3111720/results/search/drugs/results.xml">
   <result pre="by 14% (n = 5/36); medications used were antidepressants (8%)," exact="cyclandelate" post="(3%), and flunarazine (3%). The total number of days"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3129953/results/search/drugs/results.xml">
   <result pre="who used this type of treatment. 29 Focal administration of" exact="lidocaine" post="into jaw muscles (mainly the lateral pterygoid or the"/>
   <result pre="deep portion of the masseter muscle, because local injection of" exact="lidocaine" post="on the ipsilateral masseter's myalgic spots relieved one patient's"/>
   <result pre="in whom tinnitus was relieved after injections with steroid and" exact="lidocaine" post="into MTPs in the cervical region. In this study,"/>
   <result pre="in 15% of the cases after cervical MTP injection of" exact="lidocaine" post="1%. In a six-month follow-up after the last injection,"/>
   <result pre="33 10.1016/j.pain.2003.10.008 14715398 59 Durham PL Cady R Regulation of" exact="calcitonin" post="gene-related peptide secretion from trigeminal nerve cells by botulinum"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3136881/results/search/drugs/results.xml">
   <result pre="CL Klein MA O'Dell JR Hooper MM et al. Glucosamine," exact="chondroitin sulfate," post="and the two in combination for painful knee osteoarthritis"/>
   <result pre="A Takazawa Y et al. Additive effects of glucosamine or" exact="risedronate" post="for the treatment of osteoarthritis of the knee combined"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3188784/results/search/drugs/results.xml">
   <result pre="Burkard RF et al. Brain imaging of the effects of" exact="lidocaine" post="on tinnitus. Hear Res 2002; 171: 43– 50 12204348"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3194009/results/search/drugs/results.xml">
   <result pre="22, she endured two seizures for which she was prescribed" exact="phenobarbital" post="for two years with no later recurrence. As a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3285181/results/search/drugs/results.xml">
   <result pre="studies of the arginine vasopressin 1a receptor (AVPR1a) and the" exact="oxytocin" post="receptor (OXTR) in human behaviour: from autism to altruism"/>
   <result pre="G Archer N et al. 2012 Association of serotonin and" exact="dopamine" post="gene pathways with behavioral subphenotypes in dementia. Neurobiol Aging"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3330267/results/search/drugs/results.xml">
   <result pre="cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and the NMDA receptor antagonist" exact="memantine" post="(for a review of the evidence see Herrmann et"/>
   <result pre="(Herrmann et al., 2011) and the FDA has also approved" exact="donepezil" post="for moderate to severe disease. These drugs show as"/>
   <result pre="to be additive benefits of combining a cholinesterase inhibitor and" exact="memantine" post="(Tariot et al., 2004; Atri et al., 2008; Lopez"/>
   <result pre="treat aggression, agitation and psychosis. Efficacy has been demonstrated for" exact="risperidone" post="(especially 2 mg/day) when prescribed for aggression, but for agitation"/>
   <result pre="doses should be used and long-term prescription avoided. Anticonvulsants, like" exact="carbamazepine" post="(useful for agitation), and benzodiazepines may be helpful in"/>
   <result pre="tested ones were not efficacious in AD. Calcium channel blocker" exact="nilvadipine" post="could also reduce the production and augment the clearance"/>
   <result pre="strategies in development include the use of nerve growth factor," exact="etanercept" post="and phosphodiesterase-5 inhibitors; interventions at the mitochondrial level (for"/>
   <result pre="T. ( 2009). Long-term effects of the concomitant use of" exact="memantine" post="with cholinesterase inhibition in Alzheimer disease . J. Neurol."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3420547/results/search/drugs/results.xml">
   <result pre="metabolic changes in patients with major depression treated with either" exact="paroxetine" post="or interpersonal therapy: preliminary findings Archives of General Psychiatry"/>
   <result pre="Brannan SK Tekell JL et al. Regional metabolic effects of" exact="fluoxetine" post="in major depression: serial changes and relationship to clinical"/>
   <result pre="flow changes in depressed patients treated with interpersonal psychotherapy or" exact="venlafaxine" post="hydrochloride: preliminary findings Archives of General Psychiatry 2001 58"/>
   <result pre="Differences in brain glucose metabolism between responders to CBT and" exact="venlafaxine" post="in a 16-week randomized controlled trial American Journal of"/>
   <result pre="16780808 32 Bardo MT Neuropharmacological mechanisms of drug reward: beyond" exact="dopamine" post="in the nucleus accumbens Critical Reviews in Neurobiology 1998"/>
   <result pre="JG Damsma G Wenkstern D Fibiger HC Sexual activity increases" exact="dopamine" post="transmission in the nucleus accumbens and striatum of female"/>
   <result pre="Svensson HM Svensson TH Nomikos GG Nicotine and food induced" exact="dopamine" post="release in the nucleus accumbens of the rat putative"/>
   <result pre="regional brain glucose metabolism measured with positron emission tomography after" exact="paroxetine" post="treatment of major depression American Journal of Psychiatry 2001"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3451646/results/search/drugs/results.xml">
   <result pre="Solomon G Times to pain relief and pain freedom with" exact="rizatriptan" post="10 mg and other oral triptans Int J Clin"/>
   <result pre="M Putnam DG et al. Effect of early intervention with" exact="sumatriptan" post="on migraine pain: retrospective analyses of data from three"/>
   <result pre="Rodgers A Hustad CM Ramsey KE et al. Efficacy of" exact="rizatriptan" post="10 mg administered early in a migraine attack Headache"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3541245/results/search/drugs/results.xml">
   <result pre="A Hauenstein K Heinrichs M Herpertz SC Effects of intranasal" exact="oxytocin" post="on emotional face processing in women Psychoneuroendocrinology 2010 35"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3621736/results/search/drugs/results.xml">
   <result pre="synaptic cleft [6]. Other central effects include increases of extracellular" exact="dopamine" post="concentrations in the striatum and the prefrontal cortex [7],"/>
   <result pre="and mediotemporal cortical regions, while other monoamine neurotransmitters such as" exact="dopamine" post="or norepinephrine remained unaffected [12]– [16]. Early studies already"/>
   <result pre="cortical regions, while other monoamine neurotransmitters such as dopamine or" exact="norepinephrine" post="remained unaffected [12]– [16]. Early studies already suggested an"/>
   <result pre="between subjects; however, the abstinence duration of MDMA, cannabis, cocaine," exact="amphetamine" post="and hallucinogens was not systematically correlated with rMRGlu in"/>
   <result pre="a novel method employing 18F-altanserin PET in combination with a" exact="dexfenfluramine" post="challenge in order to measure 5-HT release capacity [85],"/>
   <result pre="participants should especially have no substantial previous use of other" exact="amphetamine" post="derivatives (e.g., methamphetamine) or cocaine. PET scans and neuropsychological"/>
   <result pre="of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')," exact="methamphetamine" post="and D-amphetamine . Biol Chem 392: 103– 115. 21194370"/>
   <result pre="et al. ( 2012) Memory-related hippocampal functioning in ecstasy and" exact="amphetamine" post="users: A prospective fMRI study . Psychopharmacology (Berl) 49"/>
   <result pre="in ecstasy (MDMA) users who continue or discontinue ecstasy and" exact="amphetamine" post="use: evidence from an 18-month longitudinal functional magnetic resonance"/>
   <result pre="et al. ( 2002) Plasma concentrations of 5-HT, 5-HIAA, norepinephrine," exact="epinephrine" post="and dopamine in ecstasy users . Neuro Endocrinol Lett"/>
   <result pre="( 2002) Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and" exact="dopamine" post="in ecstasy users . Neuro Endocrinol Lett 23: 259–"/>
   <result pre="Assessment of serotonin release capacity in the human brain using" exact="dexfenfluramine" post="challenge and [18F]altanserin positron emission tomography . Neuroimage 59:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3654705/results/search/drugs/results.xml">
   <result pre="drugs and may increase bleeding when taken with aspirin or" exact="warfarin" post="[ 37]. Ginseng also increases hypoglycemia with antidiabetes drugs,"/>
   <result pre="to falsely increased levels of digoxin, and decreases effectiveness of" exact="warfarin" post="[ 37]. Hawthorn increases the effects of digoxin and"/>
   <result pre="effectiveness of warfarin [ 37]. Hawthorn increases the effects of" exact="digoxin" post="and increases coronary vasodilatory effects of calcium channel blockers"/>
   <result pre="nitrates [ 37]. Echinacea increases QT interval when taken with" exact="amiodarone" post="or ibutilide and increases the risk of hepatotoxic effects"/>
   <result pre="37]. Echinacea increases QT interval when taken with amiodarone or" exact="ibutilide" post="and increases the risk of hepatotoxic effects with statins,"/>
   <result pre="increases the risk of hepatotoxic effects with statins, fibrates, or" exact="niacin" post="[ 37]. St. John's wort decreases serum digoxin concentration,"/>
   <result pre="fibrates, or niacin [ 37]. St. John's wort decreases serum" exact="digoxin" post="concentration, increases activity of clopidogrel, decreases warfarin effectiveness, decreases"/>
   <result pre="wort decreases serum digoxin concentration, increases activity of clopidogrel, decreases" exact="warfarin" post="effectiveness, decreases simvastatin effectiveness, and decreases the effectiveness of"/>
   <result pre="digoxin concentration, increases activity of clopidogrel, decreases warfarin effectiveness, decreases" exact="simvastatin" post="effectiveness, and decreases the effectiveness of class IA and"/>
   <result pre="supplements that had potential interactions with warfarin, amiodarone, sotalol, or" exact="digoxin" post="[ 37]. There are innumerable other interactions and side"/>
   <result pre="levels and stimulates the sympathetic nervous system, raising levels of" exact="epinephrine" post="and norepinephrine [ 45]. Exactly how this influences cardiovascular"/>
   <result pre="stimulates the sympathetic nervous system, raising levels of epinephrine and" exact="norepinephrine" post="[ 45]. Exactly how this influences cardiovascular morbidity and"/>
   <result pre="on heart rate variability seen was similar to that of" exact="propranolol" post="in the Beta Blocker Heart Attack Trial [ 57]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3687555/results/search/drugs/results.xml">
   <result pre="diaphragmatic breathing and systematic relaxation were equally as effective as" exact="propranolol" post="in reducing the frequency, severity and duration of migraine"/>
   <result pre="et al. Biofeedback assisted diaphragmatic breathing and systematic relaxation versus" exact="propranolol" post="in long term prophylaxis of migraine Complement Ther Med"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3696105/results/search/drugs/results.xml">
   <result pre="have the following interests: This study received financial support and" exact="duloxetine" post="from Eli Lilly, Copenhagen Denmark ( https://www.eli-lilly.dk/), and AstraZeneca,"/>
   <result pre="Funding The authors acknowledge financial support and the receipt of" exact="duloxetine" post="from Eli Lilly, Copenhagen Denmark ( https://www.eli-lilly.dk/); The Danish"/>
   <result pre="therapy and sleep phase advance [7], bright light therapy and" exact="lithium" post="[8], pindolol [9], bright light therapy and transcranial magnetic"/>
   <result pre="sleep phase advance [7], bright light therapy and lithium [8]," exact="pindolol" post="[9], bright light therapy and transcranial magnetic stimulation [10]."/>
   <result pre="study started with a one-week run-in phase where medication with" exact="duloxetine" post="was begun and diurnal variation assessed. Then followed a"/>
   <result pre="continued with sleep time stabilisation, daily morning light therapy and" exact="duloxetine" post="60 mg daily dosage and patients in the exercise"/>
   <result pre="individual exercise program of at least 30 minutes duration and" exact="duloxetine" post="in a daily dosage of 60 mg. In this"/>
   <result pre="Medication Patient received a fixed daily dosage of 60 mg" exact="duloxetine" post="in the morning, begun at the run-in phase, a"/>
   <result pre="therapy) to exercise in major depressive disorder patients treated with" exact="duloxetine" post=". J Clin Psychiatry 73: 1234– 1242. 23059149 2"/>
   <result pre=", et al. ( 2000) Total sleep deprivation combined with" exact="lithium" post="and light therapy in the treatment of bipolar depression:"/>
   <result pre="( 1999) Sustained antidepressant effect of sleep deprivation combined with" exact="pindolol" post="in bipolar depression. A placebo-controlled trial . Neuropsychopharmacol 20:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3759268/results/search/drugs/results.xml">
   <result pre="16 Paniagua OA Bryant MB Panza JA Role of endothelial" exact="nitric oxide" post="in shear stress-induced vasodilation of human microvasculature: diminished activity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3800126/results/search/drugs/results.xml">
   <result pre="non-responders. PTSD patients were provided with 10 weeks of open-label" exact="sertraline" post="and those who did not remit were then randomized"/>
   <result pre="were then randomized to either receive five additional weeks of" exact="sertraline" post="alone or with 10 sessions of twice weekly PE."/>
   <result pre="for patients who showed a partial response to phase I" exact="sertraline" post="treatment. PE augmentation was associated with lower PTSD severity"/>
   <result pre="an almost mirror design, no beneficial effects were found for" exact="paroxetine" post="enhancement when given in addition to PE to exposure"/>
   <result pre="2012) found that when the combination of exposure therapy and" exact="paroxetine" post="(an SSRI) was provided from the beginning of treatment,"/>
   <result pre="by follow-up. Even though initial treatment with exposure therapy and" exact="paroxetine" post="may lead to good clinical outcome, there are also"/>
   <result pre="rate and skin conductance in response to trauma script in" exact="propranolol" post="group. Yehuda et al. 2010 Hydrocortisone Veteran, male, N=2"/>
   <result pre="2010 Hydrocortisone Veteran, male, N=2 Controlled case study; 30 mg" exact="hydrocortisone" post="or placebo 30 minutes prior to 8 prolonged exposure"/>
   <result pre="Hydrocortisone: 43.0 Placebo: 52.0 Self-report (PSS-SR): more symptom decline in" exact="hydrocortisone" post="treated than placebo treated patient. Suris et al. 2010"/>
   <result pre="Suris et al. 2010 Hydrocortisone Veteran, male, N=20 RCT; 4mg/kg" exact="hydrocortisone" post="or placebo immediately after 1 memory reactivation session Traumatic"/>
   <result pre="1 session. N/A Self-report (IES-R): lower avoidance/numbing symptoms in the" exact="hydrocortisone" post="group compared to placebo. Brunet et al. 2011 Propranolol"/>
   <result pre="mixed trauma, N=28 Open label; 0.67 mg/kg short-acting+1 mg/kg long-acting" exact="propranolol" post="(modal dose resp. 40 and 60 mg), 90 minutes"/>
   <result pre="survivors, N=7 (treated) Open label; 40 mg short-acting+80 mg LA" exact="propranolol" post="90 minutes prior to session 1, 80 mg LA"/>
   <result pre="propranolol 90 minutes prior to session 1, 80 mg LA" exact="propranolol" post="90 minutes prior to sessions 2–6 Traumatic memory reactivation;"/>
   <result pre="extinction learning in rats previously exposed to the tricyclic antidepressant" exact="imipramine" post="(Werner-Seidler &amp;amp; Richardson, 2007), but no evidence was found"/>
   <result pre="receptor, and to a lesser extent to the release of" exact="norepinephrine" post="and dopamine (Johansen &amp;amp; Krebs, 2009; Sessa, 2008). MDMA"/>
   <result pre="to a lesser extent to the release of norepinephrine and" exact="dopamine" post="(Johansen &amp;amp; Krebs, 2009; Sessa, 2008). MDMA is known"/>
   <result pre="Second, MDMA might enhance extinction learning via enhanced cortisol and" exact="norepinephrine" post="levels. And a third, more indirect way, may be"/>
   <result pre="a third, more indirect way, may be that MDMA increases" exact="oxytocin" post="levels, which may strengthen the therapeutic alliance, and thereby"/>
   <result pre="the hypothesis that MDMA strengthens the therapeutic alliance via enhanced" exact="oxytocin" post="release. In both animal (Thompson, Callaghan, Hunt, Cornish, &amp;amp;"/>
   <result pre="2012) it was found that MDMA leads to higher blood" exact="oxytocin" post="levels, and in humans it was shown that blood"/>
   <result pre="oxytocin levels, and in humans it was shown that blood" exact="oxytocin" post="levels were strongly and positively correlated to subjective pro-social"/>
   <result pre="empirical data suggests that medication that inhibits serotonin (5-HT) and" exact="norepinephrine" post="(NE) uptake (respectively SSRI's and SNRI's), drugs commonly used"/>
   <result pre="indirectly via improvement of the therapeutic alliance due to heightened" exact="oxytocin" post="levels, the question arises whether direct administration of oxytocin"/>
   <result pre="heightened oxytocin levels, the question arises whether direct administration of" exact="oxytocin" post="would also enhance exposure therapy. Olff and colleagues ("/>
   <result pre="be more powerful than MDMA. Currently, Olff's group is examining" exact="oxytocin" post="enhancement of exposure therapy in refugees suffering from PTSD."/>
   <result pre="drug (&quot;ecstasy&quot;) is criminalized in most countries. The alternative of" exact="oxytocin" post="enhancement may have better clinical utility, considering that it"/>
   <result pre="memories (Aerni et al., 2004). Enhancement of exposure therapy with" exact="hydrocortisone" post="could be beneficial via both mechanisms: (1) enhanced consolidation"/>
   <result pre="2010). Two randomized studies provided support for exposure augmentation with" exact="hydrocortisone" post="in anxiety-disordered patients. Hydrocortisone given prior to exposure sessions"/>
   <result pre="clinical trials on the augmentation effects of exposure therapy with" exact="hydrocortisone" post="in PTSD patients. Two large scaled clinical studies by"/>
   <result pre="Yehuda and colleagues ( 2010) published a case study on" exact="hydrocortisone" post="enhancement in two male veterans suffering from severe PTSD"/>
   <result pre="depressive disorder. Participants were treated with PE therapy and either" exact="hydrocortisone" post="(30 mg, oral, 30 minutes prior to exposure session"/>
   <result pre="placebo (following the same time schedule). The patient who received" exact="hydrocortisone" post="improved more over the course of treatment than the"/>
   <result pre="design, Suris and colleagues ( 2010) investigated the effects of" exact="hydrocortisone" post="in 20 male veterans suffering from PTSD. Participants received"/>
   <result pre="in 20 male veterans suffering from PTSD. Participants received either" exact="hydrocortisone" post="(intravenous, 4 mg/kg) or placebo, directly after one exposure-based"/>
   <result pre="et al. found that, compared to placebo, participants who received" exact="hydrocortisone" post="had lower self-reported PTSD avoidance and numbing symptoms at"/>
   <result pre="and more lasting. Dosing, administration, adverse effects and contra-indications for" exact="hydrocortisone" post="enhancement Hydrocortisone can be administered orally, intramuscularly or intravenously."/>
   <result pre="a half-life of approximately 1.5 hours. Dosing and administration of" exact="hydrocortisone" post="given in supplementary fashion to exposure-based treatment in PTSD"/>
   <result pre="&amp;amp; Greene, 2010)]. In the two non-PTSD exposure enhancement trials," exact="hydrocortisone" post="was given three or four times, 60 minutes prior"/>
   <result pre="et al., 2011; Soravia et al., 2006). Low doses of" exact="hydrocortisone" post="(e.g., 10–30 mg once a week) do not cause"/>
   <result pre="2009). There is no need to physically monitor patients after" exact="hydrocortisone" post="intake. Besides the regular exclusion criteria for drug trials"/>
   <result pre="appear to be no major drug specific exclusion criteria for" exact="hydrocortisone" post="enhanced treatment relevant to the PTSD population. While participants"/>
   <result pre="medication are included. Discussion The evidence for beneficial effects of" exact="hydrocortisone" post="enhancement of exposure therapy in PTSD patients is very"/>
   <result pre="generalizes to PTSD patients. In PTSD patients, it appears that" exact="hydrocortisone" post="specifically affects avoidance symptoms. Avoidance has been implicated in"/>
   <result pre="al., 2010). Further, it is of interest to note that" exact="hydrocortisone" post="may have acute anxiolytic effects. A clinical trial in"/>
   <result pre="A clinical trial in patients with social phobia showed that" exact="hydrocortisone" post="(25 mg) given 1 hour prior to an exposure"/>
   <result pre="(Soravia et al., 2006). What the effect is of presession" exact="hydrocortisone" post="on fear levels during exposure therapy in PTSD patients,"/>
   <result pre="treatment efficacy, has yet to be established. The proposition that" exact="hydrocortisone" post="impairs retrieval of the traumatic memory targeted during an"/>
   <result pre="acceptability is of great relevance. Reflecting on its clinical utility," exact="hydrocortisone" post="seems safe, well tolerated and easy to administer. There"/>
   <result pre="exclusion criteria relevant to the PTSD population. So, albeit premature," exact="hydrocortisone" post="appears to be feasible to implement in routine clinical"/>
   <result pre="Squire, 1984). Indeed, experimental studies in non-clinical samples demonstrated that" exact="propranolol" post="has effects on memory reconsolidation (see for overview: Lonergan,"/>
   <result pre="2009) found that disruption of reconsolidation by oral administration of" exact="propranolol" post="resulted in diminished fear responses to conditioned stimuli. Even"/>
   <result pre="trial, Brunet and colleagues ( 2008) examined the effects of" exact="propranolol" post="given directly after one exposure-based session in 19 chronic"/>
   <result pre="19 chronic PTSD patients following mixed trauma. Participants received either" exact="propranolol" post="(40 mg short acting (SA) and 2 hours later"/>
   <result pre="i.e., facial frowning muscle) were measured. Participants who had received" exact="propranolol" post="postsession responded with lower heart rate and skin conductance"/>
   <result pre="on PTSD symptoms. There is support for the efficacy of" exact="propranolol" post="as a treatment enhancement strategy from three open-label studies"/>
   <result pre="28 patients with chronic PTSD following mixed trauma received six" exact="propranolol" post="enhanced exposure-based treatment sessions. Ninety minutes prior to the"/>
   <result pre="subsequent enhanced treatment sessions, participants received both SA and LA" exact="propranolol" post="90 minutes prior to the start of the session"/>
   <result pre="instead of a written account of the index trauma and" exact="propranolol" post="was given in fixed doses of 40 mg SA"/>
   <result pre="diagnostic criteria. In study 3, 32 participants self-selected to receive" exact="propranolol" post="enhanced treatment (N=7) or no treatment at all (N=25)."/>
   <result pre="protocol was similar to study 1 with slight differences in" exact="propranolol" post="dosing (see Table 1) and there was no administration"/>
   <result pre="line with the previous findings, for those participants who received" exact="propranolol" post="enhanced treatment, self-reported PTSD symptoms declined over time. Six"/>
   <result pre="the control group. Dosing, administration, adverse effects and contra-indications for" exact="propranolol" post="enhancement Propranolol lowers heart rate and relaxes blood vessels"/>
   <result pre="treatment of hypertension, angina pectoris, migraine and tremor. In addition," exact="propranolol" post="has anxiolytic effects (it reduces physical anxiety symptoms such"/>
   <result pre="240 mg daily, depending on treatment condition. In PTSD trials," exact="propranolol" post="was single dosed directly before or after exposure-based treatment"/>
   <result pre="ingestion and half-life is approximately 3–6 hours, while for LA" exact="propranolol" post="this is respectively 5 hours and between 10 and"/>
   <result pre="hours and between 10 and 20 hours. Adverse reactions to" exact="propranolol" post="appear to be dose related and include light headedness,"/>
   <result pre="sedation (Brunet et al., 2011). Propranolol is orally administered. Because" exact="propranolol" post="lowers blood pressure, in the Brunet trials blood pressure"/>
   <result pre="the Brunet trials blood pressure was monitored after the first" exact="propranolol" post="intake. If systolic blood pressure levels did not drop"/>
   <result pre="block or certain cardiac arrhythmias) were excluded from participation in" exact="propranolol" post="studies. Like propranolol, alcohol relaxes blood vessels, and simultaneous"/>
   <result pre="participants who used medication that could involve dangerous interactions with" exact="propranolol" post="were excluded from participation. Notably, this includes antidepressants that"/>
   <result pre="such as the SSRI paroxetine. Discussion Combined, the findings with" exact="propranolol" post="enhancement are promising and we await a placebo-controlled randomized"/>
   <result pre="promising and we await a placebo-controlled randomized clinical trial on" exact="propranolol" post="enhancement in PTSD patients. However, due to the uncontrolled"/>
   <result pre="PTSD patients. However, due to the uncontrolled methodology of the" exact="propranolol" post="treatment enhancement studies, the question of whether the observed"/>
   <result pre="question of whether the observed benefits were a consequence of" exact="propranolol" post="enhancement or the psychological intervention in itself remains unanswered."/>
   <result pre="proposed working mechanism, it is unclear from Brunet's studies whether" exact="propranolol" post="blocked fear-memory reconsolidation or, alternatively, enhanced extinction consolidation. Parsons"/>
   <result pre="enhanced extinction consolidation. Parsons &amp;amp; Ressler ( 2013) question whether" exact="propranolol" post="would succeed in reconsolidation blockage in PTSD patients, based"/>
   <result pre="will provide us with more information on the potential of" exact="propranolol" post="as a treatment enhancer in PTSD patients¯ Considering the"/>
   <result pre="a treatment enhancer in PTSD patients¯ Considering the feasibility of" exact="propranolol" post="for exposure treatment enhancement in PTSD patients, propranolol appears"/>
   <result pre="feasibility of propranolol for exposure treatment enhancement in PTSD patients," exact="propranolol" post="appears to be well tolerated and easy to administer."/>
   <result pre="cardiovascular problems, and alcohol use should be carefully monitored during" exact="propranolol" post="enhanced treatment, especially considering that alcohol abuse is a"/>
   <result pre="2006). PTSD patients who use SSRI's have been excluded from" exact="propranolol" post="enhancement studies (and will be excluded in upcoming trials,"/>
   <result pre="and the same research group conducted all the studies on" exact="propranolol" post="enhancement. For most enhancers the empirical evidence is still"/>
   <result pre="&amp;amp; Rothbaum, 1998), and Yehuda and colleagues ( 2010) added" exact="hydrocortisone" post="to PE therapy. This variation in exposure dose is"/>
   <result pre="symptoms) separately. The two reviewed studies on hydrocortisone, showed that" exact="hydrocortisone" post="appears to be beneficial primarily via diminishment of avoidance"/>
   <result pre="as a cognitive enhancer, the doses of DCS, hydrocortisone, and" exact="propranolol" post="are relatively low and infrequent, while adverse effects of"/>
   <result pre="antidepressants (SSRI's) is an exclusion criterion for enhancement studies with" exact="propranolol" post="and MDMA, generalizability of findings with these cognitive enhancers,"/>
   <result pre="www.clinicaltrials.gov; www.clinicaltrialsregister.eu) reveals that large(r) clinical trials on DCS (N&amp;gt;100)," exact="hydrocortisone" post="(N=60), and propranolol (N=50) enhancement in PTSD patients are"/>
   <result pre="that large(r) clinical trials on DCS (N&amp;gt;100), hydrocortisone (N=60), and" exact="propranolol" post="(N=50) enhancement in PTSD patients are currently enrolling patients."/>
   <result pre="Robertson K Nader K Pitman R. K Effect of post-retrieval" exact="propranolol" post="on psychophysiologic responding during subsequent script-driven traumatic imagery in"/>
   <result pre="S. P et al. Trauma reactivation under the influence of" exact="propranolol" post="decreases posttraumatic stress symptoms and disorder: 3 open-label trials"/>
   <result pre="K. T Rothbaum B Bell J et al. Efficacy of" exact="sertraline" post="in preventing relapse of posttraumatic stress disorder: Results of"/>
   <result pre="R Donders A. R Touw D. J et al. Increased" exact="oxytocin" post="concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine)"/>
   <result pre="3,4-methylenedioxymethamphetamine (MDMA, &quot;Ecstasy&quot;) are attenuated by the serotonin uptake inhibitor" exact="citalopram" post="Neuropsychopharmacology 2000 22 5 513 521 10731626 Litz B."/>
   <result pre="A review of safety, side-effects and subjective reactions to intranasal" exact="oxytocin" post="in human research Psychoneuroendocrinology 2011 36 8 1114 1126"/>
   <result pre="Langeland W Witteveen A Denys D A psychobiological rationale for" exact="oxytocin" post="in the treatment of posttraumatic stress disorder CNS Spectrum"/>
   <result pre="T Compton J Connor K. M et al. Augmentation of" exact="sertraline" post="with prolonged exposure in the treatment of posttraumatic stress"/>
   <result pre="J Amsel L et al. Combined prolonged exposure therapy and" exact="paroxetine" post="for PTSD related to the World Trade Center attack:"/>
   <result pre="E Cornish J. L McGregor I. S A role for" exact="oxytocin" post="and 5-HT(1A) receptors in the prosocial effects of 3,4"/>
   <result pre="Effects of D-cycloserine on extinction: Consequences of prior exposure to" exact="imipramine" post="Biological Psychiatry 2007 62 10 1195 1197 17555721 Yehuda"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3800812/results/search/drugs/results.xml">
   <result pre="indicating functional improvement with selective serotonin reuptake inhibitors (SSRIs), such" exact="fluoxetine" post="( De Long, 1999 ). SSRIs block serotonin transporters,"/>
   <result pre="and phobias become less prominent. Depleting brain serotonin in a" exact="tryptophan" post="depletion paradigm, on the other hand, results in a"/>
   <result pre="as the increased serotonin levels apparently inhibited synesthesia. However, both" exact="fluoxetine" post="and carbamazepine have been shown to significantly increase GABA"/>
   <result pre="increased serotonin levels apparently inhibited synesthesia. However, both fluoxetine and" exact="carbamazepine" post="have been shown to significantly increase GABA and reduce"/>
   <result pre="Heninger G. R. Price L. H. ( 1996). Effects of" exact="tryptophan" post="depletion in drug-free adults with autistic disorder. Arch. Gen."/>
   <result pre="R. A. Carcillo J. A. et al. ( 2001). Increased" exact="adenosine" post="in cerebrospinal fluid after severe traumatic brain injury in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3820628/results/search/drugs/results.xml">
   <result pre="finding to clinical application [ 157– 159]. Its reversibility by" exact="naloxone" post="indicated the recruitment of endogenous opioidergic mechanisms [ 157]."/>
   <result pre="the level of the spinal cord by the release of" exact="norepinephrine" post="and serotonin [ 163, 174, 175]. Disinhibition of these"/>
   <result pre="maintenance of enhanced abnormal pain states [ 179]. Microinjection of" exact="lidocaine" post="into the RVM inhibited neuronal firing of dorsal horn"/>
   <result pre="is enhanced by peripheral nerve injury [ 183]. Microinjection of" exact="lidocaine" post="into the RVM of rats abolished hyperalgesia during naloxone-precipitated"/>
   <result pre="peripheral nerve injury [ 188]. Blockade of RVM activity with" exact="lidocaine" post="blocked signs of neuropathic pain in nerve-injured rats with"/>
   <result pre="driven by enhanced excitability of nociceptors [ 210]. Microinjection of" exact="lidocaine" post="into the RVM also abolished evidence of ongoing or"/>
   <result pre="the PAG or RVM produced antinociception along with release of" exact="norepinephrine" post="into the spinal CSF [ 218, 241]. Antinociception from"/>
   <result pre="shown that epidural administration of the α 2 adrenergic agonist" exact="clonidine" post="produces effective pain relief in patients with neuropathic cancer"/>
   <result pre="neuropathic cancer pain [ 252]. Furthermore, spinal, but not systemic," exact="clonidine" post="blocked capsaicin-induced pain in normal, healthy volunteers [ 253]."/>
   <result pre="and driven by the PRSx8 promoter, which codes for the" exact="dopamine" post="β-hydroxylase (DBH) gene [ 254]. Projections from A6 were"/>
   <result pre="sympathetic preganglionic neurons [ 254]. Electrical stimulation of A6 releases" exact="norepinephrine" post="in the spinal dorsal horns [ 257] and attenuates"/>
   <result pre="antagonists or spinal administration of the α 2 adrenergic antagonist" exact="yohimbine" post="[ 263]. Peripheral nerve injury increases responses of A6"/>
   <result pre="conditions [ 264]. Peripheral nerve injury results in upregulation of" exact="norepinephrine" post="synthesis in A6 and in a remarkable increase in"/>
   <result pre="the nerve-injured state [ 265]. The antinociceptive effect of spinal" exact="clonidine" post="was markedly enhanced in mice with diabetic neuropathy, which"/>
   <result pre="act at least in part through noradrenergic mechanisms. The drugs" exact="tramadol" post="and tapentadol are notable examples. Based on its fairly"/>
   <result pre="least in part through noradrenergic mechanisms. The drugs tramadol and" exact="tapentadol" post="are notable examples. Based on its fairly low affinity"/>
   <result pre="Based on its fairly low affinity for the μ-opiate receptor," exact="tramadol" post="would normally be expected to show little analgesic efficacy"/>
   <result pre="expected to show little analgesic efficacy [ 267, 268]. However," exact="tramadol" post="also blocks the neuronal reuptake of norepinephrine and of"/>
   <result pre="267, 268]. However, tramadol also blocks the neuronal reuptake of" exact="norepinephrine" post="and of serotonin, and its analgesic efficacy is the"/>
   <result pre="α 2 adrenergic receptors subsequent to elevated spinal levels of" exact="norepinephrine" post="[ 267– 269]. Tramadol is efficacious and well tolerated"/>
   <result pre="noradrenergic activity [ 276– 278]. The mixed serotonin/norepinephrine reuptake inhibitor" exact="duloxetine" post="was the first to be approved by the US"/>
   <result pre="efficacy in some patients with fibromyalgia [ 282]. The gabapentinoids" exact="gabapentin" post="and pregabalin show clinical efficacy against neuropathic and fibromyalgia"/>
   <result pre="some patients with fibromyalgia [ 282]. The gabapentinoids gabapentin and" exact="pregabalin" post="show clinical efficacy against neuropathic and fibromyalgia pain ["/>
   <result pre="may also play a role in its efficacy. Microinjection of" exact="gabapentin" post="into the A6 of rats with peripheral nerve injury"/>
   <result pre="was blocked by spinal administration of the α 2-adrenergic antagonist" exact="idazoxan" post="[ 285]. Spinal or systemic gabapentin also blocked incision-induced"/>
   <result pre="the α 2-adrenergic antagonist idazoxan [ 285]. Spinal or systemic" exact="gabapentin" post="also blocked incision-induced hyperalgesia in rats and was reversed"/>
   <result pre="blocked incision-induced hyperalgesia in rats and was reversed by spinal" exact="idazoxan" post="[ 286]. Finally, studies in human volunteers showed that"/>
   <result pre="idazoxan [ 286]. Finally, studies in human volunteers showed that" exact="gabapentin" post="elevated spinal CSF levels of norepinephrine in surgical patients"/>
   <result pre="human volunteers showed that gabapentin elevated spinal CSF levels of" exact="norepinephrine" post="in surgical patients and reduced the opioid requirement for"/>
   <result pre="[ 295]. Using combinations of warmth, noxious heat, placebo, and" exact="remifentanil" post="injections, a significant covariance between ACC and PAG activity"/>
   <result pre="and [ 11C] raclopride and fMR were used to image" exact="dopamine" post="levels in individuals that received placebo infusion followed by"/>
   <result pre="stimulus, those individuals that reported greater pain relief showed increased" exact="dopamine" post="in the NAc [ 300]. These results show activation"/>
   <result pre="Volunteers that were preconditioned to expectation of pain relief with" exact="ketorolac" post="and subsequently informed that they would receive a hyperalgesic"/>
   <result pre="A β and C-fibers. Moreover, DNIC was abolished by systemic" exact="naloxone" post="or spinal cord section, indicating the involvement of descending"/>
   <result pre="23 Bautista DM Siemens J Glazer JM et al. The" exact="menthol" post="receptor TRPM8 is the principal detector of environmental cold"/>
   <result pre="the central gray matter in humans and its reversal by" exact="naloxone" post="Science 1977 197 4299 183 186 301658 158 Richardson"/>
   <result pre="Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with" exact="gabapentin" post="Pain 2005 117 3 292 303 16150546 220 Sasaki"/>
   <result pre="Dickenson AH Descending serotonergic facilitation and the antinociceptive effects of" exact="pregabalin" post="in a rat model of osteoarthritic pain Molecular pain"/>
   <result pre="Barbaro NM Hammond DL Fields HL Effects of intrathecally administered" exact="methysergide" post="and yohimbine on microstimulation-produced antinociception in the rat Brain"/>
   <result pre="Hammond DL Fields HL Effects of intrathecally administered methysergide and" exact="yohimbine" post="on microstimulation-produced antinociception in the rat Brain Research 1985"/>
   <result pre="Yaksh TL Antagonism of stimulation-produced antinociception by intrathecal administration of" exact="methysergide" post="or phentolamine Brain Research 1984 298 2 329 337"/>
   <result pre="Antagonism of stimulation-produced antinociception by intrathecal administration of methysergide or" exact="phentolamine" post="Brain Research 1984 298 2 329 337 6326954 247"/>
   <result pre="the antinociceptive effect of systemically and intrathecally administered combinations of" exact="clonidine" post="and opiates Journal of Pharmacology and Experimental Therapeutics 1990"/>
   <result pre="JC DuPen S Dubois M Miguel R Allin D Epidural" exact="clonidine" post="analgesia for intractable cancer pain Pain 1995 61 3"/>
   <result pre="Eisenach JC Hood DD Curry R Intrathecal, but not intravenous," exact="clonidine" post="reduces experimental thermal or capsaicin-induced pain and hyperalgesia in"/>
   <result pre="K Mu opioid receptor-dependent and independent components in effects of" exact="tramadol" post="Neuropharmacology 2006 51 3 651 658 16793069 268 Raffa"/>
   <result pre="W Flores CM et al. Mechanistic and functional differentiation of" exact="tapentadol" post="and tramadol Expert Opinion on Pharmacotherapy 2012 13 10"/>
   <result pre="CM et al. Mechanistic and functional differentiation of tapentadol and" exact="tramadol" post="Expert Opinion on Pharmacotherapy 2012 13 10 1437 1449"/>
   <result pre="al. Complementary and synergistic antinociceptive interaction between the enantiomers of" exact="tramadol" post="Journal of Pharmacology and Experimental Therapeutics 1993 267 1"/>
   <result pre="340 342 20219399 275 Pierce DM Shipstone E Pharmacology update:" exact="tapentadol" post="for neuropathic pain The American Journal of Hospice &amp;amp;"/>
   <result pre="483 490 15712623 279 Smith T Nicholson RA Review of" exact="duloxetine" post="in the management of diabetic peripheral neuropathic pain Vascular"/>
   <result pre="CS Choy EH Chandran A Zlateva G The cost-effectiveness of" exact="pregabalin" post="in the treatment of fibromyalgia: US perspective Journal of"/>
   <result pre="312 Le Bars D Chitour D Kraus E Effect of" exact="naloxone" post="upon diffuse noxious inhibitory controls (DNIC) in the rat"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3892961/results/search/drugs/results.xml">
   <result pre="the acute symptoms. Prophylactic treatment is usually carried out with" exact="cyproheptadine" post="(age ≤5 years) or amitriptyline (age &amp;gt;5 years). Some"/>
   <result pre="is usually carried out with cyproheptadine (age ≤5 years) or" exact="amitriptyline" post="(age &amp;gt;5 years). Some patients may benefit from flunarizine,"/>
   <result pre="antiemetic medication, like ondansetron, antimigrainous drugs, α-blocking agents such as" exact="dexmedetomidine" post="or clonidine, proton-pump inhibitors, or sedatives are applied. 5"/>
   <result pre="in episodes of CVS. 43 In patients with intractable vomiting," exact="valproate" post="or phenobarbital may be helpful as a prophylaxis of"/>
   <result pre="of CVS. 43 In patients with intractable vomiting, valproate or" exact="phenobarbital" post="may be helpful as a prophylaxis of vomiting. 43"/>
   <result pre="12884425 38 Erturk O Uluduz D Karaali-Savrun F Efficacy of" exact="nebivolol" post="and amitriptyline in the prophylaxis of cyclic vomiting syndrome:"/>
   <result pre="Erturk O Uluduz D Karaali-Savrun F Efficacy of nebivolol and" exact="amitriptyline" post="in the prophylaxis of cyclic vomiting syndrome: a case"/>
   <result pre="Effective prophylactic therapy for cyclic vomiting syndrome in children using" exact="valproate" post="Brain Dev 2009 31 6 411 413 18752910 44"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3916334/results/search/drugs/results.xml">
   <result pre="Trinka E , Ladurner G ( 1999) The effect of" exact="lidocaine" post="on chronic tinnitus: a quantitative cerebral perfusion study. Audiology"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3920463/results/search/drugs/results.xml">
   <result pre="to music. Also, listening to music has been related to" exact="dopamine" post="release from the caudate and the nucleus accumbens (Salimpoor"/>
   <result pre="caudate and the nucleus accumbens (Salimpoor et al., 2011), and" exact="dopamine" post="itself is know to have a role in central"/>
   <result pre="and Bushnell, 2009). Reward mechanisms in analgesia are related to" exact="dopamine" post="and opioid release. Reappraisal and expectation of pain relief"/>
   <result pre="are strongly present in music and possibly activating the mesocorticolimbic" exact="dopamine" post="pathway involved in reward and pleasure (Pereira et al.,"/>
   <result pre="K. Dagher A. Zatorre R. J. ( 2011). Anatomically distinct" exact="dopamine" post="release during anticipation and experience of peak emotion to"/>
   <result pre="10.1002/art.1780330203 2306288 Wood P. B. ( 2008). Role of central" exact="dopamine" post="in pain and analgesia. Expert Rev. Neurother. 8, 781–"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC3996073/results/search/drugs/results.xml">
   <result pre="most frequently with migraine headache (94%) and treated with prescribed" exact="ibuprofen" post="(57%) and/or nortriptyline (17%). Table 3 shows the breakdown"/>
   <result pre="migraine headache (94%) and treated with prescribed ibuprofen (57%) and/or" exact="nortriptyline" post="(17%). Table 3 shows the breakdown of these values"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4010966/results/search/drugs/results.xml">
   <result pre="communication with regard to EMF sensitivity is the messenger molecule" exact="nitric oxide" post="(NO). NO diffuses freely and rapidly across cell membranes,"/>
   <result pre="don't you understand? Some answers to the cardinal questions in" exact="nitric oxide" post="biology . J Biol Chem. 2010 6 25; 285("/>
   <result pre="WR Vernon J Garthwaite J Exquisite sensitivity to subsecond, picomolar" exact="nitric oxide" post="transients conferred on cells by guanylyl cyclase-coupled receptors ."/>
   <result pre="(PEF) increases human chondrocyte proliferation through a transduction pathway involving" exact="nitric oxide" post="signaling . J Orthop Res. 2008 6; 26( 6):"/>
   <result pre="Koo TW Cho YH Chung SM Enhanced expression of neuronal" exact="nitric oxide" post="synthase and phospholipase C-gamma1 in regenerating murine neuronal cells"/>
   <result pre="M Extremely low frequency electromagnetic fields modulate expression of inducible" exact="nitric oxide" post="synthase, endothelial nitric oxide synthase and cyclooxygenase-2 in the"/>
   <result pre="electromagnetic fields modulate expression of inducible nitric oxide synthase, endothelial" exact="nitric oxide" post="synthase and cyclooxygenase-2 in the human keratinocyte cell line"/>
   <result pre="316– 25 21664476 137. Pilla AA Electromagnetic fields instantaneously modulate" exact="nitric oxide" post="signaling in challenged biological systems . Biochem Biophys Res"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4061890/results/search/drugs/results.xml">
   <result pre="treatment of this syndrome has been reported by use of" exact="aripiprazole" post="presumably as its use as a partial agonist of"/>
   <result pre="aripiprazole presumably as its use as a partial agonist of" exact="dopamine" post="D 2 receptors in the olfactory bulb [ 91]."/>
   <result pre="induction. Gustatory and olfactory hallucinations have occurred after treatment with" exact="bupropion" post="[ 100]. Phantosmia without associated seizure induction has also"/>
   <result pre="seizure activity [ 114, 115, 116] and after treatment with" exact="rasagiline" post="[ 117]. Olfactory hallucinations without associated seizure activity have"/>
   <result pre="resection of the olfactory bulbs [ 120] by use of" exact="venlafaxine" post="[ 121] or by use of topiramate [ 122]."/>
   <result pre="by use of venlafaxine [ 121] or by use of" exact="topiramate" post="[ 122]. One group of investigators reported that what"/>
   <result pre="of these drugs although one patient reported temporary relief from" exact="phenobarbital" post="treatment. Some patients went to otolaryngologists. Thirteen (32.5%) were"/>
   <result pre="inhibition with daily smoking of THC (v.s.). Two patients received" exact="thioridazine" post="with one noting diminution in phantosmia intensity after the"/>
   <result pre="metabolic enzymes [ 205, 228, 229] mediated by induction of" exact="dopamine" post="uptake inhibition [ 230, 231] or through complex chemical"/>
   <result pre="232]. Other drugs, which activate CNS GABA (e.g., baclofen, vigabatrin," exact="gabapentin" post="[ 234, 235, 236, 237, 238]) inhibited dystonic movements"/>
   <result pre="in factor VIII concentration attributed to an increase in circulating" exact="epinephrine" post="[ 254]. Perhaps some aspect of changes in CSF"/>
   <result pre="during pregnancy or immediately postpartum suggesting a role for estrogen," exact="progesterone" post="and/or prolactin. In at least 72% of women suffering"/>
   <result pre="exacerbated seizures related, in part, to withdrawal of allopregnanolone, a" exact="progesterone" post="metabolite, which acts as an endogenous anticonvulsant neurocorticosteroid that"/>
   <result pre="GABA concentration [ 370], Estrogen also acts to release neuronal" exact="epinephrine" post="and nonepinepherine [ 371, 372] although GABA may suppress"/>
   <result pre="and nonepinepherine [ 371, 372] although GABA may suppress CNS" exact="norepinephrine" post="release [ 371]. Pregnenolone modulates GABA and GABA A"/>
   <result pre="effects similar to GABA [ 418] including increasing attenuation of" exact="dopamine" post="turnover after haloperidol [ 419] and stereospecifically increased in"/>
   <result pre="GABA [ 418] including increasing attenuation of dopamine turnover after" exact="haloperidol" post="[ 419] and stereospecifically increased in vivo 3H-flunitrazepan binding"/>
   <result pre="observation levo-, but not dextro-mantradol enhanced potency and efficacy of" exact="diazepam" post="blockade of pentylenetetrazol induced seizures [ 417]. Chronic injections"/>
   <result pre="453], inhibited phantosmia in one patient with CUP. Indeed, both" exact="thioridazine" post="and haloperidol, neuroleptics that enhance GABAergic CNS activity ["/>
   <result pre="S. Gambini O. An olfactory reference syndrome successfully treated by" exact="aripiprazole" post="augmentation of antidepressant therapy Cogn. Behav. Neurol. 2008 21"/>
   <result pre="Kawohl W. Gustatory and olfactory hallucinations under therapeutic dosing of" exact="bupropion" post="J. Neuropsychiatry Clin. Neurosci. 2011 23 E53 10.1176/appi.neuropsych.23.2.E53 21677231"/>
   <result pre="B.N. Croy I. Haehner A. Long lasting phantosmia treated with" exact="venlafaxine" post="Neurocase 2012 18 112 114 10.1080/13554794.2011.568497 21942993 122. Johnson"/>
   <result pre="J. Bourgeois J.A. Quanbeck C. Treatment of olfactory hallucinations with" exact="topiramate" post="J. Clin. Psychopharmacol. 2006 26 340 341 10.1097/01.jcp.0000218406.10362.27 16702906"/>
   <result pre="227 5857747 150. Hauptman B. Glick I.D. Auditory hallucinations with" exact="imipramine" post="J. Hillside Hosp. 1968 17 32 34 151. Gordon"/>
   <result pre="phantoms by functional magnetic resonance imaging (fMRI) by treatment with" exact="valproic acid" post="and thioridazine J. Invest. Med. 1997 45 238A 157."/>
   <result pre="magnetic resonance imaging (fMRI) by treatment with valproic acid and" exact="thioridazine" post="J. Invest. Med. 1997 45 238A 157. Henkin R.I."/>
   <result pre="277 283 10.1016/S0892-0362(98)00058-0 10386831 198. Gale K. Chronic blockade of" exact="dopamine" post="receptors by antischizophrenic drugs enhances GABA binding in substantia"/>
   <result pre="inhibits the effects of cocaine on locomotor activity and extracellular" exact="dopamine" post="in the nucleus accumbens shell without tolerance liability J."/>
   <result pre="Tedeschi D. Russo N.B. et al. ABAergic attenuation of cocaine-induced" exact="dopamine" post="release and locomotor activity Synapse 1997 25 393 398"/>
   <result pre="increases in brain GABA levels on cocaine-induced changes in extracellular" exact="dopamine" post="Synapse 1998 28 60 65 10.1002/(SICI)1098-2396(199801)28:1&amp;lt;60::AID-SYN7&amp;gt;3.0.CO;2-A 9414018 225. Shoaib"/>
   <result pre="L.S. Beyer C.E. Goldberg S.R. Schindler C.W. The GABAB agonist" exact="baclofen" post="modifies cocaine self-administration in rats Behav. Pharmacol. 1998 9"/>
   <result pre="Duc D.O. Meier D. Leenders K.L. Boesiger P. Effects of" exact="vigabatrin" post="intake on brain GABA activity as monitored by spectrally"/>
   <result pre="Siebner H.R. Dressmandt J. Auer C. Conrad B. Continuous tracheal" exact="baclofen" post="infusions induced a marked increase of the transcranially evoked"/>
   <result pre="Jr. Hyder F. Shevell M. Rothman D.L. GABA changes with" exact="vigabatrin" post="in the developing human brain Epilepsia 1999 40 462"/>
   <result pre="R.H. Human brain GABA levels rise rapidly after initiation of" exact="vigabatrin" post="therapy Neurology 1996 47 1567 1571 10.1212/WNL.47.6.1567 8960747 354."/>
   <result pre="Herbison A.E. Direct regulation of postnatal GnRH neurons by the" exact="progesterone" post="derivative allopregnanolone in the mouse Endocrinology 2001 142 4448"/>
   <result pre="495 370. Wallis C.J. Luttge W.G. Influence of estrogen and" exact="progesterone" post="on glutamic acid decarboxylase activity in discrete regions of"/>
   <result pre="Wuttke W. Involvement of GABA in the feedback action of" exact="estradiol" post="on gonadotropin and prolactin release: Hypothalamic GABA and catecholamine"/>
   <result pre="T. Epileptic seizures in women related to plasma estrogen and" exact="progesterone" post="during the menstrual cycle Acta Neurol. Scand. 1976 54"/>
   <result pre="Phenothiazine drugs: Structure-activity relationships explained by a conformation that mimics" exact="dopamine" post="Proc. Natl. Acad. Sci. USA 1975 72 1899 1903"/>
   <result pre="C.M. Pesquero S.M. Turchetti-Maia R.M. Francischi J.N. Tatsuo M.A. Acute" exact="phenobarbital" post="administration induces hyperalgesia: Pharmacological evidence for the involvement of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4074975/results/search/drugs/results.xml">
   <result pre="114 Zöger S Svedlund J Holgers K The effects of" exact="sertraline" post="on severe tinnitus suffering: a randomized, double-blind, placebo-controlled study"/>
   <result pre="43 46 16514262 118 Bauer CA Brozoski TJ Effect of" exact="gabapentin" post="on the sensation and impact of tinnitus Laryngoscope 2006"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4158257/results/search/drugs/results.xml">
   <result pre="epileptic seizures and nervous disorders until the 1912 discovery of" exact="phenobarbital" post="[ 110]. In 1912, Hauptmann (1881–1948), a German physician,"/>
   <result pre="[ 110]. In 1912, Hauptmann (1881–1948), a German physician, introduced" exact="phenobarbital" post="in the therapy of epilepsy, one of the first"/>
   <result pre="The next drug introduced in the therapy of epilepsy was" exact="phenytoin" post="in 1938. Although phenytoin was already known from 1908"/>
   <result pre="in the therapy of epilepsy was phenytoin in 1938. Although" exact="phenytoin" post="was already known from 1908 and was synthesized by"/>
   <result pre="with Putnam (1894–1975), discovered, in 1938, the anticonvulsant properties of" exact="phenytoin" post="(Dilantin) and its effect on the control of epileptic"/>
   <result pre="116]. During the 1950s, new drugs came up such as" exact="carbamazepine" post="in 1953 [ 117], primidone in 1954, ethosuximide in"/>
   <result pre="drugs came up such as carbamazepine in 1953 [ 117]," exact="primidone" post="in 1954, ethosuximide in 1958 by Vossen [ 118],"/>
   <result pre="such as carbamazepine in 1953 [ 117], primidone in 1954," exact="ethosuximide" post="in 1958 by Vossen [ 118], sodium valproate in"/>
   <result pre="in 1954, ethosuximide in 1958 by Vossen [ 118], sodium" exact="valproate" post="in 1963 by Meunier et al. [ 119], and"/>
   <result pre="of the antiepileptic drugs in the blood [ 120]. Although" exact="carbamazepine" post="and valproate were available in Europe during the 1960s,"/>
   <result pre="antiepileptic drugs in the blood [ 120]. Although carbamazepine and" exact="valproate" post="were available in Europe during the 1960s, no other"/>
   <result pre="other drug was licensed in the USA. The development of" exact="carbamazepine" post="was based on the neuroleptic drug chlorpromazine from Firma"/>
   <result pre="The development of carbamazepine was based on the neuroleptic drug" exact="chlorpromazine" post="from Firma Rhône-Poulenc in Lyon. Jean Pierre (1907–1987) and"/>
   <result pre="Jean Pierre (1907–1987) and Pierre Deniker (1917–1998), French psychiatrists, used" exact="chlorpromazine" post="in Centre Hospitalier Sainte Anne in Paris to treat"/>
   <result pre="schizophrenia. However, research on neuroleptic drugs continued in Geigy labs;" exact="carbamazepine" post="was synthesized by Schindler and Blattner (1921-?) at J."/>
   <result pre="1953, in the course of development of another antidepressant drug" exact="imipramine" post="[ 117]. Initial animal screening showed that carbamazepine was"/>
   <result pre="antidepressant drug imipramine [ 117]. Initial animal screening showed that" exact="carbamazepine" post="was effective against trigeminal neuralgia, which was confirmed by"/>
   <result pre="1950s for the therapy of absence &quot;petit mal.&quot; In 1967," exact="valproate" post="came up as a new promising antiepileptic drug. Valproate"/>
   <result pre="employed as an organic solvent [ 125]; his research on" exact="valproate" post="begun in Würzburg, Germany. The anticonvulsant properties of valproate"/>
   <result pre="on valproate begun in Würzburg, Germany. The anticonvulsant properties of" exact="valproate" post="were reported by Pierre Eymard, who worked at Firma"/>
   <result pre="[ 128]. Other antiepileptic drugs introduced during the 1970s were" exact="clobazam" post="(1,5-benzodiazepine) (1970), clonazepam (1,4-benzodiazepine) (1970), and piracetam. The last"/>
   <result pre="antiepileptic drugs introduced during the 1970s were clobazam (1,5-benzodiazepine) (1970)," exact="clonazepam" post="(1,4-benzodiazepine) (1970), and piracetam. The last decade newer antiepileptic"/>
   <result pre="and piracetam. The last decade newer antiepileptic drugs such as" exact="vigabatrin" post="(1989), lamotrigine (1990), oxcarbazepine (1990), gabapentin (1993), felbamate (1993),"/>
   <result pre="The last decade newer antiepileptic drugs such as vigabatrin (1989)," exact="lamotrigine" post="(1990), oxcarbazepine (1990), gabapentin (1993), felbamate (1993), topiramate (1995),"/>
   <result pre="decade newer antiepileptic drugs such as vigabatrin (1989), lamotrigine (1990)," exact="oxcarbazepine" post="(1990), gabapentin (1993), felbamate (1993), topiramate (1995), tiagabine (1998),"/>
   <result pre="antiepileptic drugs such as vigabatrin (1989), lamotrigine (1990), oxcarbazepine (1990)," exact="gabapentin" post="(1993), felbamate (1993), topiramate (1995), tiagabine (1998), zonisamide (1989"/>
   <result pre="such as vigabatrin (1989), lamotrigine (1990), oxcarbazepine (1990), gabapentin (1993)," exact="felbamate" post="(1993), topiramate (1995), tiagabine (1998), zonisamide (1989 in Japan"/>
   <result pre="vigabatrin (1989), lamotrigine (1990), oxcarbazepine (1990), gabapentin (1993), felbamate (1993)," exact="topiramate" post="(1995), tiagabine (1998), zonisamide (1989 in Japan and 2000"/>
   <result pre="lamotrigine (1990), oxcarbazepine (1990), gabapentin (1993), felbamate (1993), topiramate (1995)," exact="tiagabine" post="(1998), zonisamide (1989 in Japan and 2000 in the"/>
   <result pre="oxcarbazepine (1990), gabapentin (1993), felbamate (1993), topiramate (1995), tiagabine (1998)," exact="zonisamide" post="(1989 in Japan and 2000 in the USA), levetiracetam"/>
   <result pre="(1998), zonisamide (1989 in Japan and 2000 in the USA)," exact="levetiracetam" post="(2000), stiripentol (2002), pregabalin (2004), rufinamide (2004), lacosamide (2008),"/>
   <result pre="(1989 in Japan and 2000 in the USA), levetiracetam (2000)," exact="stiripentol" post="(2002), pregabalin (2004), rufinamide (2004), lacosamide (2008), eslicarbazepine (2009),"/>
   <result pre="Japan and 2000 in the USA), levetiracetam (2000), stiripentol (2002)," exact="pregabalin" post="(2004), rufinamide (2004), lacosamide (2008), eslicarbazepine (2009), and perampanel"/>
   <result pre="2000 in the USA), levetiracetam (2000), stiripentol (2002), pregabalin (2004)," exact="rufinamide" post="(2004), lacosamide (2008), eslicarbazepine (2009), and perampanel (2012) were"/>
   <result pre="the USA), levetiracetam (2000), stiripentol (2002), pregabalin (2004), rufinamide (2004)," exact="lacosamide" post="(2008), eslicarbazepine (2009), and perampanel (2012) were used. FDA"/>
   <result pre="(2002), pregabalin (2004), rufinamide (2004), lacosamide (2008), eslicarbazepine (2009), and" exact="perampanel" post="(2012) were used. FDA ended clinical use of felbamate"/>
   <result pre="and perampanel (2012) were used. FDA ended clinical use of" exact="felbamate" post="in 1994 due to its association with complications. The"/>
   <result pre="gabapentin, lamotrigine, tiagabine, topiramate, levetiracetam, oxcarbazepine, zonisamide, pregabalin, rufinamide, and" exact="lacosamide" post="have improved tolerability and safety compared to their older"/>
   <result pre="to their older counterparts. Stiripentol, pregabalin, rufinamide, lacosamide, eslicarbazepine, and" exact="perampanel" post="are licensed for adjunctive use only. The research in"/>
   <result pre="120 Buchtal F Svensmark O Aspects of the pharmacology of" exact="phenytoin" post="(dilantin) and phenobarbital relevant to their dosage in the"/>
   <result pre="Svensmark O Aspects of the pharmacology of phenytoin (dilantin) and" exact="phenobarbital" post="relevant to their dosage in the treatment of epilepsy"/>
   <result pre="124 Fertig EJ Mattson RH Engel J Pedley TA Mattson:" exact="carbamazepine" post="Epilepsy: A Comprehensive Textbook 2007 Philadelphia, Pa, USA Lippincott"/>
   <result pre="H Gil-Nagel A et al. Efficacy and safety of adjunctive" exact="ezogabine" post="(retigabine) in refractory partial epilepsy Neurology 2010 75 20"/>
   <result pre="Nohria V Safety and tolerability of different titration rates of" exact="retigabine" post="(ezogabine) in patients with partial-onset seizures Epilepsy Research 2013"/>
   <result pre="Brodie MJ Leroy R et al. Safety and efficacy of" exact="ezogabine" post="(retigabine) in adults with refractory partial-onset seizures: interim results"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4160640/results/search/drugs/results.xml">
   <result pre="work is properly cited. Abstract We have previously shown that" exact="adenosine" post="amine congener (ADAC), a selective A 1 adenosine receptor"/>
   <result pre="shown that adenosine amine congener (ADAC), a selective A 1" exact="adenosine" post="receptor agonist, can ameliorate noise- and cisplatin-induced cochlear injury."/>
   <result pre="that boost residual hearing functionality. We and others have identified" exact="adenosine" post="receptors as one of the most promising targets for"/>
   <result pre="substance released from tissues in response to stress. Acting on" exact="adenosine" post="receptors (AR), adenosine augments antioxidant defences, increases oxygen supply,"/>
   <result pre="tissues in response to stress. Acting on adenosine receptors (AR)," exact="adenosine" post="augments antioxidant defences, increases oxygen supply, improves blood flow,"/>
   <result pre="and promotes antiapoptotic pathways [ 4– 6]. Neuroprotective actions of" exact="adenosine" post="receptors in CNS disorders such as stroke, epilepsy, migraine,"/>
   <result pre="disorders have been well documented [ 7– 9]. Four distinct" exact="adenosine" post="receptor subtypes have been characterised and designated as A"/>
   <result pre="currently being investigated in clinical trials [ 11]. All four" exact="adenosine" post="receptors are expressed in the mammalian cochlea and they"/>
   <result pre="cells, supporting Deiters' cells and spiral ganglion neurons, express multiple" exact="adenosine" post="receptors [ 12]. The sources of extracellular adenosine in"/>
   <result pre="express multiple adenosine receptors [ 12]. The sources of extracellular" exact="adenosine" post="in cochlear fluids include active transport from the intracellular"/>
   <result pre="include active transport from the intracellular compartment by nucleoside transporters," exact="adenosine" post="release from damaged cells, and extracellular ATP hydrolysis ["/>
   <result pre="cells, and extracellular ATP hydrolysis [ 13, 14]. Adenosine activates" exact="adenosine" post="receptors on target cells in a paracrine or autocrine"/>
   <result pre="in a paracrine or autocrine fashion, whilst the clearance of" exact="adenosine" post="from the extracellular space is provided by nucleoside transporters"/>
   <result pre="[ 14]. Previous studies have shown that prophylactic treatment with" exact="adenosine" post="receptor agonists mitigates hearing loss from noise [ 15,"/>
   <result pre="loss from noise [ 15, 16] and the anticancer drug" exact="cisplatin" post="[ 17]. We have shown that the local or"/>
   <result pre="that the local or systemic administration of selective A 1" exact="adenosine" post="receptor (A 1R) agonists, such as 2-chloro- N 6-cyclopentyladenosine"/>
   <result pre="(A 1R) agonists, such as 2-chloro- N 6-cyclopentyladenosine (CCPA) and" exact="adenosine" post="amine congener (ADAC), can ameliorate cochlear injury and hearing"/>
   <result pre="animals. After completion of manipulations, animals were euthanised using sodium" exact="pentobarbital" post="(100 mg/kg, i.p.) and cochlear tissues collected for histology. 2.2."/>
   <result pre="after noise exposure. Rats were anaesthetised with a mixture of" exact="ketamine" post="(90 mg/kg) and xylazine (10 mg/kg) intraperitoneally and then placed onto"/>
   <result pre="Administration Male Wistar rats (8 weeks old) were anaesthetised with" exact="ketamine" post="(90 mg/kg i.p.) plus xylazine (10 mg/kg i.p.) and the femoral"/>
   <result pre="to treat cochlear injury postexposure. We have previously shown that" exact="adenosine" post="receptor agonists provide an effective postexposure treatment of acoustic"/>
   <result pre="67 5 1385 1387 15703375 7 Cunha RA Neuroprotection by" exact="adenosine" post="in the brain: from A 1 receptor activation to"/>
   <result pre="Pharmacology 2009 193 535 587 10 Jacobson KA Introduction to" exact="adenosine" post="receptors as therapeutic targets Handbook of Experimental Pharmacology 2009"/>
   <result pre="of basic and clinical pharmacology. LXXXI. Nomenclature and classification of" exact="adenosine" post="receptors—an update Pharmacological Reviews 2011 63 1 1 34"/>
   <result pre="S Wang CJH Housley GD Thorne PR Differential distribution of" exact="adenosine" post="receptors in rat cochlea Cell and Tissue Research 2007"/>
   <result pre="Wang CJH Housley GD Vlajkovic SM Nucleoside transporter expression and" exact="adenosine" post="uptake in the rat cochlea NeuroReport 2007 18 3"/>
   <result pre="Ramkumar V Jones B Tsukasaki N Rybak LP Protection against" exact="cisplatin" post="ototoxicity by adenosine agonists Biochemical Pharmacology 2004 67 9"/>
   <result pre="B Tsukasaki N Rybak LP Protection against cisplatin ototoxicity by" exact="adenosine" post="agonists Biochemical Pharmacology 2004 67 9 1801 1807 15081879"/>
   <result pre="GD Thorne PR Vlajkovic SM Post exposure administration of A1" exact="adenosine" post="receptor agonists attenuates noise-induced hearing loss Hearing Research 2010"/>
   <result pre="DKJE Lin RC Paul IA et al. Postischemic administration of" exact="adenosine" post="amine congener (ADAC): analysis of recovery in gerbils European"/>
   <result pre="RC Bischofberger N et al. Protection against ischemic damage by" exact="adenosine" post="amine congener, a potent and selective adenosine A 1"/>
   <result pre="ischemic damage by adenosine amine congener, a potent and selective" exact="adenosine" post="A 1 receptor agonist European Journal of Pharmacology 1999"/>
   <result pre="KA Daly JW Purine functionalized congeners as molecular probes for" exact="adenosine" post="receptors Nucleosides and Nucleotides 1991 10 5 1029 1038"/>
   <result pre="D Galas M D'Alcantara P Bantubungi K Schiffmann SN The" exact="adenosine" post="A1 receptor agonist adenosine amine congener exerts a neuroprotective"/>
   <result pre="P Bantubungi K Schiffmann SN The adenosine A1 receptor agonist" exact="adenosine" post="amine congener exerts a neuroprotective effect against the development"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4247377/results/search/drugs/results.xml">
   <result pre="(FCD). Patients had a positive response to low doses of" exact="carbamazepine" post="or oxcarbazepine, showing a consistent reduction of seizure frequency."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4330892/results/search/drugs/results.xml">
   <result pre="et al. ( 56) found that the intravenously applied anesthetic" exact="etomidate" post="significantly increased both LFP amplitude and slope of the"/>
   <result pre="the animals reached this state, multi-unit recordings were obtained under" exact="ketamine" post="anesthesia from AI contralateral to the kindled site. The"/>
   <result pre="JW . Investigation into the effect of the general anaesthetic" exact="etomidate" post="on local neuronal synchrony in the mouse neocortical slice"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4391049/results/search/drugs/results.xml">
   <result pre="609 doi: 10.1007/s11832-014-0609-9 : Original Clinical Article Long-term follow-up of" exact="thalidomide" post="embryopathy: malformations and development of osteoarthritis in the lower"/>
   <result pre="children with multiple malformations were born after maternal intake of" exact="thalidomide" post="during pregnancy, known as thalidomide embryopathy (TE). Objectives The"/>
   <result pre="born after maternal intake of thalidomide during pregnancy, known as" exact="thalidomide" post="embryopathy (TE). Objectives The aim of this study was"/>
   <result pre="many countries worldwide [ 1– 3]. Due to its teratogenicity," exact="thalidomide" post="was withdrawn from the market in November 1961. The"/>
   <result pre="substances in medical history&quot; [ 5]. Routine screening tests of" exact="thalidomide" post="on rodents found the substance to be non-toxic; therefore,"/>
   <result pre="found the substance to be non-toxic; therefore, the teratogenicity of" exact="thalidomide" post="in humans was not anticipated [ 6]. Serious birth"/>
   <result pre="and visceral defects, have also been observed in patients with" exact="thalidomide" post="embryopathy (TE) [ 3, 10, 15]. Autism spectrum disorders"/>
   <result pre="have malformations in multiple organ systems. Although the teratogenicity of" exact="thalidomide" post="in humans has been well documented [ 18], thalidomide"/>
   <result pre="of thalidomide in humans has been well documented [ 18]," exact="thalidomide" post="was remarketed after 1965 in several countries, mostly for"/>
   <result pre="(Table 1). Table 1 Description of the five individuals with" exact="thalidomide" post="embryopathy (TE) who had proximal femoral focal deficiency (PFFD)"/>
   <result pre="(Table 2). Table 2 Description of the 26 individuals with" exact="thalidomide" post="embryopathy (TE) that did not show any signs of"/>
   <result pre="(OA) in the lower extremities in the 26 individuals with" exact="thalidomide" post="embryopathy (TE) but without proximal femoral focal deficiency (PFFD)"/>
   <result pre="evaluated function of the lower extremities in 31 individuals with" exact="thalidomide" post="embryopathy (TE) N All Occurrence of PFFD No ("/>
   <result pre="evaluated function of the upper extremities in 31 individuals with" exact="thalidomide" post="embryopathy (TE) N All Anatomical pincer grasp Functional grip"/>
   <result pre="accepted the invitation to participate. The tragic circumstances surrounding the" exact="thalidomide" post="disaster and the apparent anomalies with sometimes lack of"/>
   <result pre="60 5 306 321 10.1002/(SICI)1096-9926(199911)60:5&amp;lt;306::AID-TERA11&amp;gt;3.0.CO;2-Y 10525208 5. Newman CG The" exact="thalidomide" post="syndrome: risks of exposure and spectrum of malformations Clin"/>
   <result pre="RL Holmes LB Clinical and basic science lessons from the" exact="thalidomide" post="tragedy: what have we learned about the causes of"/>
   <result pre="Knobloch J Rüther U Shedding light on an old mystery:" exact="thalidomide" post="suppresses survival pathways to induce limb defects Cell Cycle"/>
   <result pre="the shoulder joints in distal ectromelia in the scope of" exact="thalidomide" post="embryopathy Z Orthop Ihre Grenzgeb 1974 112 4 1003"/>
   <result pre="Nordin V Miller M Akerström B Gillberg C Autism in" exact="thalidomide" post="embryopathy: a population study Dev Med Child Neurol 1994"/>
   <result pre="and oral function in an adult group of subjects with" exact="thalidomide" post="embryopathy—a clinical and questionnaire study Acta Odontol Scand 2008"/>
   <result pre="E Schwartz IV Waldman C Castilla EE New cases of" exact="thalidomide" post="embryopathy in Brazil Birth Defects Res A Clin Mol"/>
   <result pre="EE Schüler-Faccini L Epidemiological surveillance of birth defects compatible with" exact="thalidomide" post="embryopathy in Brazil PLoS One 2011 6 7 e21735"/>
   <result pre="21. Sjögreen L Kiliaridis S Facial palsy in individuals with" exact="thalidomide" post="embryopathy: frequency and characteristics J Laryngol Otol 2012 126"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4422459/results/search/drugs/results.xml">
   <result pre="cystitis, painful bladder syndrome Irritable bowel syndrome Joint pains Low" exact="testosterone" post="or hypogonadism (with normal test results) Lupus (self-diagnosed) Lyme"/>
   <result pre="2, B 6, B 12 Paresthesias, burning mouth Vitamin C," exact="ascorbic acid" post="Burning mouth Vitamin D Pain Folate Burning mouth Ferritin"/>
   <result pre="exercise therapy, and cognitive behavioral therapy ( Table 5). Serotonin" exact="norepinephrine" post="reuptake inhibitors (duloxetine, milnacipran), gabapentinoids (pregabalin, gabapentin), and γ-hydroxybutyrate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4449495/results/search/drugs/results.xml">
   <result pre="Syndrome, Parkinson’s. VMAT2 Antidepressant treatment outcome, Parkinson’s, ADHD, cocaine and" exact="methamphetamine" post="dependence, spirituality&quot;GOD Gene&quot;. CLOCK Circadian system, mood, bipolar, endocrine"/>
   <result pre="of the most important neuro-transmitters that involved in mood are" exact="dopamine" post="and serotonin. Positive mood and negative mood mediated by"/>
   <result pre="dopamine and serotonin. Positive mood and negative mood mediated by" exact="dopamine" post="and serotonin levels. Perhaps the most influential neurochemical theory"/>
   <result pre="associated with (but not necessarily caused by) increased levels of" exact="dopamine" post="in the brain and (ii) some of the changes"/>
   <result pre="cognition observed in positive mood are due to the increased" exact="dopamine" post="levels associated with positive mood. In contrast, Ashby et"/>
   <result pre="might predict that negative mood is simply associated with lower" exact="dopamine" post="levels ( 22). Another neurochemical agent that associated with"/>
   <result pre="with the level of happiness. Antidepressants such as the selective" exact="norepinephrine" post="reuptake inhibitor (Reboxetine) also induce a positive emotional perceptual"/>
   <result pre="a positive emotional perceptual bias in healthy subjects suggesting that" exact="norepinephrine" post="positively colors the emotional perception of facial expressions in"/>
   <result pre="the emotional perception of facial expressions in humans. &quot;Recognition that" exact="norepinephrine" post="regulates neuronal excitability in the basolateral amygdale by facilitation"/>
   <result pre="then decrease in the morning ( 26). Studies showed that" exact="melatonin" post="level is related to happiness level. Melatonin has a"/>
   <result pre="a role in depression and some of antidepressants increase the" exact="melatonin" post="in blood ( 26). Since each neurotransmitter coded by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4462041/results/search/drugs/results.xml">
   <result pre="of NPS, such as synthetic cannabinoids, synthetic cathinones, phenylethylamines, piperazines," exact="ketamine" post="derivatives and tryptamines. Tryptamines are naturally occurring compounds, which"/>
   <result pre="naturally occurring compounds, which can derive from the amino acid" exact="tryptophan" post="by several biosynthetic pathways: their structure is a combination"/>
   <result pre="addition of a 2-carbon side chain. Tryptamines include serotonin and" exact="melatonin" post="as well as other compounds known for their hallucinogenic"/>
   <result pre="following psychoactive drug categories: synthetic cannabinoids, synthetic cathinones, phenylethylamines, piperazines," exact="ketamine" post="derivatives and tryptamines. Tryptamines are a group of monoamine"/>
   <result pre="an alpha carbon methyl group, a characteristic in common with" exact="amphetamine" post="[ 14, 18]. The synthesis and the effects of"/>
   <result pre="originally synthesized from a fungus ergot, among which is the" exact="lysergic acid diethylamide" post="(LSD). Fantegrossi divided tryptamines in three subgroups: (1) simple"/>
   <result pre="[ 21]. AMT activity is linked with the release of" exact="dopamine" post="and its re-uptake inhibition. AMT also acts on serotonin"/>
   <result pre="2012) compared to tryptamine or 5-methoxy-diallyltryptamine (5-MeO-DALT) [ 25]. Also" exact="alpha-ethyltryptamine" post="(AET) was firstly introduced as an antidepressant agent by"/>
   <result pre="mammals. The biosynthesis of DMT begins with the decarboxylation of" exact="tryptophan" post="that leads to the production of tryptamine. Further, tryptamine"/>
   <result pre="possess affinity for the α 1 and α 2-adrenergic receptors," exact="dopamine" post="D 1, and sigma-1 (σ 1). The psychedelic activity"/>
   <result pre="blocks the serotonin uptake and it has little interaction with" exact="dopamine" post="or norepinephrine transporters [ 16]. Effective dosage, orally administered,"/>
   <result pre="serotonin uptake and it has little interaction with dopamine or" exact="norepinephrine" post="transporters [ 16]. Effective dosage, orally administered, ranges from"/>
   <result pre="Moreover, it did not show effect on dopamine, serotonin and" exact="norepinephrine" post="re-uptake and presented a slight monoamine-releasing activity [ 16]."/>
   <result pre="5-MeO-DiPT, suppressed the re-uptake of 5-HT and the re-uptake of" exact="dopamine" post="and norepinephrine. It showed little dopamine, 5-HT or norepinephrine"/>
   <result pre="of dopamine and norepinephrine. It showed little dopamine, 5-HT or" exact="norepinephrine" post="releasing activity [ 61]. 5-MeO-MiPT can be smoked or"/>
   <result pre="normal, and the patient was immediately sedated with 6 mg" exact="lorazepam" post="administrating by intramuscular route. Routine laboratory tests were normal,"/>
   <result pre="agitation and tachycardia (200 bpm). Clinicians administered 3 mg of" exact="lorazepam" post="to resolve the state of agitation. Toxicological analysis did"/>
   <result pre="5-MeO-DiPT. Symptoms were resolved within two hours after administration of" exact="lorazepam" post="[ 87]. Meatherall described a 21-year-old man who arrived"/>
   <result pre="the most common drugs of abuse (phencyclidine, benzodiazepines, cocaine metabolites," exact="amphetamine" post="and methamphetamine, cannabinoids, opiates, barbiturates, and tricyclic antidepressants). He"/>
   <result pre="marked tachycardia (180–200 bpm) and tachypnea was observed. Benzodiazepines and" exact="haloperidol" post="were administered in order to try to manage the"/>
   <result pre="Johnson M.P Nichols D.E Reduction in brain serotonin markers by" exact="alpha-ethyltryptamine" post="(Monase) Eur. J. Pharmacol 1991 200 1 187 190"/>
   <result pre="detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and" exact="yohimbine" post="in human urine and plasma using standard urine screening"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4574220/results/search/drugs/results.xml">
   <result pre="Hassler for example showed that a certain androgynous level of" exact="testosterone" post="is characteristic of musicians, and that differences between musicians"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4591427/results/search/drugs/results.xml">
   <result pre="Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: a comparison with" exact="methylphenidate" post=". Appl. Psychophysiol. Biofeedback 28, 1– 12. 10.1023/A:1022353731579 12737092"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4603896/results/search/drugs/results.xml">
   <result pre="was prescribed: ranitidine, aspirin, furosemide, simvastatin, levothyroxine, zopiclone, ramipril, sodium" exact="valproate" post="as Epilim ®. On the second use of the"/>
   <result pre="Alzheimer’s disease was prescribed mirtazapine, lactulose, senna, diazepam, aspirin, omeprazole," exact="folic acid," post="alendronic acid, vitamin D supplements as Calcichew D3 forte"/>
   <result pre="was prescribed mirtazapine, lactulose, senna, diazepam, aspirin, omeprazole, folic acid," exact="alendronic acid," post="vitamin D supplements as Calcichew D3 forte ®, simvastatin,"/>
   <result pre="vitamin D supplements as Calcichew D3 forte ®, simvastatin, and" exact="risperidone" post="as needed. Initial monitoring (Step 4) indicated several problems"/>
   <result pre="the Profile this increased to 9/41, and ranged from transdermal" exact="fentanyl" post="to liquid paracetamol. Use of the Profile increased pain-related"/>
   <result pre="syringing; nausea (P12), which resolved when the daily dose of" exact="lactulose" post="was divided; difficulties with urination which triggered a prescription"/>
   <result pre="was divided; difficulties with urination which triggered a prescription for" exact="tamsulosin" post="(P33); identification of gastro-intestinal ulceration (P20, Table 7). c."/>
   <result pre="following opticians’ input, combined with reduction of medicines such as" exact="diazepam" post="and antipsychotics, which are associated with dizziness, falls and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4620514/results/search/drugs/results.xml">
   <result pre="MD Pasternak SH Mitchell DG et al. The effects of" exact="oxytocin" post="on social cognition and behaviour in frontotemporal dementia. Brain"/>
   <result pre="association with pain networks in irritable bowel patients assessed via" exact="lidocaine" post="treatment . J Pain 2013; 14: 1077– 87. 23743257"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4654784/results/search/drugs/results.xml">
   <result pre="put forth, including local inflammatory responses, cytoskeletal remodeling, release of" exact="adenosine" post="(antinociceptive effects), neuromodulation, endogenous opioid production, and alteration of"/>
   <result pre="al. Entamoeba histolytica and Trichomonas vaginalis: trophozoite growth inhibition by" exact="metronidazole" post="electro-transferred water . Exp Parasitol. 2011; 127( 1): 80–"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4702057/results/search/drugs/results.xml">
   <result pre="respective treatment effectiveness is limited. In CRSwNP the application of" exact="doxycycline" post="over 3 weeks leads to a little reduction of"/>
   <result pre="[ 33]. Patients with CRSsNP and low IgE who received" exact="roxithromycin" post="observed a minimal reduction of their symptoms [ 34]."/>
   <result pre="tablets at disposition. The following pharmaceuticals have been applied: e.g." exact="prednisolone" post="50 mg for 14 days, methyl-prednisolone 32-16-8 mg for"/>
   <result pre="for 14 days, methyl-prednisolone 32-16-8 mg for 1 week each," exact="prednisolone" post="25-12.5 mg for 1 week each and 12.5 mg"/>
   <result pre="and adrenaline are similarly effective [ 109]. Injections with 0.25%" exact="bupivacaine" post="with adrenaline 1:200,000 neither reduce intraoperative blood loss nor"/>
   <result pre="Appropriate choice of anesthesia. Today TIVA (total intravenous anesthesia with" exact="propofol" post="and remifentanil) is the preferred type and at least"/>
   <result pre="[96]. Specific additional drugs commonly used are beta blockers like" exact="esmolol" post="[ 112], [ 115] or clonidine [ 116], ["/>
   <result pre="are beta blockers like esmolol [ 112], [ 115] or" exact="clonidine" post="[ 116], [ 117], [ 118]. Use of a"/>
   <result pre="evidence for effectiveness. Usually 30–50 mg (up to 1 mg/kg)" exact="prednisolone" post="are given for 5–7 days [ 139]. The arguments"/>
   <result pre="it can be omitted in routine cases. The application of" exact="tranexamic acid," post="systemic or topical, leads to reduced bleeding by 30–40%"/>
   <result pre="thrombo-embolic events are more frequent or not after application of" exact="tranexamic acid." post="As systemic application, a dosage of 1 g per"/>
   <result pre="effective in all in-vitro and in-vivo studies is a chitosan" exact="dextran" post="gel [ 282], [ 485], [ 486], [ 487]."/>
   <result pre="An increased pressure can also be reduced by application of" exact="acetazolamide" post="[ 764]. If autologous mucosal transplantations are performed, a"/>
   <result pre="symptoms for at least 6 months ([ 139]; 30 mg" exact="prednisolone" post="for 5 days preoperatively until 9 days postoperatively). Alternatively,"/>
   <result pre="healing as well as working as microbicide in combination with" exact="tranexamic acid" post="[ 1402]. In summary there are reasonable indications for"/>
   <result pre="of the frontal sinus neo-ostium [ 1405]. The application of" exact="doxycycline" post="releasing stents was effective as well [ 1412]. Both"/>
   <result pre="in an animal model and was able to release incorporated" exact="dexamethasone" post="over 15 days or to eradicate bacteria in the"/>
   <result pre="Available from: http://dx.doi.org/10.2500/ajra.2013.27.3976 24274224 48 Smith TL Sautter NB Is" exact="montelukast" post="indicated for treatment of chronic rhinosinusitis with polyposis? Laryngoscope"/>
   <result pre="Orlandi RR Warrier S Sato S Han JK Concentrated topical" exact="epinephrine" post="is safe in endoscopic sinus surgery Am J Rhinol"/>
   <result pre="RK Hoy E Roberson DW Nielsen D Errors with concentrated" exact="epinephrine" post="in otolaryngology Laryngoscope 11 2008 118 11 1928 1930"/>
   <result pre="Available from: http://dx.doi.org/10.1111/pan.12192 23679077 108 Thrush DN Cardiac arrest after" exact="oxymetazoline" post="nasal spray J Clin Anesth 9 1995 7 6"/>
   <result pre="Genoway K Yunker WK Effect of intraoperative injection of 0.25%" exact="bupivacaine" post="with 1:200,000 epinephrine on intraoperative blood loss in FESS"/>
   <result pre="WK Effect of intraoperative injection of 0.25% bupivacaine with 1:200,000" exact="epinephrine" post="on intraoperative blood loss in FESS Am J Rhinol"/>
   <result pre="111 Boonmak S Boonmak P Laopaiboon M Deliberate hypotension with" exact="propofol" post="under anaesthesia for functional endoscopic sinus surgery (FESS) Cochrane"/>
   <result pre="Kusza K Cywinski JB Burduk PK Kazmierczak W Premedication with" exact="clonidine" post="before TIVA optimizes surgical field visualization and shortens duration"/>
   <result pre="23943734 118 Mohseni M Ebneshahidi A The effect of oral" exact="clonidine" post="premedication on blood loss and the quality of the"/>
   <result pre="144 Elhakim M Siam A Rashed I Hamdy MH Topical" exact="tenoxicam" post="from pharyngeal pack reduces postoperative sore throat Acta Anaesthesiol"/>
   <result pre="150 Ker K Beecher D Roberts I Topical application of" exact="tranexamic acid" post="for the reduction of bleeding Cochrane Database Syst Rev"/>
   <result pre="I Systematic review, meta-analysis and meta-regression of the effect of" exact="tranexamic acid" post="on surgical blood loss Br J Surg 9 2013"/>
   <result pre="Pundir V Pundir J Georgalas C Fokkens WJ Role of" exact="tranexamic acid" post="in endoscopic sinus surgery - a systematic review and"/>
   <result pre="of the maxillary sinus ostium on the nasal and sinus" exact="nitric oxide" post="levels Am J Rhinol Sep-Oct 2002 16 5 261"/>
   <result pre="PS Sacks R Marcells GN Cohen NA Harvey RJ Nasal" exact="nitric oxide" post="and sinonasal disease: a systematic review of published evidence"/>
   <result pre="492 Chaudhry AL Chaaban MR Ranganath NK Woodworth BA Topical" exact="triamcinolone" post="acetonide/carboxymethylcellulose foam for acute exacerbations of chronic rhinosinusitis/nasal polyposis"/>
   <result pre="M Nejat F Ketabchi E Esmaeeli B Prophylactic administration of" exact="ceftriaxone" post="for the prevention of meningitis after traumatic pneumocephalus: results"/>
   <result pre="Blumenthal H Webster CJ Richardson MS Ames M Efficacy of" exact="sumatriptan" post="tablets in migraineurs self-described or physician-diagnosed as having sinus"/>
   <result pre="ME Borish LO Han JK Borish LC Pilot study of" exact="budesonide" post="inhalant suspension irrigations for chronic eosinophilic sinusitis J Allergy"/>
   <result pre="19932850 1356 Bhalla RK Payton K Wright ED Safety of" exact="budesonide" post="in saline sinonasal irrigations in the management of chronic"/>
   <result pre="MA Thawley SE Vlahiotis A The effect of nasally administered" exact="budesonide" post="respules on adrenal cortex function in patients with chronic"/>
   <result pre="serum and urinary cortisol levels of topical intranasal irrigations with" exact="budesonide" post="added to saline in patients with recurrent polyposis after"/>
   <result pre="Feldman RM Orlander PR Citardi MJ The effect of intranasal" exact="fluticasone" post="propionate irrigations on salivary cortisol, intraocular pressure, and posterior"/>
   <result pre="Psaltis A Foreman A Wormald PJ A randomized trial of" exact="mupirocin" post="sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic"/>
   <result pre="http://dx.doi.org/10.1002/lary.23486 22865576 1368 Jervis-Bardy J Wormald PJ Microbiological outcomes following" exact="mupirocin" post="nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following"/>
   <result pre="1369 Uren B Psaltis A Wormald PJ Nasal lavage with" exact="mupirocin" post="for the treatment of surgically recalcitrant chronic rhinosinusitis Laryngoscope"/>
   <result pre="Available from: http://dx.doi.org/10.1128/AAC.05463-11 22024824 1402 Bartley J Should chitosan and" exact="tranexamic acid" post="be combined for improved hemostasis after sinus surgery? Med"/>
   <result pre="D Palmer JN Chiu AG Cohen NA Chitosan glycerophosphate-based semirigid" exact="dexamethasone" post="eluting biodegradable stent Am J Rhinol Allergy Jan-Feb 2009"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4810374/results/search/drugs/results.xml">
   <result pre="[TNF]-α), leptin (which also acts as pro-inflammatory peptide) 8, and" exact="somatostatin" post="(which down-modulates a number of immune functions, such as"/>
   <result pre="stress induces inflammatory activity involving IL-6 33, TNF-α 34, and" exact="somatostatin" post="35; (3) beyond these HPA, sympathetic, and inflammatory parameters,"/>
   <result pre="Serum levels of cortisol, ACTH, interleukin-6 (IL-6), noradrenalin (NA), leptin," exact="somatostatin" post="(SIH), and TNF-α were measured at six time points:"/>
   <result pre="L. A. The diurnal variation of immunoreactive thyrotropin-releasing hormone and" exact="somatostatin" post="in the cerebrospinal fluid of the rhesus monkey ."/>
   <result pre="2007). 17869482 Ward M. M. et al. . Epinephrine and" exact="norepinephrine" post="responses in continuously collected human plasma to a series"/>
   <result pre="Polinsky R. J. &amp;amp; Kopin I. J. Relationship between plasma" exact="norepinephrine" post="and sympathetic neural activity. Hypertension 5, 552– 559 ("/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4817427/results/search/drugs/results.xml">
   <result pre="6 am CTR day, an ICU nurse administered 1 gr" exact="acetaminophen" post="intravenously to all study subjects. Cold packs were kept"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4892319/results/search/drugs/results.xml">
   <result pre="Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: A comparison with" exact="methylphenidate" post=". Applied Psychophysiol Biofeedback, 28( 1), 1– 12. Gevensleben"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4928147/results/search/drugs/results.xml">
   <result pre="de la Fuente-Fernandez and Stoessl, 2002) showed release of endogenous" exact="dopamine" post="in the striatum following the administration of placebo. No"/>
   <result pre="following the administration of placebo. No relationship was found between" exact="dopamine" post="activity in the nucleus accumbens and placebo effect on"/>
   <result pre="the nucleus accumbens and placebo effect on motor function, suggesting" exact="dopamine" post="release was indeed related to the expectation of reward."/>
   <result pre="Robinson T. E. ( 1998). What is the role of" exact="dopamine" post="in reward: hedonic impact, reward learning, or incentive salience?"/>
   <result pre="25649275 de la Fuente-Fernandez R. ( 2009). The placebo-reward hypothesis:" exact="dopamine" post="and the placebo effect. Parkinsonism. Relat. Disord. 15(Suppl. 3),"/>
   <result pre="Calne D. B. Stoessl A. J. ( 2001). Expectation and" exact="dopamine" post="release: mechanism of the placebo effect in Parkinson’s disease."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4928724/results/search/drugs/results.xml">
   <result pre="Olness K. MacDonald J.T. Uden D.L. Comparison of self-hypnosis and" exact="propranolol" post="in the treatment of juvenile classic migraine Pediatrics 1987"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC4940890/results/search/drugs/results.xml">
   <result pre="sweets. Attempted interventions by her family and a trial of" exact="fluoxetine" post="were unsuccessful in controlling the behaviors. Discussion These patients"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5046013/results/search/drugs/results.xml">
   <result pre="normalized in an enriched environment [ 127]. Fetal exposure to" exact="valproic acid" post="increases the expression of ASD symptoms in humans, and"/>
   <result pre="has similar effects in rats [ 128]. Animals exposed to" exact="valproic acid" post="in fetal life have a suppressed pain response, increased"/>
   <result pre="of ASD. In another example of gene x environment interaction," exact="valproic acid" post="has been given to pregnant women for the treatment"/>
   <result pre="[ 170]. Recall that when fetal rats are exposed to" exact="valproic acid," post="they develop autism-like symptoms that are greatly ameliorated by"/>
   <result pre="decreased, depending on environmental experiences. Decreased sensory stimulation, along with" exact="valproic acid" post="exposure, increases the expression of ASD symptoms and increased"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5114030/results/search/drugs/results.xml">
   <result pre="Because FLT4 is an LEC-specific promoter, activation of Cre with" exact="tamoxifen" post="results in knockout of PTEN, an intracellular inhibitor of"/>
   <result pre="implantable, sustained-release nanoparticle formulation of a known angiogenic small molecule," exact="deferoxamine" post="(DFO) that obviates the need for serial injections of"/>
   <result pre="analysis after 3 weeks. Given its known effects on tendon," exact="ciprofloxacin" post="was used to treat mesenchymal cells in vitro followed"/>
   <result pre="and osteogenic differentiation assays. Finally, mice treated with control or" exact="ciprofloxacin" post="(10 mg/kg) received burn/tenotomy followed by micro-computed tomography after"/>
   <result pre="decrease in osteogenic differentiation (C). Treatment of burn/tenotomy mice with" exact="ciprofloxacin" post="significantly reduced HO after 9 weeks (8.50 v 3.67"/>
   <result pre="PGF2α analog, tafluprost, was investigated in this study. METHODS: Topical" exact="tafluprost" post="was applied once daily on either telogen skin or"/>
   <result pre="± 0.7) than control (day 42). In depilation-induced anagen mice," exact="tafluprost" post="elongated early anagen phase, but did not elongate mid-late"/>
   <result pre="cultured human dermal papilla cells (hDPCs) was not affected by" exact="tafluprost" post="in BrdU incorporation analysis. Chick chorioallantoic membrane assay showed"/>
   <result pre="cells (LECs) in LM tissues relative to control tissues, whereas" exact="propranolol" post="inhibits proliferation of LM-derived LECs. We hypothesized that LECs"/>
   <result pre="for podoplanin (LEC marker) and Ki67 (proliferative marker). To assess" exact="propranolol" post="effects on LEC gene expression, LM-derived LECs were treated"/>
   <result pre="effects on LEC gene expression, LM-derived LECs were treated with" exact="propranolol" post="or vehicle for 48 hours and quantitative reverse transcription"/>
   <result pre="Matrigel were implanted in nude mice; half were treated with" exact="propranolol" post="or vehicle (n = 4) for 5 weeks. Sections"/>
   <result pre="podoplanin, LYVE1, VEGFR-2, and VEGFR-3. In the in vivo model," exact="propranolol" post="reduced lymphatic vessel density and dilation. CONCLUSIONS: We demonstrate"/>
   <result pre="contribute to abnormal vessel dilation and dysfunction. In LM patients," exact="propranolol" post="may reduce abnormal LEC proliferation and increase LEC differentiation"/>
   <result pre="and BMP2. Finally, burn/tenotomy mice were depleted of macrophages with" exact="clodronate" post="and killed at 3 weeks to evaluate cartilage formation."/>
   <result pre="TGF-β by 93.87% ± 2.19% (B). Depletion of macrophages using" exact="clodronate" post="reduced cartilage presence. CONCLUSIONS: Cartilage formation in HO is"/>
   <result pre="aim of this study was to investigate the efficacy of" exact="belatacept" post="to reduce the requirement for conventional immunosuppression such as"/>
   <result pre="total body and 300 cGy thymic irradiation pretransplant. RESULTS: High-dose" exact="tacrolimus" post="led to maintenance of VCA in 3 of 3"/>
   <result pre="bone marrow can be achieved with our conditioning regimen of" exact="belatacept" post="and peritransplant tacrolimus without the requirement for myeloablative conditioning."/>
   <result pre="be achieved with our conditioning regimen of belatacept and peritransplant" exact="tacrolimus" post="without the requirement for myeloablative conditioning. 38 Oxygen Tension"/>
   <result pre="RESULTS: Long-term allograft survival (&amp;gt;120 days) was successfully achieved with" exact="cyclosporine" post="A (10 mg/kg/day). Animals in the control group did"/>
   <result pre="(6.4-fold, P &amp;lt; 0.0001), interleukin-10 (1.4-fold, P &amp;lt; 0.05), inducible" exact="nitric oxide" post="synthase (2.1-fold, P &amp;lt; 0.0001), PGE2 (1.7-fold, P &amp;lt;"/>
   <result pre="an isotype control. IFN-γ-primed MSCs packaged greater quantities of inducible" exact="nitric oxide" post="synthase and transforming growth factor-β compared with normoxic and"/>
   <result pre="the rats were killed. Plasma was collected for nicotine and" exact="cotinine" post="analysis, and flap tissues were harvested for histopathological and"/>
   <result pre="were created (n = 8) that included application of topical" exact="minoxidil" post="and iloprost for various durations beginning 2 weeks before"/>
   <result pre="(n = 8) that included application of topical minoxidil and" exact="iloprost" post="for various durations beginning 2 weeks before flap elevation."/>
   <result pre="were analyzed. RESULTS: Pharmacologic delay with preoperative application of topical" exact="minoxidil" post="or iloprost was found to have equivalent flap viability"/>
   <result pre="RESULTS: Pharmacologic delay with preoperative application of topical minoxidil or" exact="iloprost" post="was found to have equivalent flap viability when compared"/>
   <result pre="using immunohistochemistry. RESULTS: After 6 hours, 100 and 1000 μg/mL" exact="minocycline" post="decreased bacteria in wound tissue to 3.5 ± 0.87"/>
   <result pre="in control wounds ( P &amp;lt; 0.001). After 2 hours," exact="minocycline" post="reduced inflammatory cytokines IL-1β, IL-6, and tumor necrosis factor-α"/>
   <result pre="after 1 hour ( P &amp;lt; 0.05). In noninfected wounds," exact="minocycline" post="significantly reduced IL-1β, IL-6, and inflammatory cell counts after"/>
   <result pre="decreased after 1-hour treatment ( P &amp;lt; 0.05). CONCLUSIONS: Topical" exact="minocycline" post="rapidly decontaminates infected wounds while significantly reducing local inflammation."/>
   <result pre="infected wounds while significantly reducing local inflammation. The ability of" exact="minocycline" post="to reduce inflammation exists even independent of its antibacterial"/>
   <result pre="C3H/HeJ female mice were injected intradermally on the back with" exact="bleomycin" post="(100 μg/d) for 3 weeks. Immediately after bleomycin, some"/>
   <result pre="reduction in dermal thickness with minimal collagen deposition compared with" exact="bleomycin" post="alone. CONCLUSIONS: Our study confirms ROS trigger bleomycin-induced dermal"/>
   <result pre="and significantly decreased perilymphatic accumulation of inflammatory cells and inducible" exact="nitric oxide" post="synthase expression, compared with sedentary obese mice. In addition,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5203901/results/search/drugs/results.xml">
   <result pre="risk of adverse events than opioids alone. Conclusions. Ibuprofen and" exact="acetaminophen" post="have similar reported adverse effects and notably less adverse"/>
   <result pre="[ 14, 20– 24]. With the FDA boxed warning regarding" exact="codeine" post="use in children post-ENT surgery [ 23] as well"/>
   <result pre="European Medicines Agency and Health Canada's advisory to avoid all" exact="codeine" post="use in children less than 12 years of age"/>
   <result pre="age [ 24, 25], clinicians have reduced their use of" exact="codeine" post="and now search for a suitable alternative oral opioid."/>
   <result pre="cumulatively more GI AEs than all other analgesics. NSAIDS and" exact="acetaminophen" post="reported less than 10% rate of GI AEs. Opioid/nonopioid"/>
   <result pre="morphine demonstrated the highest reported risk of nausea, followed by" exact="acetaminophen" post="with codeine combination medication. Placebo-related AEs of nausea and"/>
   <result pre="the highest reported risk of nausea, followed by acetaminophen with" exact="codeine" post="combination medication. Placebo-related AEs of nausea and vomiting were"/>
   <result pre="drowsiness/tiredness being noted in close to one-third of children receiving" exact="oxycodone" post="or oral morphine and half of children receiving codeine."/>
   <result pre="demonstrated a greater risk of dermatologic symptoms. Children receiving only" exact="codeine" post="had almost double the risk of experiencing dermatologic manifestations"/>
   <result pre="receiving a NSAID experienced bronchospasm. 4. Registry Data We requested" exact="acetaminophen" post="data from the U.S. Food and Drug Administration (FDA)"/>
   <result pre="PDF comprising 7,523 pages with 17,806 reports of AEs for" exact="acetaminophen" post="for all ages (i.e., adults and children). The team"/>
   <result pre="no further description was provided. Respiratory distress was plausible with" exact="codeine" post="use. Case  4 was a 3-month-old, 4 kg child who was"/>
   <result pre="of children use at least one medication [ 77], with" exact="acetaminophen" post="and ibuprofen being the most common. There is an"/>
   <result pre="use at least one medication [ 77], with acetaminophen and" exact="ibuprofen" post="being the most common. There is an alarming paucity"/>
   <result pre="for children in the outpatient setting has demonstrated that (1)" exact="acetaminophen" post="and ibuprofen have similar risk of nausea and vomiting,"/>
   <result pre="in the outpatient setting has demonstrated that (1) acetaminophen and" exact="ibuprofen" post="have similar risk of nausea and vomiting, (2) opioids"/>
   <result pre="painful conditions, are consistent with previous work that has examined" exact="acetaminophen" post="and ibuprofen in the context of its antipyretic use."/>
   <result pre="are consistent with previous work that has examined acetaminophen and" exact="ibuprofen" post="in the context of its antipyretic use. A large"/>
   <result pre="its antipyretic use. A large randomized controlled trial (RCT) of" exact="ibuprofen" post="and acetaminophen in outpatient practice showed the risk of"/>
   <result pre="use. A large randomized controlled trial (RCT) of ibuprofen and" exact="acetaminophen" post="in outpatient practice showed the risk of hospitalization for"/>
   <result pre="failure, or anaphylaxis was not increased following short-term use of" exact="ibuprofen" post="[ 78]. A notable limitation of their study was"/>
   <result pre="large RCT of febrile infants (&amp;lt;2 years of age) receiving" exact="acetaminophen" post="or ibuprofen demonstrated a 1.4% risk of serious AEs"/>
   <result pre="of febrile infants (&amp;lt;2 years of age) receiving acetaminophen or" exact="ibuprofen" post="demonstrated a 1.4% risk of serious AEs (defined as"/>
   <result pre="bronchiolitis, and vomiting/gastritis) [ 79]. A 2004 systematic review of" exact="acetaminophen" post="and ibuprofen, consisting of 3 pain studies and 14"/>
   <result pre="14 fever studies in children, concluded that single doses of" exact="ibuprofen" post="and acetaminophen had similar safety profiles, when assessing &quot;major&quot;"/>
   <result pre="studies in children, concluded that single doses of ibuprofen and" exact="acetaminophen" post="had similar safety profiles, when assessing &quot;major&quot; (e.g., abdominal"/>
   <result pre="effects were of concern for a specific child. Limiting short-term" exact="ibuprofen" post="use due to concern for GI AEs is not"/>
   <result pre="of the symptoms (e.g., nausea, agitation). Oxycodone, oral morphine, and" exact="codeine" post="monotherapy had the greatest risk of CNS side effects,"/>
   <result pre="drowsiness/tiredness being noted in close to one-third of children receiving" exact="oxycodone" post="or oral morphine and half of children receiving codeine."/>
   <result pre="sense, as opioids have CNS depressant effects which NSAIDS and" exact="acetaminophen" post="lack. A child who needs to avoid CNS symptoms"/>
   <result pre="school-aged child, during daytime hours) should likely be treated with" exact="ibuprofen" post="or acetaminophen for mild-moderate pain, as they have a"/>
   <result pre="during daytime hours) should likely be treated with ibuprofen or" exact="acetaminophen" post="for mild-moderate pain, as they have a lower AE"/>
   <result pre="analgesic agent [ 19, 27, 66]. Current evidence suggests that" exact="ibuprofen" post="likely has superior analgesic potency for many clinical conditions"/>
   <result pre="AE profile is comparable to acetaminophen, one would likely choose" exact="ibuprofen" post="as first line therapy for most such pediatric acute"/>
   <result pre="oral opioids, dual therapy (with a nonopioid medication, such as" exact="ibuprofen" post="or acetaminophen) appears to &quot;protect&quot; the child against many"/>
   <result pre="can occur with their use [ 86]. Children receiving only" exact="codeine" post="had almost double the risk of experiencing dermatologic manifestations"/>
   <result pre="and combination therapies overlapped significantly, with the notable exception of" exact="codeine" post="monotherapy; children receiving only codeine had almost double the"/>
   <result pre="with the notable exception of codeine monotherapy; children receiving only" exact="codeine" post="had almost double the risk of experiencing dermatologic manifestations."/>
   <result pre="studies receiving an NSAID experienced bronchospasm, a suggested risk for" exact="ibuprofen" post="in some medical literature pertaining to fever management ["/>
   <result pre="of this review, including other opioids. GI AEs associated with" exact="codeine" post="monotherapy are poorly tolerated by children and may result"/>
   <result pre="93] and other recommendations [ 24, 25, 94] to avoid" exact="codeine" post="use in children under 12 years of age, supports"/>
   <result pre="under 12 years of age, supports the general avoidance of" exact="codeine" post="use in opioid-naïve children, except in the exceptional circumstance"/>
   <result pre="exceptional circumstance of an older child who has previously received" exact="codeine" post="and tolerated it well. This study has also led"/>
   <result pre="sparse for NSAIDs other than ibuprofen. Results and conclusions regarding" exact="ibuprofen" post="should not be extrapolated to other NSAIDs that may"/>
   <result pre="a meaningful fashion. 7. Conclusion Based on the available evidence," exact="ibuprofen" post="and acetaminophen have similar reported adverse effects and notably"/>
   <result pre="fashion. 7. Conclusion Based on the available evidence, ibuprofen and" exact="acetaminophen" post="have similar reported adverse effects and notably less adverse"/>
   <result pre="D. C. Kim M. K. A randomized clinical trial of" exact="ibuprofen" post="versus acetaminophen with codeine for acute pediatric arm fracture"/>
   <result pre="Kim M. K. A randomized clinical trial of ibuprofen versus" exact="acetaminophen" post="with codeine for acute pediatric arm fracture pain Annals"/>
   <result pre="K. A randomized clinical trial of ibuprofen versus acetaminophen with" exact="codeine" post="for acute pediatric arm fracture pain Annals of Emergency"/>
   <result pre="10.1111/j.1365-2125.2007.03064.x 18070216 16 Voelker R. Children's deaths linked with postsurgical" exact="codeine" post="JAMA—Journal of the American Medical Association 2012 308 10"/>
   <result pre="Passi B. A randomized, controlled trial of acetaminophen, ibuprofen, and" exact="codeine" post="for acute pain relief in children with musculoskeletal trauma"/>
   <result pre="Madadi P. Koren G. Cairns J. et al. Safety of" exact="codeine" post="during breastfeeding: fetal morphine poisoning in the breastfed neonate"/>
   <result pre="morphine poisoning in the breastfed neonate of a mother presecribed" exact="codeine" post="Canadian Family Physician 2007 53 1 33 35 17872605"/>
   <result pre="et al. Drug dosing error with drops—severe clinical course of" exact="codeine" post="intoxication in twins European Journal of Pediatrics 2009 168"/>
   <result pre="Silver Spring, Md, USA FDA 24 Health Canada's review recommends" exact="codeine" post="only be used in patients aged 12 and over,"/>
   <result pre="M. S. Bair E. Shinnick P. Messner A. Acetaminophen versus" exact="acetaminophen" post="with codeine after pediatric tonsillectomy Laryngoscope 2000 110 11"/>
   <result pre="Bair E. Shinnick P. Messner A. Acetaminophen versus acetaminophen with" exact="codeine" post="after pediatric tonsillectomy Laryngoscope 2000 110 11 1824 1827"/>
   <result pre="10.1097/00005537-200011000-00011 11081593 31 Manzano S. Doyon-Trottier E. Bailey B. Myth:" exact="ibuprofen" post="is superior to acetaminophen for the treatment of benign"/>
   <result pre="S. Doyon-Trottier E. Bailey B. Myth: ibuprofen is superior to" exact="acetaminophen" post="for the treatment of benign headaches in children and"/>
   <result pre="Herd D. W. Salehi B. Palatability of two forms of" exact="paracetamol" post="(acetaminophen) suspension: a randomised trial Paediatric and Perinatal Drug"/>
   <result pre="d'Athis P. et al. Randomized, double-blind, multicenter, controlled trial of" exact="ibuprofen" post="versus acetaminophen (paracetamol) and placebo for treatment of symptoms"/>
   <result pre="et al. Randomized, double-blind, multicenter, controlled trial of ibuprofen versus" exact="acetaminophen" post="(paracetamol) and placebo for treatment of symptoms of tonsillitis"/>
   <result pre="P. et al. A randomized, double-blind, multicentre controlled trial of" exact="ibuprofen" post="versus acetaminophen and placebo for symptoms of acute otitis"/>
   <result pre="al. A randomized, double-blind, multicentre controlled trial of ibuprofen versus" exact="acetaminophen" post="and placebo for symptoms of acute otitis media in"/>
   <result pre="Lobisch M. Acute treatment of episodic childhood tension-type headache with" exact="flupirtine" post="and paracetamol—a double-blind crossover-study Schmerz 2000 14 1 1"/>
   <result pre="Naccarella C. Tozzi E. Fiumana E. Fanaro S. Nimesulide and" exact="acetaminophen" post="for the treatment of juvenile migraine: a study for"/>
   <result pre="Lewis D. W. Kellstein D. Dahl G. et al. Children's" exact="ibuprofen" post="suspension for the acute treatment of pediatric migraine Headache"/>
   <result pre="Seabrook J. A. Matsui D. Rieder M. J. Naproxen versus" exact="acetaminophen" post="for therapy of soft tissue injuries to the ankle"/>
   <result pre="Schootman M. Kennedy R. M. Luhmann J. D. Oxycodone versus" exact="codeine" post="for triage pain in children with suspected forearm fracture:"/>
   <result pre="Jamone R. et al. A randomized, double-blind, placebo-controlled trial of" exact="paracetamol" post="and ketoprofren lysine salt for pain control in children"/>
   <result pre="C. et al. Treatment of childhood migraine attacks with oral" exact="zolmitriptan" post="and ibuprofen Neurology 2006 67 3 497 499 10.1212/01.wnl.0000231138.18629.d5"/>
   <result pre="al. Treatment of childhood migraine attacks with oral zolmitriptan and" exact="ibuprofen" post="Neurology 2006 67 3 497 499 10.1212/01.wnl.0000231138.18629.d5 16775229 72"/>
   <result pre="M. L. Hoppu K. Valkeila E. Santavuori P. Ibuprofen or" exact="acetaminophen" post="for the acute treatment of migraine in children: a"/>
   <result pre="74 Neri E. Maestro A. Minen F. et al. Sublingual" exact="ketorolac" post="versus sublingual tramadol for moderate to severe post-traumatic bone"/>
   <result pre="Maestro A. Minen F. et al. Sublingual ketorolac versus sublingual" exact="tramadol" post="for moderate to severe post-traumatic bone pain in children:"/>
   <result pre="G. Lin K. et al. Oral administration of morphine versus" exact="ibuprofen" post="to manage postfracture pain in children: a randomized trial"/>
   <result pre="79 Lesko S. M. Mitchell A. A. The safety of" exact="acetaminophen" post="and ibuprofen among children younger than two years old"/>
   <result pre="S. M. Mitchell A. A. The safety of acetaminophen and" exact="ibuprofen" post="among children younger than two years old Pediatrics 1999"/>
   <result pre="T. Goodenough B. Champion G. D. Efficacy and safety of" exact="acetaminophen" post="vs ibuprofen for treating children's pain or fever: a"/>
   <result pre="B. Champion G. D. Efficacy and safety of acetaminophen vs" exact="ibuprofen" post="for treating children's pain or fever: a meta-analysis Archives"/>
   <result pre="E. Sommer D. D. Ramakrishna J. et al. Morphine or" exact="ibuprofen" post="for post-tonsillectomy analgesia: a randomized trial Pediatrics 2015 135"/>
   <result pre="83 Gazal G. Mackie I. C. A comparison of paracetamol," exact="ibuprofen" post="or their combination for pain relief following extractions in"/>
   <result pre="18978006 93 FDA Drug Safety Communication: Safety review update of" exact="codeine" post="use in children; new Boxed Warning and Contraindication on"/>
   <result pre="vomiting, gastric pain No significant difference in number of AEs;" exact="acetaminophen" post="and ibuprofen are effective and well-tolerated for acute migraine,"/>
   <result pre="pain No significant difference in number of AEs; acetaminophen and" exact="ibuprofen" post="are effective and well-tolerated for acute migraine, with acetaminophen"/>
   <result pre="and ibuprofen are effective and well-tolerated for acute migraine, with" exact="acetaminophen" post="having faster onset but slightly less effect and ibuprofen"/>
   <result pre="with acetaminophen having faster onset but slightly less effect and" exact="ibuprofen" post="giving best relief Pothmann and Lobisch, 2000, Germany, NR"/>
   <result pre="Mild abdominal discomfort, nausea No significant difference in side effects;" exact="nimesulide" post="associated with low occurrence of ADRs especially in GI"/>
   <result pre="(ii) Placebo, n = 69 Nausea, vomiting, photophobia, phonophobia Children's" exact="ibuprofen" post="suspension (7.5 mg/kg) is effective and well-tolerated for pain relief"/>
   <result pre="being read to), n = 24  (iii) Standard care +" exact="ibuprofen" post="(10 mg/kg), n = 26 NR One child experienced nausea"/>
   <result pre="n = 26 NR One child experienced nausea after taking" exact="ibuprofen" post="Wille et al., 2005, France, NR Prospective cohort (single"/>
   <result pre="days of injury Patients ( n = 98) received ibuprofen," exact="acetaminophen" post="+ codeine, acetaminophen, other narcotics (hydrocodone, oxycodone, and rofecoxib),"/>
   <result pre="oxycodone, and rofecoxib), or a combination of ibuprofen, acetaminophen, and" exact="acetaminophen" post="+ codeine; 6 patients received no pain medication; 3"/>
   <result pre="from the medication AEs not reported by drug; those receiving" exact="acetaminophen" post="+ codeine appeared to experience more other effects. Physicians"/>
   <result pre="medication AEs not reported by drug; those receiving acetaminophen +" exact="codeine" post="appeared to experience more other effects. Physicians and caregivers"/>
   <result pre="serious AEs occurred; all AEs were mild and resolved completely;" exact="zolmitriptan" post="but not ibuprofen produced significantly more AEs than placebo"/>
   <result pre="all AEs were mild and resolved completely; zolmitriptan but not" exact="ibuprofen" post="produced significantly more AEs than placebo Clark et al.,"/>
   <result pre="of ankle (no history of gastric ulcers or allergy to" exact="acetaminophen" post="or naproxen) (i) Naproxen (20 mg/kg), n = 41  (ii)"/>
   <result pre="acetaminophen's wider safety margin and a large experience in children," exact="acetaminophen" post="may be the preferred agent for therapy of soft"/>
   <result pre="history of neck and back pain (i) Acetaminophen (500 mg) and" exact="ibuprofen" post="(200 mg), n = 1 NA Ibuprofen is generally safe"/>
   <result pre="22  (ii) Ibuprofen (10 mg/kg), n = 22  (iii) Oxycodone +" exact="ibuprofen" post="(0.1 mg/kg, 10 mg/kg), n = 22 NR Oxycodone or ibuprofen"/>
   <result pre="+ ibuprofen (0.1 mg/kg, 10 mg/kg), n = 22 NR Oxycodone or" exact="ibuprofen" post="monotherapy avoids the increase in AEs more than when"/>
   <result pre="dry mouth Minor AEs in both groups; itching less in" exact="oxycodone" post="group Drendel et al., 2009, USA, hospital foundation RCT"/>
   <result pre="radius, ulna, or humerus (no open fracture) (i) Acetaminophen +" exact="codeine" post="(120 mg/5 mg per 5 mL), n = 167  (ii) Ibuprofen (100 mg/5 mL),"/>
   <result pre="= 169 Nausea, vomiting, drowsy, dizzy, constipation, other Children receiving" exact="ibuprofen" post="had significantly fewer AEs; both children and parents were"/>
   <result pre="significantly higher rates of nausea and vomiting for children receiving" exact="acetaminophen" post="+ codeine Friday et al., 2009, USA, NR RCT"/>
   <result pre="rates of nausea and vomiting for children receiving acetaminophen +" exact="codeine" post="Friday et al., 2009, USA, NR RCT ED Isolated"/>
   <result pre="score ≥ 5 (of 10) at triage (i) Acetaminophen +" exact="codeine" post="(1 mg/kg, max 60 mg), n = 34  (ii) Ibuprofen (10 mg/kg,"/>
   <result pre="agitation, hypotension, and paresthesias were observed in association with a" exact="dopamine" post="receptor antagonist Ruperto et al., 2011, Italy, industry, research"/>
   <result pre="No significant differences in AEs; fewer side effects reported in" exact="ketorolac" post="group Poonai et al., 2014, Canada, university research grant"/>
   <result pre="information) Respiratory failure was reported 18 years Physician Tylenol and" exact="acetaminophen" post="plus codeine (both oral; no dosing information) None reported"/>
   <result pre="failure was reported 18 years Physician Tylenol and acetaminophen plus" exact="codeine" post="(both oral; no dosing information) None reported 4 years"/>
   <result pre="information) None reported 4 years Nonphysician health professional Acetaminophen plus" exact="codeine" post="(oral; no dosing information) Patient described as having a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5351793/results/search/drugs/results.xml">
   <result pre="AB. Network dynamics predict improvement in working memory performance following" exact="donepezil" post="administration in healthy young adults . NeuroImage 2013; 88C:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5368427/results/search/drugs/results.xml">
   <result pre="relate to parenting children exposed to ACEs. Parents in inner-city" exact="methadone" post="programs demonstrated reduced ratings on the Child Abuse Potential"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5406678/results/search/drugs/results.xml">
   <result pre="iPad at night to help her sleep. She occasionally took" exact="melatonin" post="to help her sleep. Her mom reported that she"/>
   <result pre="anxiety&quot; by psychiatrist after one visit and told to take" exact="sertraline" post="but she never started as her mother did not"/>
   <result pre="emergency room (ED) visit. He was started on short acting" exact="alprazolam" post="for acute panic attacks in ED. Was prescribed escitalopram"/>
   <result pre="acting alprazolam for acute panic attacks in ED. Was prescribed" exact="escitalopram" post="but did not take it because he &quot;(did not)"/>
   <result pre="significant for attention deficit disorder for which he was prescribed" exact="methylphenidate" post="for a few months but stopped two years prior."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5446455/results/search/drugs/results.xml">
   <result pre="2003 The effects of exercise and exercise-related changes in blood" exact="nitric oxide" post="level on migraine headache Clin Rehabil 17 624 12971707"/>
   <result pre="J Barbosa A 1982 Effects of frontalis EMG Biofeedback and" exact="diazepam" post="in treatment of tension headache Headache 22 216 220"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5456318/results/search/drugs/results.xml">
   <result pre="18718351 67 Lackner JR , Graybiel A . Use of" exact="promethazine" post="to hasten adaptation to provocative motion. J Clin Pharmacol."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5461882/results/search/drugs/results.xml">
   <result pre="relating to individual patient level analyses of trial data regarding" exact="tapentadol" post="in osteoarthritis and back pain (2015). He has received"/>
   <result pre="MT . The comorbidity of insomnia, chronic pain, and depression:" exact="dopamine" post="as a putative mechanism . Sleep Medicine Reviews 2013;"/>
   <result pre="relief and numbers needed to treat in a meta‐analysis of" exact="etoricoxib" post="osteoarthritis trials: bridging a gap between clinical trials and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5474682/results/search/drugs/results.xml">
   <result pre="or ferritin Vitamin B 12 and folate Vitamin D3, 25-hydroxy" exact="cholecalciferol" post="Celiac screening: tissue transglutaminase IgA and IgG, with serum"/>
   <result pre="listed in Table 7. For more severe problems, Zolpidem and" exact="trazodone" post="can be used with caution. Controlling pain (see Pain)"/>
   <result pre="medications might be needed. Over-the-counter medications such as aspirin, acetaminophen," exact="paracetamol" post="and NSAIDS are rarely effective for ME/CFS pain, but"/>
   <result pre="but NSAIDS can ameliorate dysmenorrhea. Topical treatment for pain includes" exact="lidocaine" post="patches. Some commonly used prescription pain medications and their"/>
   <result pre="Can cause weight loss Gabapentin 300–1,200 mg tid Adverse effects of" exact="topiramate" post="include suicidal feelings and cognitive problems with doses &amp;gt;50 mg"/>
   <result pre="caffeine-containing drinks. The use of prescribed stimulants such as low-dose" exact="methylphenidate" post="can benefit some patients; the patient should be warned"/>
   <result pre="nuts, and soy sauce. Avoid Increasing Catecholamines Epinephrine (Epi) and" exact="norepinephrine" post="(NE) levels are increased in those with OI and"/>
   <result pre="example, in those with asthma, beta-adrenergic agonists like albuterol and" exact="salbutamol" post="mimic the effects of Epi, and can contribute to"/>
   <result pre="contraindicated, we try to use inhaled glucocorticoids, sodium chromoglycate, or" exact="montelukast" post="for asthma control. Medications that promote vasodilation, such as"/>
   <result pre="Table 11. Some physicians recommend a low-dose beta blocker or" exact="midodrine" post="as the first-line agents. Alternatively an initial medication can"/>
   <result pre="blockers might be chosen for those with elevated supine HRs," exact="fludrocortisone" post="might be chosen if there is a low resting"/>
   <result pre="family history of ADHD, joint hypermobility. The optimum dosage of" exact="dextroamphetamine" post="is usually half the optimum dose of methylphenidate Dextroamphetamine"/>
   <result pre="dosage of dextroamphetamine is usually half the optimum dose of" exact="methylphenidate" post="Dextroamphetamine Sustained-release form: 5–10 mg q AM. Increase by 5–10 mg"/>
   <result pre="increased salt appetite. Add KCl 10 m Eq for every 0.1 mg" exact="fludrocortisone" post="to prevent hypokalemia Hormonal Contraceptives Medroxyprogesterone Most are fine."/>
   <result pre="that bring one menstrual period every 90 days. A long-acting injectable" exact="progesterone" post="can be considered. The mechanism by which hormones improve"/>
   <result pre="refractory to other therapies ( 128). In those with fibromyalgia," exact="duloxetine" post="(a SNRI) can be effective for pain, independent of"/>
   <result pre="membrane such as cromolyn, quercetin and the leukotriene receptor antagonists" exact="zafirlukast" post="and montelukast. Several detailed reviews of the clinical features,"/>
   <result pre="develop serious side effects (syncope) from the use of the" exact="epinephrine" post="(Epi)/(adrenalin) which is included with local anesthetic agents. In"/>
   <result pre="AM Godang K Muller F et al. Disease mechanisms and" exact="clonidine" post="treatment in adolescent chronic fatigue syndrome: a combined cross-sectional"/>
   <result pre="Randomized clinical trial to evaluate the efficacy and safety of" exact="valganciclovir" post="in a subset of patients with chronic fatigue syndrome"/>
   <result pre="et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody" exact="rituximab" post="in chronic fatigue syndrome. A double-blind and placebo-controlled study"/>
   <result pre="J Demitrack M Sharma G Deloria M et al. Low-dose" exact="hydrocortisone" post="for treatment of chronic fatigue syndrome: a randomized controlled"/>
   <result pre="D Persoons P van Houdenhove B Bobbaers H . Does" exact="methylphenidate" post="reduce the symptoms of chronic fatigue syndrome? Am J"/>
   <result pre="167.e23– 30. 10.1016/j.amjmed.2005.07.047 16443425 107 Young JL . Use of" exact="lisdexamfetamine" post="dimesylate in treatment of executive functioning deficits and chronic"/>
   <result pre="B Zachrisson O et al. Response to vitamin B12 and" exact="folic acid" post="in myalgic encephalomyelitis and fibromyalgia. PLoS One ( 2015)"/>
   <result pre="Samoil D Kosinski D Kip K Brewster P Use of" exact="sertraline" post="chloride in the treatment of refractory neurocardiogenic syncope in"/>
   <result pre="extra IV fluids in the perioperative period. Propofol, midazolam, and" exact="fentanyl" post="are generally well-tolerated. However, studies in adults have shown"/>
   <result pre="system and adrenal hormone responses lead to increased release of" exact="epinephrine" post="(Epi) and norepinephrine (NE). It is postulated that the"/>
   <result pre="hormone responses lead to increased release of epinephrine (Epi) and" exact="norepinephrine" post="(NE). It is postulated that the relative balance of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5486528/results/search/drugs/results.xml">
   <result pre="positive effect on regulation of circadian rhythm, temperature and nocturnal" exact="melatonin" post="secretion [ 23]. Furthermore, in a mice model of"/>
   <result pre="ZG Effects of electroacupuncture on circadian rhythm of temperature and" exact="melatonin" post="in depression rats model induced by chronic stress Zhongguo"/>
   <result pre="et al. Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose" exact="nifedipine" post="in humans. Clin Pharmacol Ther. 1998;63:54–63. 53. Fang L"/>
   <result pre="53. Fang L Turtschi S Mozaffarieh M The effect of" exact="nifedipine" post="on retinal venous pressure of glaucoma patients with the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5590362/results/search/drugs/results.xml">
   <result pre="the level of stress through the reduction of cortisol and" exact="norepinephrine" post="serum levels. Its primary effect is the improvement of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5626766/results/search/drugs/results.xml">
   <result pre="TS Winn HR Regulation of blood-brain barrier endothelial cells by" exact="nitric oxide" post="Circ Res. 1994 75 528 538 10.1161/01.RES.75.3.528 8062426 35."/>
   <result pre="53 58 39. Barbanti P et al. Increased density of" exact="dopamine" post="D5 receptor in peripheral blood lymphocytes of migraineurs: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5648334/results/search/drugs/results.xml">
   <result pre="activation of the locus coeruleus and raphe nuclei, which release" exact="norepinephrine" post="and serotonin, respectively, and have significant modulatory roles in"/>
   <result pre="2014). In studies using tVNS to modulate the GABA and" exact="norepinephrine" post="pathways, tVNS has been shown to increase reaction time"/>
   <result pre="Chmielewski W. Effects of concomitant stimulation of the GABAergic and" exact="norepinephrine" post="system on inhibitory control – a study using transcutaneous"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5654244/results/search/drugs/results.xml">
   <result pre="therapy. One case study [ 49] reported that diazide and" exact="methylprednisolone" post="improved unilateral hearing loss but did not diminish hyperacusis."/>
   <result pre="of dizziness and hyperacusis returned. The patient was prescribed bisphosphonate" exact="risedronate" post="and reported reduced complaints of symptoms and feeling best"/>
   <result pre="case study, Brookler [ 54] reported a patient prescribed metformin," exact="risedronate" post="(30 mg twice weekly), calcium, vitamin D, and sodium monofluorophosphate"/>
   <result pre="Alternating the regime with etidronate (400 mg/day for 2 weeks) and" exact="risedronate" post="(30 mg twice weekly for 4 weeks) did not improve"/>
   <result pre="weekly for 4 weeks) did not improve hyperacusis but increasing" exact="risedronate" post="intake to 30 mg twice weekly for 6 weeks and"/>
   <result pre="conditions in which the patient was unmedicated and medicated with" exact="fluvoxamine" post="(50 mg/day) and fluoxetine (20 mg/day), with improved LDLs above 100 dB"/>
   <result pre="the patient was unmedicated and medicated with fluvoxamine (50 mg/day) and" exact="fluoxetine" post="(20 mg/day), with improved LDLs above 100 dB in the medicated"/>
   <result pre="condition. Lee et al. [ 53] reported that antihypertensives and" exact="gabapentin" post="(600 mg/day) reduced the intensity of both tinnitus and hyperacusis"/>
   <result pre="al. [ 50] reported that although six weeks of intravenous" exact="ceftriaxone" post="led to a remission of &quot;all symptoms,&quot; excluding mild"/>
   <result pre="short-term lessening of hyperacusis symptoms but increased emotional lability. Following" exact="carbamazepine" post="(blood level of 6  μg/ml.), the patient reported that"/>
   <result pre="Nagarkar A. N. Resolution of hyperacusis associated with depression, following" exact="lithium" post="administration and directive counselling Journal of Laryngology and Otology"/>
   <result pre="report 1 Within symptom set No Self-report Not stated Intravenous" exact="ceftriaxone" post="led to a remission of all symptoms, but hyperacusis"/>
   <result pre="increased and sounds no longer seemed to &quot;add up&quot; following" exact="carbamazepine" post="and patient reported increased ability to recover more quickly."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5693816/results/search/drugs/results.xml">
   <result pre="multimodal analgesic therapies, including migraine therapies, regional anesthesia, subdissociative-dose ketamine," exact="nitrous oxide," post="intravenous lidocaine and gabapentinoids, as well as broad programmatic"/>
   <result pre="including migraine therapies, regional anesthesia, subdissociative-dose ketamine, nitrous oxide, intravenous" exact="lidocaine" post="and gabapentinoids, as well as broad programmatic initiatives promoting"/>
   <result pre="analgesics and nonpharmacologic interventions. Results While migraine therapies, regional anesthesia," exact="nitrous oxide" post="and subdissociative-dose ketamine are supported by a relatively robust"/>
   <result pre="Results While migraine therapies, regional anesthesia, nitrous oxide and subdissociative-dose" exact="ketamine" post="are supported by a relatively robust evidence base, data"/>
   <result pre="was the single most commonly administered analgesic (20%), followed by" exact="ibuprofen" post="(17%; Table 2). Despite rather small reductions in pain"/>
   <result pre="and giving primacy to non-opioid interventions of known efficacy (i.e.," exact="dopamine" post="agonists, serotonin agonists) has been remarkably slow [ 25]."/>
   <result pre="with permission from Morrison et al. [ 37] Intravenous subdissociative-dose" exact="ketamine" post="has also been the subject of a number of"/>
   <result pre="subject of a number of recent ED studies. Perhaps because" exact="ketamine" post="has long been used for procedural sedation and as"/>
   <result pre="and as an induction agent for rapid sequence intubation, subdissociative-dose" exact="ketamine" post="(0.1–0.4 mg/kg) as monotherapy or adjunctive therapy has become"/>
   <result pre="position paper from the American Academy of Emergency Medicine, subdissociative-dose" exact="ketamine" post="was judged safe and effective both as a single"/>
   <result pre="opioids for the treatment of acute pain [ 38]. Although" exact="ketamine" post="is well known to cause troubling neuropsychiatric adverse effects"/>
   <result pre="to be minor and short-lived. Eight supportive studies of subdissociative-dose" exact="ketamine" post="pertinent to pre-hospital and ED settings have been published"/>
   <result pre="Another recent study examined adverse effects and analgesic efficacy of" exact="ketamine" post="administered as either a single intravenous push (IVP) or"/>
   <result pre="analgesic efficacy with fewer reports of adverse effects for when" exact="ketamine" post="was infused over a 15-min infusion period. While subdissociative-dose"/>
   <result pre="physicians should inform patients about potential side effects and avoid" exact="ketamine" post="for patients with underlying psychiatric disorders or substance abuse-induced"/>
   <result pre="and analgesic among pediatric ED patients. Administered as a 50%–70%" exact="nitrous oxide" post="vapor, it is used for children undergoing a number"/>
   <result pre="ED patients. In a recent non-controlled pilot study of self-administered" exact="nitrous oxide" post="among 85 ED patients with abscesses or orthopedic injuries,"/>
   <result pre="oxide among 85 ED patients with abscesses or orthopedic injuries," exact="nitrous oxide" post="appeared to be safe and well tolerated. Given the"/>
   <result pre="decreasing opioid use in the ED, it is likely that" exact="nitrous oxide" post="use will increase over time [ 49]. In contrast"/>
   <result pre="have recently been promoted for ED use [ 50]. Intravenous" exact="lidocaine" post="has demonstrated efficacy for central pain syndromes and neuropathic"/>
   <result pre="setting. Two Iranian research groups recently published studies of intravenous" exact="lidocaine" post="for ED the treatment of renal colic. The first"/>
   <result pre="ED the treatment of renal colic. The first studied intravenous" exact="lidocaine" post="as an adjuvant to opioid therapy in 110 patients"/>
   <result pre="The investigators reported that those treated with a combination of" exact="lidocaine" post="and morphine reported fewer episodes of nausea and more"/>
   <result pre="240 patients with renal colic directly compared monotherapy with intravenous" exact="lidocaine" post="to morphine [ 52]. Pain reduction was reported to"/>
   <result pre="those treated with lidocaine. In another US study comparing intravenous" exact="lidocaine" post="to intravenous ketorolac for ED patients with acute radicular"/>
   <result pre="lidocaine. In another US study comparing intravenous lidocaine to intravenous" exact="ketorolac" post="for ED patients with acute radicular back pain, lidocaine"/>
   <result pre="intravenous ketorolac for ED patients with acute radicular back pain," exact="lidocaine" post="was less impressive, failing to reach a clinically significant"/>
   <result pre="reported pain intensity over 60 min [ 53]. While intravenous" exact="lidocaine" post="has thus far received limited investigation in the ED,"/>
   <result pre="specifically non-steroidal anti-inflammatory agents, ketamine, lidocaine/ropivacaine, benzodiazepines, corticosteroids, gabapentinoids and" exact="nitrous oxide." post="Ultrasound-guided regional anesthesia is advised for appropriate extremity fractures"/>
   <result pre="S et al. Is there a role for intravenous subdissociative-dose" exact="ketamine" post="administered as an adjunct to opioids or as a"/>
   <result pre="The effect of combined treatment with morphine sulphate and low-dose" exact="ketamine" post="in a prehospital setting Scand J Trauma Resusc Emerg"/>
   <result pre="Jennings PA Cameron P Bernard S et al. Morphine and" exact="ketamine" post="is superior to morphine alone for out-of-hospital trauma analgesia:"/>
   <result pre="et al. Management of severe acute pain in emergency settings:" exact="ketamine" post="reduces morphine consumption Am J Emerg Med 2007 25"/>
   <result pre="Herring AA Stone MB Frazee BW Effective analgesia with low-dose" exact="ketamine" post="and reduced dose hydromorphone in ED patients with severe"/>
   <result pre="Frazee BW Effective analgesia with low-dose ketamine and reduced dose" exact="hydromorphone" post="in ED patients with severe pain Am J Emerg"/>
   <result pre="44. Beaudoin FL Lin C Guan W Merchant RC Low-dose" exact="ketamine" post="improves pain relief in patients receiving intravenous opioids for"/>
   <result pre="45. Miller JP Schauer SG Ganem VJ Bebarta VS Low-dose" exact="ketamine" post="vs morphine for acute pain in the ED: a"/>
   <result pre="Motov S Rockoff B Cohen V et al. Intravenous subdissociative-dose" exact="ketamine" post="vs. morphine for analgesia in the emergency department: a"/>
   <result pre="A prospective randomized, double-dummy trial comparing IV push low dose" exact="ketamine" post="to short infusion of low dose ketamine for treatment"/>
   <result pre="push low dose ketamine to short infusion of low dose" exact="ketamine" post="for treatment of pain in the ED Am J"/>
   <result pre="Chudnofsky CR Manur R et al. The use of inhaled" exact="nitrous oxide" post="for analgesia in adult ED patients: a pilot study"/>
   <result pre="A Rashidian Dezfouli H Zamani Kiasari A et al. Does" exact="lidocaine" post="as an adjuvant to morphine improve pain relief in"/>
   <result pre="K Vaezi H Golzari SE et al. Effectiveness of intravenous" exact="lidocaine" post="versus intravenous morphine for patients with renal colic in"/>
   <result pre="53. Tanen DA Shimada M Danish DC et al. Intravenous" exact="lidocaine" post="for the emergency department treatment of acute radicular low"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5709272/results/search/drugs/results.xml">
   <result pre="and a pharmacological treatment with carbonic anhydrase inhibitors such as" exact="acetazolamide" post="and topiramate. Invasive treatments should only be considered in"/>
   <result pre="C, Goadsby PJ. Brain activations in the premonitory phase of" exact="nitroglycerin" post="triggered migraine attacks. Brain. 2014;137:232-42. 6. Giffin NJ, Lipton"/>
   <result pre="inductive antiepileptics (EiAED) like carbamazepine, phenytoin, primidone, phenobarbitone, rufinamide, lamotrigine," exact="topiramate" post="and COCs is well-known. Therefore, while taking this medication,"/>
   <result pre="in the development of inflammatory response and releasing CGRP and" exact="nitric oxide" post="from trigeminal nerve endings. Animal studies investigating the mechanisms"/>
   <result pre="be treated by SC sumatriptan, intravenous non-steroidal anti-inflammatory drugs and/or" exact="dopamine" post="antagonists. The treatment of secondary headaches requires the treatment"/>
   <result pre="the underlying cause and a symptomatic treatment based on intravenous" exact="acetaminophen" post="or on opiates depending on the pain intensity. S23"/>
   <result pre="and intensity in users of the progestin-only pill (POP) with" exact="desogestrel" post="75microgram. Both, inhibition of ovulation and ist continous use"/>
   <result pre="electrical stimulation of the trigeminal ganglion or chemical stimulation by" exact="nitroglycerin" post="of the trigeminovascular system [3]. A magnetic resonance imaging"/>
   <result pre="Comorbid migraine with aura, anxiety, and depression is associated with" exact="dopamine" post="D2 receptor (DRD2) NcoI alleles. Mol Med. 1998;4:14–21. 6."/>
   <result pre="preclinical data will be presented showing that chronic exposure to" exact="eletriptan" post="or indomethacin alter trigeminal ganglion gene expression patterns broadly"/>
   <result pre="will be presented showing that chronic exposure to eletriptan or" exact="indomethacin" post="alter trigeminal ganglion gene expression patterns broadly and to"/>
   <result pre="sumatriptan, and nasal zolmitriptan. When a preventive medication is required," exact="verapamil" post="is the reference treatment. PH attack features are characterized"/>
   <result pre="responds to lamotrigine, limited the evidences for topiramate, gabapentin, carbamazepine," exact="duloxetine" post="and oxcarbazepine. In HC, clinical attack features have been"/>
   <result pre="a double-blind, placebo-contolled, randomized study for repetitive sphenopalatine blockade with" exact="bupivacaine" post="vs. saline with the Tx360 device for treatment of"/>
   <result pre="palpation of the supraorbital notch. She was treated by anesthetic" exact="lidocaine" post="blockade successfully and was managed during 6 years with"/>
   <result pre="to compare the efficacy, safety, and tolerability of onabotulinumtoxinA and" exact="topiramate" post="for headache prophylaxis in adults with chronic migraine: the"/>
   <result pre="To compare the efficacy, safety, and tolerability of onabotulinumtoxinA and" exact="topiramate" post="for preventive treatment of chronic migraine (CM) in adults."/>
   <result pre="every 12 weeks (±7 days) for 3 treatment cycles or" exact="topiramate" post="50-100 mg/day administered up to week 36. Patients who"/>
   <result pre="50-100 mg/day administered up to week 36. Patients who discontinued" exact="topiramate" post="at any time were allowed the option of crossing-over"/>
   <result pre="[19.7%]) and AEs (onabotulinumtoxinA, n=5 [3.6%]; topiramate, n=72 [50.7%]). 80" exact="topiramate" post="patients crossed-over to onabotulinumtoxinA. OnabotulinumtoxinA demonstrated significantly higher proportion"/>
   <result pre="with ≥50% reduction in headache frequency compared to baseline vs" exact="topiramate" post="(40.0% vs 12.0%, respectively; adjusted OR, 5.0 [95% CI,"/>
   <result pre="AEs were reported by 45.5% of onabotulinumtoxinA and 76.8% of" exact="topiramate" post="patients; serious AEs by 1.4% and 4.2%, respectively. Only"/>
   <result pre="a number of individual AEs were reported in ≥5% receiving" exact="topiramate" post="(Table 1). Treatment-related AEs were reported by 17.3% of"/>
   <result pre="AEs were reported by 17.3% of onabotulinumtoxinA and 69.0% of" exact="topiramate" post="patients. One serious AE ( nephrolithiasis) was reported as"/>
   <result pre="for differences in discontinuation rates, onabotulinumtoxinA was more effective than" exact="topiramate" post="based on ≥50% responder rates and headache day reduction."/>
   <result pre="in a headache unit. They had been previously treated with" exact="topiramate" post="and at least one other medication from beta-blocker and"/>
   <result pre="topiramate and at least one other medication from beta-blocker and" exact="flunarizine" post="for at least three month, as recommended in local"/>
   <result pre="under fluoroscopy (Figs.1, 2 and 3). 1.2 ml of 1%" exact="lidocaine" post="was injected at each medial branch of C 3"/>
   <result pre="longer pain relief than diagnostic local anesthetics. 1.8ml of 1%" exact="lidocaine" post="and BoNT (BOTOX® Type A, Allergan Inc., Irvine, CA,"/>
   <result pre="EM for erenumab. This low NNT is numerically comparable to" exact="topiramate" post="and onabotulinumtoxinA and show the strong treatment benefit of"/>
   <result pre="EM respectively. In comparison, LHHs were lower in CM for" exact="topiramate" post="(1.6 and 3.3) and onabotulinumtoxinA (4.3), and in EM,"/>
   <result pre="(1.6 and 3.3) and onabotulinumtoxinA (4.3), and in EM, for" exact="topiramate" post="(1.6) and propranolol (2.2). Sensitivity analyses showed results’ robustness"/>
   <result pre="and onabotulinumtoxinA (4.3), and in EM, for topiramate (1.6) and" exact="propranolol" post="(2.2). Sensitivity analyses showed results’ robustness despite residual variations"/>
   <result pre="in migraineurs (Table 1). Triptans (31.9%), nonsteroidal anti-inflammatory drugs (28.7%)," exact="acetaminophen" post="(18.9%) and opioids (8.4%), and were self-reported as the"/>
   <result pre="is a fully human monoclonal antibody that selectively inhibits the" exact="calcitonin" post="gene-related peptide (CGRP) receptor under investigation for migraine prevention."/>
   <result pre="trials, fremanezumab, a fully humanized monoclonal antibody that selectively targets" exact="calcitonin" post="gene-related peptide, reduced the frequency, severity, and duration of"/>
   <result pre="oral or ev fluid therapy (at least 2000ml/day), and 1g" exact="paracetamol" post="PRN up to a maximum of 3g. Results On"/>
   <result pre="few years, some nutraceutical preparations as magnesium, CoQ10, vitamin D," exact="melatonin" post="and others have been proposed as potential treatment for"/>
   <result pre="trials, fremanezumab, a fully humanized monoclonal antibody that selectively targets" exact="calcitonin" post="gene-related peptide, reduced the frequency, severity, and duration of"/>
   <result pre="clinical presentation and instrumental findings. Treatment included weight loss and" exact="acetazolamide" post="(maximum 5mg/kg/die) in 28 patients (82.3%). Furosemide was added"/>
   <result pre="(maximum 5mg/kg/die) in 28 patients (82.3%). Furosemide was added to" exact="acetazolamide" post="in 2 patients (5.8%) and in 2 other patients"/>
   <result pre="migraine. Fremanezumab is a fully humanized monoclonal antibody targeting the" exact="calcitonin" post="gene-related peptide (CGRP) ligand, a preventive treatment designed to"/>
   <result pre="management. Most prokinetic medications that are used in migraine are" exact="dopamine" post="antagonists and therefore have the potential to cause drug-induced"/>
   <result pre="in patients with migraine. P56 Topiramate is more effective than" exact="acetazolamide" post="at lowering intracranial pressure in healthy rodents Hannah Botfield"/>
   <result pre="with mild visual loss. Other drugs used include topiramate, furosemide," exact="amiloride" post="and octreotide, despite there being little mechanistic or clinical"/>
   <result pre="serum concentration). Drugs evaluated, with clinical and high doses, were:" exact="acetazolamide" post="(1g and 4g), topiramate (50mg and 200mg), furosemide (40mg"/>
   <result pre="with clinical and high doses, were: acetazolamide (1g and 4g)," exact="topiramate" post="(50mg and 200mg), furosemide (40mg and 240mg), amiloride (5mg"/>
   <result pre="doses, were: acetazolamide (1g and 4g), topiramate (50mg and 200mg)," exact="furosemide" post="(40mg and 240mg), amiloride (5mg and 20mg) and octreotide"/>
   <result pre="and 4g), topiramate (50mg and 200mg), furosemide (40mg and 240mg)," exact="amiloride" post="(5mg and 20mg) and octreotide (350μg and 2mg). In"/>
   <result pre="12 hours after oral administration of equivalent high doses of" exact="acetazolamide" post="and topiramate. Dose conversion between rodents and humans followed"/>
   <result pre="Administration (FDA) guidance. Results At clinical doses, subcutaneous administration of" exact="topiramate" post="lowered ICP by 32% ( p=0.0009). There was no"/>
   <result pre="p=0.0009). There was no significant reduction in ICP noted with" exact="acetazolamide" post="(-19%), amiloride (-11%), furosemide (-1%) or octreotide (-1%). At"/>
   <result pre="was no significant reduction in ICP noted with acetazolamide (-19%)," exact="amiloride" post="(-11%), furosemide (-1%) or octreotide (-1%). At high doses,"/>
   <result pre="significant reduction in ICP noted with acetazolamide (-19%), amiloride (-11%)," exact="furosemide" post="(-1%) or octreotide (-1%). At high doses, subcutaneous administration"/>
   <result pre="(-1%) or octreotide (-1%). At high doses, subcutaneous administration of" exact="topiramate" post="lowered ICP by 21% ( p=0.015) whilst there was"/>
   <result pre="significant reduction in ICP noted with high subcutaneous doses of" exact="acetazolamide" post="(-20%), furosemide (-13%), amiloride (-27%) and octreotide (-18%). Oral"/>
   <result pre="in ICP noted with high subcutaneous doses of acetazolamide (-20%)," exact="furosemide" post="(-13%), amiloride (-27%) and octreotide (-18%). Oral administration of"/>
   <result pre="noted with high subcutaneous doses of acetazolamide (-20%), furosemide (-13%)," exact="amiloride" post="(-27%) and octreotide (-18%). Oral administration of equivalent high"/>
   <result pre="and octreotide (-18%). Oral administration of equivalent high doses of" exact="topiramate" post="lowered ICP by 22% ( p=0.018), compared to only"/>
   <result pre="22% ( p=0.018), compared to only a 5% reduction with" exact="acetazolamide" post="( p=&amp;gt;0.999). Conclusions Our in-vivo studies have demonstrated that,"/>
   <result pre="subcutaneous doses, as well as high oral doses, administration of" exact="topiramate" post="significantly lowers ICP. Other drugs tested, including the acetazolamide"/>
   <result pre="of topiramate significantly lowers ICP. Other drugs tested, including the" exact="acetazolamide" post="the current first line oral therapy in IIH, did"/>
   <result pre="IIH, did not significantly reduce ICP. In the clinical setting" exact="topiramate" post="may have additional advantages in IIH due to migraine"/>
   <result pre="considered. Future clinical trials evaluating efficacy and side effects of" exact="topiramate" post="in IIH would be of interest. P57 National awareness"/>
   <result pre="brain CT scan were normal. The patient was started on" exact="acetazolamide" post="375 mg/die. However, a low serum calcium level (6.3"/>
   <result pre="normal thyroid, while parathyroids were not viewable. Oral supplementation with" exact="calcitriol" post="(0.50 mcg/day) and calcium (500 mg/day) was started. CONCLUSIONS"/>
   <result pre="of LP attempts, CSF red blood cell count, acute analgesics," exact="acetazolamide" post="use and Frisén papilloedema grade. Conclusion The majority of"/>
   <result pre="delle Cefalee.2006; 2:10-12. P71 Tanacethum Parthenium , 5 - hydroxy" exact="tryptophan" post="and magnesium (Aurastop©) efficacy in episodic migraine prevention. A"/>
   <result pre="the novel phytotherapic combination of Tanacethum Parthenium (150 mg), 5-hydroxy" exact="tryptophan" post="(20 mg) and magnesium (185 mg) (Aurastop©) acts on"/>
   <result pre="phytotherapic combination of Tanacethum Parthenium (150 mg), 5 - Hydroxy" exact="tryptophan" post="(20 mg) and Magnesium (185 mg) (Aurastop®) is now"/>
   <result pre="the efficacy of the combined action of Tanacethum Parthenium, 5-Hydroxy" exact="tryptophan" post="and magnesium in the reduction/disappearance of the aura phenomenon"/>
   <result pre="puncture. The intracranial hypertension treated in all three cases with" exact="acetazolamide" post="per os with complete remission. In one case, it"/>
   <result pre="of increasing efficacy of the prevention of migraine attacks using" exact="quetiapine" post="as an additional (supplementary) medicine in patients suffering from"/>
   <result pre="in cases of non-response. In cases of response to treatment" exact="quetiapine" post="was added as a supplementary (secondary) medicine after 6-month"/>
   <result pre="after 6-month treatment with sodium valproat. A single dose of" exact="quetiapine" post="was prescribed at night. The dosage was titrated from"/>
   <result pre="of patients complete absence of attacks as result of supplementing" exact="quetiapine" post="to the achieved existing level of their individual therapeutic"/>
   <result pre="valproat respectively. The following side-effects were observed when dosage of" exact="quetiapine" post="was rapidly increased (up to 100mg per 1-1.5 months):"/>
   <result pre="serotonin may be underlying reason basis of high efficacy of" exact="quetiapine" post="in resistant and chronic forms of migraine (with and"/>
   <result pre="such as weight loss, ureteric stone. In contrast with topiramate," exact="zonisamide" post="has no cognitive impairment or learning difficulty [2]. Therefore"/>
   <result pre="zonisamide has no cognitive impairment or learning difficulty [2]. Therefore" exact="zonisamide" post="could be one of the therapies for prevention of"/>
   <result pre="Results 8 patients were male. The average add-on dose of" exact="zonisamide" post="was 230 (range: 200-300). Frequency and severity of headache"/>
   <result pre="MMSE and CDR. Conclusions Our findings support the use of" exact="zonisamide" post="and an effective therapy for headache prophylaxis in patients"/>
   <result pre="migraine is not well understood, but studies have shown that" exact="calcitonin" post="gene-related peptide (CGRP) plays a strong role. Recently there"/>
   <result pre="neurogenic motor responses in isolated rat urinary bladder, release of" exact="calcitonin" post="gene related peptide (CGRP) from mouse spinal cord in"/>
   <result pre="is a fully human monoclonal antibody that selectively inhibits the" exact="calcitonin" post="gene-related peptide (CGRP) receptor. In the STRIVE placebo-controlled Phase"/>
   <result pre="fully human monoclonal antibody that selectively targets and inhibits the" exact="calcitonin" post="gene-related peptide (CGRP) receptor and is under investigation for"/>
   <result pre="a preclinical mouse model of migraine Bianca Mason The neuropeptide" exact="calcitonin" post="gene-related peptide (CGRP) is a key player in migraine."/>
   <result pre="Importantly, two clinically effective migraine drugs, the 5-HT 1B/D agonist" exact="sumatriptan" post="and a CGRP-blocking monoclonal antibody, attenuated the peripheral CGRP-induced"/>
   <result pre="allodynic pain responses by using two approaches (1) injection of" exact="phenylephrine" post="to minimize vasodilation induced by CGRP (2) genetic overexpression"/>
   <result pre="trials, fremanezumab, a fully humanized monoclonal antibody that selectively targets" exact="calcitonin" post="gene-related peptide, reduced the frequency of headaches and migraines"/>
   <result pre="trials, fremanezumab, a fully humanized monoclonal antibody that selectively targets" exact="calcitonin" post="gene-related peptide, reduced the frequency of headaches in patients"/>
   <result pre="trials, fremanezumab, a fully humanized monoclonal antibody that selectively targets" exact="calcitonin" post="gene-related peptide, reduced the frequency, severity, and duration of"/>
   <result pre="more difficult, especially in paediatric age, the absolute response to" exact="indomethacin" post="represents the diagnostic key for CPH in both adults"/>
   <result pre="migraine. Fremanezumab is a fully humanized monoclonal antibody targeting the" exact="calcitonin" post="gene-related peptide (CGRP) ligand, a preventive treatment designed to"/>
   <result pre="Aycardi Background: Fremanezumab, a fully humanized monoclonal antibody targeting the" exact="calcitonin" post="gene-related peptide (CGRP) ligand, is a preventive treatment designed"/>
   <result pre="Ernesto Aycardi Background: Fremanezumab, a fully-humanized monoclonal antibody targeting the" exact="calcitonin" post="gene-related peptide (CGRP) ligand, is a preventive treatment designed"/>
   <result pre="receptor subgroups. Following data concern 102 chronic migraine sufferers reporting" exact="topiramate" post="– induced relief -14.2 ± 0.7 hours with pain,"/>
   <result pre="times/daily for 15 -150 min. Patients of Group A received" exact="topiramate" post="that was the therapy they referred as ineffective. Group"/>
   <result pre="negative modulators at metabotrobic glutamatergic receptors level. Escape medication was" exact="sumatriptan" post="100 mg. Plan: a 14 days run-in, a 3"/>
   <result pre="likely act on rage–despair pathways [6]. On the other hand," exact="topiramate" post="appertains to the same drug-category. Finally, it seems interesting"/>
   <result pre="or more classes of headache abortive medications, including triptans, NSAIDs," exact="paracetamol" post="and the analgesics combination [1]. MOH is one of"/>
   <result pre="outcome data were obtained from 29.4% of cases. Amitriptyline and" exact="topiramate" post="had the highest efficacy (p&amp;lt;0.05). We found that 59.2%"/>
   <result pre="efficacy (p&amp;lt;0.05). We found that 59.2% of patients who received" exact="amitriptyline" post="showed significant reduction in the attack frequency, while 48.4%"/>
   <result pre="significant reduction in the attack frequency, while 48.4% patients receiving" exact="topiramate" post="improved their headache attack frequency (p&amp;gt;0.05). Conclusions: Our results"/>
   <result pre="was related with CM onset and adolescent age. Amitriptyline and" exact="topiramate" post="had the best effectiveness. However, it is to be"/>
   <result pre="A (2010) Epidural blood patch in Trendelenburg position pre-medicated with" exact="acetazolamide" post="to treat spontaneous intracranial hypotension. Eur J Neurol 17:715–719."/>
   <result pre="4. Nicolodi M, Del Bianco E. Sensory neuropeptides (substance P," exact="calcitonin" post="gene-related peptide) andvasoactive intestinal polypeptide in human saliva: their"/>
   <result pre="SUNCT, as the first therapeutic choice is Lamotrigina or intravenous" exact="lidocaine" post="2,3. The therapeutic and clinical similarities in SUNCT and"/>
   <result pre="signaling pain and releasing the neuropeptides substance P (SP) and" exact="calcitonin" post="gene-related peptide (CGRP), which mediate neurogenic inflammation. The possible"/>
   <result pre="expression of blood-brain barrier damage or demyelination. The patient started" exact="gabapentin" post="until a dose of 300 mg/bid, with a complete"/>
   <result pre="in more common craniofacial neuralgias, including anticonvulsivants, such as carbamazepine," exact="lamotrigine" post="or gabapentin. A surgical approach is reserved for refractory"/>
   <result pre="recovery the patient reported another right migrainous episode, resolved with" exact="acetaminophen" post="treatment, while right face hypoestesia showed some initial improvement"/>
   <result pre="analgesics should be avoided to prevent chronic headache. In childhood," exact="paracetamol" post="and ibuprofen are drugs of choice. Triptans are approved"/>
   <result pre="be avoided to prevent chronic headache. In childhood, paracetamol and" exact="ibuprofen" post="are drugs of choice. Triptans are approved over twelve"/>
   <result pre="age and different triptans are available in different countries: e.g." exact="sumatriptan" post="and zolmutriptan in Italy and almotriptan and rizatriptan in"/>
   <result pre="in different countries: e.g. sumatriptan and zolmutriptan in Italy and" exact="almotriptan" post="and rizatriptan in USA. Finally, preventive therapy should be"/>
   <result pre="countries: e.g. sumatriptan and zolmutriptan in Italy and almotriptan and" exact="rizatriptan" post="in USA. Finally, preventive therapy should be discussed with"/>
   <result pre="The expression levels of the genes coding for c-Fos, TRPA1," exact="calcitonin" post="gene-related peptide (CGRP) and substance P (SP) in peripheral"/>
   <result pre="the trigeminal level. P182 Chronic and Intermittent administration of systemic" exact="nitroglycerin" post="in the rat induces an increase in c-Fos and"/>
   <result pre="animal model was based on chronic and intermittent administration of" exact="nitroglycerin" post="(NTG). Male Sprague-Dawley rats were injected with NTG (5mg/kg,"/>
   <result pre="clinical presentation and instrumental findings. Treatment included weight loss and" exact="acetazolamide" post="(maximum 5mg/kg/die) in 28 patients (82.3%). Furosemide was added"/>
   <result pre="(maximum 5mg/kg/die) in 28 patients (82.3%). Furosemide was added to" exact="acetazolamide" post="in 2 patients (5.8%) and in 2 other patients"/>
   <result pre="more difficult, especially in paediatric age, the absolute response to" exact="indomethacin" post="represents the diagnostic key for CPH in both adults"/>
   <result pre="therapy is necessary. SISC Italian guidelines [2] suggest to use" exact="amitriptyline" post="as one of first choices, which is a tricyclic"/>
   <result pre="the possible cognitive and driving effects of prophylactic therapy with" exact="amitriptyline" post="in relation to its plasma level. Material and Methods"/>
   <result pre="acoustic stimuli. Plasma assay were set to determine level of" exact="amitriptyline" post="and its active metabolites in patients’ blood. Results Sample"/>
   <result pre="20,31 and 1,65 m 2. Patients are all treated with" exact="amitriptyline" post="16 mg per os (most employed dosage in our"/>
   <result pre="The patient suffered from chronic migraine too: prophylactic treatments with" exact="topiramate" post="50 mg x 2 die and botulin injection were"/>
   <result pre="clinical practice guidelines. Headache 2012; 52(6):930-45. P199 Tanacethum Parthenium, 5-hydroxy" exact="tryptophan" post="and magnesium (Aurastop®) in the prophylaxis of episodic migraine"/>
   <result pre="Correspondence:Alessandra Mandelli (alessandra. mandelli@gavazzeni.it) Background Tanacethum parthenium, 5 - hydroxy" exact="tryptophan" post="and magnesium have an effect on various pathological mechanisms"/>
   <result pre="effect on various pathological mechanisms of migraine. 5 - hydroxy" exact="tryptophan" post="(by his metabolite, kynurenic acid) and magnesium inhibit the"/>
   <result pre="novel combination between Tanacethum parthenium 150 mg, 5 - hydroxy" exact="tryptophan" post="20 mg and magnesium 185 mg (TP-5HT-M) Aurastop ®"/>
   <result pre="A new phytotherapic combination of Tanacethum Parthenium (150 mg), 5-Hydroxy" exact="tryptophan" post="(20 mg) and Magnesium (185 mg) (Aurastop®) is now"/>
   <result pre="the efficacy of the combined action of Tanacethum Parthenium, 5-Hydroxy" exact="tryptophan" post="and magnesium in the reduction/disappearance of the aura phenomenon"/>
   <result pre="brain CT scan were normal. The patient was started on" exact="acetazolamide" post="375 mg/die. However, a low serum calcium level (6.3"/>
   <result pre="normal thyroid, while parathyroids were not viewable. Oral supplementation with" exact="calcitriol" post="(0.50 mcg/day) and calcium (500 mg/day) was started. CONCLUSIONS"/>
   <result pre="prevention of a combination of Tanacethum Parthenium, 5 - hydroxy" exact="tryptophan" post="and magnesium (Aurastop©) A multicentric observational study Paola Merlo"/>
   <result pre="the novel phytotherapic combination of Tanacethum Parthenium (150 mg), 5-hydroxy" exact="tryptophan" post="(20 mg) and magnesium (185 mg) (Aurastop©) acts on"/>
   <result pre="Materials and methods We evaluated 18 patients, previously treated with" exact="verapamil" post="and note responding to transitional steroids. The study group"/>
   <result pre="2013; 53:1183-90. P204 Association of Tanacethum Parthenium, 5 - hydroxy" exact="tryptophan" post="and magnesium ( Aurastop) versus Mg tablet impact on"/>
   <result pre="of Tanacethum Parthenium ( 150 mg ), 5 - hydroxy" exact="tryptophan" post="( 20 mg ) and magnesium ( 185 mg"/>
   <result pre="disability of the combination of Tanacethum Parthenium, 5 - hydroxy" exact="tryptophan" post="and magnesium versus magnesium alone, when taken at the"/>
   <result pre="children. HandbClin Neurol. 2010; 97: 739-54. P206 Tanacethum Parthenium, 5-hydroxy" exact="tryptophan" post="and magnesium in the prophylaxis of migraine without aura"/>
   <result pre="al Tagliamento Hospital Correspondence:Federico Mainardi (fmainardi@iol.it) Background: Tanacethum parthenium, 5-hydroxy" exact="tryptophan" post="and magnesium have an extensive literature supporting their role"/>
   <result pre="novel combination between tanacethum parthenium 150 mg, 5 - hydroxy" exact="tryptophan" post="20 mg and magnesium 185 mg (TP-5HT-M) in the"/>
   <result pre="splenial lesion. After an efficacious composite prophylactic therapy with Candesartan," exact="amitriptyline" post="and Baclophene, and no other visual auras, a six-month"/>
   <result pre="drugs for headache, including NSAIDs (69 out of 86, 80%)," exact="paracetamol" post="(26 out of 86, 30%), analgesic combinations (2 out"/>
   <result pre="shift in the pattern of medication use in favour of" exact="paracetamol" post="(35 out of 86, 41%). Conclusions Headache is common"/>
   <result pre="therapy, STPP alone seems not to be inferior to sodium" exact="valproate" post="[4]. We investigated a large cohort of CM patients"/>
   <result pre="reduce the analgesics’ consumption. Patients complained more side effects with" exact="pizotifen" post="than the other two treatments. In conclusion our data"/>
   <result pre="Our group previously demonstrated the efficacy and tolerability of sodium" exact="valproate" post="(VPA) in a 12-week treatment period of MOH patients"/>
   <result pre="Savino A. Epidural blood patch in Trendelenburg position pre-medicated with" exact="acetazolamide" post="to treat spontaneous intracranial hypotension. Eur J Neurol 2010;"/>
   <result pre="accessibility of 3 effective medicines for CH (sumatriptan s.c, oxygen" exact="zolmitriptan" post="spray) across EU Materials and Methods: A brief survey"/>
   <result pre="of ETs was defined as: a) complete: both oxygen and" exact="sumatriptan" post="s.c fully reimbursable and accessible; b) restricted: partial reimbursment"/>
   <result pre="between Oxy and Suma s.c; c) lacking: both oxygen and" exact="sumatriptan" post="s.c not reimbursable and not accessible Oxygen was reimbursable"/>
   <result pre="Erenumab is a fully human monoclonal antibody that blocks the" exact="calcitonin" post="gene-related peptide receptor. In a large, multicenter, double-blind, placebo"/>
   <result pre="patients, and also in patients with kidney-liver diseases. In pregnancy," exact="lidocaine" post="is considered a category B drug. Greater occipital nerve"/>
   <result pre="mg monthly), a humanized monoclonal antibody that selectively binds to" exact="calcitonin" post="gene-related peptide, was superior to placebo in the prevention"/>
   <result pre="and funded by Allergan, plc (Dublin, Ireland). O14 Effects of" exact="calcitonin" post="gene-related peptide and sildenafil on CNS metabolism: A pharmacological"/>
   <result pre="plc (Dublin, Ireland). O14 Effects of calcitonin gene-related peptide and" exact="sildenafil" post="on CNS metabolism: A pharmacological proton magnetic resonance spectroscopy"/>
   <result pre="success to study the cerebrovascular effects of headache-inducing substances, including" exact="calcitonin" post="gene-related peptide (CGRP) and sildenafil. The role of the"/>
   <result pre="placebo-controlled, double-blinded, double-dummy, three-way cross-over design, using the headache-inducing substances" exact="calcitonin" post="gene-related peptide (CGRP) and sildenafil, with peripheral and central"/>
   <result pre="level increased in pons at 40 – 70 min after" exact="sildenafil" post="administration, when compared to placebo (5.6%, P=0.037). We found"/>
   <result pre="peripheral nervous system and/or the trigeminal ganglion. O15 Effect of" exact="calcitonin" post="gene-related peptide and sildenafil on intracranial dural arteries: A"/>
   <result pre="the trigeminal ganglion. O15 Effect of calcitonin gene-related peptide and" exact="sildenafil" post="on intracranial dural arteries: A 3T MR- angiography study"/>
   <result pre="Copenhagen, Denmark Correspondence:Messoud Ashina Background Calcitonin gene-related peptide (CGRP) and" exact="sildenafil" post="are vasoactive substances that induce migraine attacks in patients."/>
   <result pre="involved, but these have never been examined in vivo. Furthermore," exact="sildenafil" post="is the only migraine inducing compound, where cephalic dilation"/>
   <result pre="not reported. Here, we investigate the effect of CGRP and" exact="sildenafil" post="on the extracranial and intradural parts of the middle"/>
   <result pre="AUC Baseline-120min was significantly larger on both the CGRP and" exact="sildenafil" post="days in the extracranial MMA (CGRP, p=0.0003; sildenafil, p=0.021)"/>
   <result pre="finding of the present study is that both CGRP and" exact="sildenafil" post="dilate intradural arteries, supporting the notion that all pharmacological"/>
   <result pre="Galcanezumab, a humanized monoclonal antibody that selectively binds to the" exact="calcitonin" post="gene-related peptide, was investigated in two Phase 3 studies"/>
   <result pre="outcome data were obtained from 29.4% of cases. Amitriptyline and" exact="topiramate" post="had the highest efficacy (p&amp;lt;0.05). We found that 59.2%"/>
   <result pre="efficacy (p&amp;lt;0.05). We found that 59.2% of patients who received" exact="amitriptyline" post="showed significant reduction in the attack frequency, while 48.4%"/>
   <result pre="significant reduction in the attack frequency, while 48.4% patients receiving" exact="topiramate" post="improved their headache attack frequency (p&amp;gt;0.05). However, for both"/>
   <result pre="was related with CM onset and adolescent age. Amitriptyline and" exact="topiramate" post="had the best effectiveness. However, it is to be"/>
   <result pre="study of 637 young M and TTH patients, supplements and" exact="melatonin" post="were used respectively by 205 (32%) and 61 (10%)"/>
   <result pre="H, Passchier J, Locher H, Dijkstra N, Arts W-F. Medium-dose" exact="riboflavin" post="as a prophylactic agent in children with migraine: A"/>
   <result pre="FM, Forrest KML, Ratanayake PD, Fagan E, Antony J. High-dose" exact="riboflavin" post="for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5722017/results/search/drugs/results.xml">
   <result pre="examination was unremarkable in all patients. All patients were given" exact="carbamazepine" post="300–900 mg daily. In addition, 19 age- and gender-matched"/>
   <result pre="secondary visual cortex, extending to the precuneus and a more" exact="dopamine" post="pathway network. The dorsal attention network, activated in the"/>
   <result pre="There are several limitations in this study. The role of" exact="carbamazepine" post="on intrinsic brain activity is largely unknown, but we"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5749131/results/search/drugs/results.xml">
   <result pre="dependency (Suboxone) is a combination of two old drugs, namely" exact="buprenorphine" post="(a weak partial opioid agonist) and naloxone (an opioid"/>
   <result pre="old drugs, namely buprenorphine (a weak partial opioid agonist) and" exact="naloxone" post="(an opioid antagonist). A more recent article 14 describes"/>
   <result pre="counteract opioid-related side effects (for example, nausea, constipation, and reduced" exact="testosterone" post="levels) and overdoses. In 2016, US pharmaceutical companies had"/>
   <result pre="patients with knee osteoarthritis than the potent non-steroidal anti-inflammatory drug" exact="meloxicam" post="53 . Interestingly, acupotomy EA was reported to be"/>
   <result pre="al. : A randomized controlled comparison of electro-acupoint stimulation or" exact="ondansetron" post="versus placebo for the prevention of postoperative nausea and"/>
   <result pre="timing of acustimulation for antiemetic prophylaxis as an adjunct to" exact="ondansetron" post="in patients undergoing plastic surgery. Anesth Analg. 2005; 100("/>
   <result pre="Y Wang H : [Clinical efficacy comparison between electroacupuncture and" exact="meloxicam" post="in the treatment of knee os- teoarthritis at the"/>
   <result pre="al. : Effects of low power laser and low dose" exact="amitriptyline" post="therapy on clinical symptoms and quality of life in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5771233/results/search/drugs/results.xml">
   <result pre="inhibitory interneurons. Aspirin, acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAIDS; e.g.," exact="ibuprofen" post="or naproxen) are the first choice in the pharmacological"/>
   <result pre="non-specific low back pain) compared to neuropathic pain. In addition," exact="naproxen" post="has been FDA approved for pain associated with ankylosing"/>
   <result pre="and chronic musculoskeletal pain), although antidepressants with dual serotonin and" exact="norepinephrine" post="reuptake inhibition are used off-label to provide pain relief"/>
   <result pre="neuronal firing, including nociceptors. First and second generation anticonvulsants (e.g.," exact="gabapentin" post="and pregabalin) are FDA approved for the treatment of"/>
   <result pre="is also increasing evidence that patients may misuse or abuse" exact="gabapentin" post="( Chiappini and Schifano, 2016; Smith et al., 2016)."/>
   <result pre="lasting 3–6 months ( Boyles et al., 2015). Injection of" exact="lidocaine" post="or corticosteroid is also performed in some trigger point"/>
   <result pre="Staal et al., 2009). Nerve blocks (involving epidural injections of" exact="lidocaine" post="without steroids), however, do provide significant pain relief for"/>
   <result pre="Allan L Richarz U Simpson K Slappendel R 2005 Transdermal" exact="fentanyl" post="versus sustained release oral morphine in strong-opioid naive patients"/>
   <result pre="McIlwain H Ahdieh H 2005 Safety, tolerability, and effectiveness of" exact="oxymorphone" post="extended release for moderate to severe osteoarthritis pain: a"/>
   <result pre="L 2001 Evaluation of long-term efficacy and safety of transdermal" exact="fentanyl" post="in the treatment of chronic noncancer pain J. Pain"/>
   <result pre="Sensory and signaling mechanisms of bradykinin eicosanoids, platelet-activating factor, and" exact="nitric oxide" post="in peripheral nociceptors Physiol. Rev 92 1699 1775 23073630"/>
   <result pre="M Colucci SV Richards P 2007 Long-term use of controlled-release" exact="oxycodone" post="for noncancer pain: results of a 3-year registry study"/>
   <result pre="than 10 days at a time without instruction from physician." exact="ibuprofen" post="200 to 800 mg every 4–6 h (Max 3.2"/>
   <result pre="stroke, Stevens-Johnson syndrome, and hearing loss Should not take OTC" exact="ibuprofen" post="for more than 10 days at a time without"/>
   <result pre="than 10 days at a time without instruction from physician." exact="naproxen" post="250 to 500 mg every 12 h (Max 1"/>
   <result pre="myocardial infarction, stroke, Stevens-Johnson syndrome, bleeding, and renal failure OTC" exact="naproxen" post="can be taken for 6 months without instruction from"/>
   <result pre="be taken for 6 months without instruction from physician. Anti-depressants" exact="duloxetine" post="30 to 60 mg daily Diabetic peripheral neuropathy, fibromyalgia,"/>
   <result pre="relief may take 4–6 weeks after achieving an effective dose." exact="venlafaxine" post="75 to 225 mg daily None. Hyponatremia, bleeding, hepatitis,"/>
   <result pre="relief may take 4–6 weeks after achieving an effective dose." exact="nortriptyline" post="50 to 100 mg daily None. Sudden cardiac death,"/>
   <result pre="take 4–6 weeks after achieving an effective dose. Anti-epileptic drugs" exact="gabapentin" post="300 to 600 mg every 8 h Post-herpetic neuralgia"/>
   <result pre="sedation, suicidal thoughts, dizziness, and falls. Misuse and/or abuse of" exact="gabapentin" post="has also been reported. RCTs have also shown efficacy"/>
   <result pre="relief may take 4–6 weeks after achieving an effective dose." exact="pregabalin" post="75 to 150 mg every 12 h (Max 450"/>
   <result pre="sham procedures. Nerve block 0.25%-0.5% bupivacaine, 2% lignocaine, or 1%" exact="lidocaine" post="One diagnostic block and then second long-term nerve block"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5784532/results/search/drugs/results.xml">
   <result pre="pain, one patient reported recreational ecstasy use, one reported prescribed" exact="methylphenidate" post="use, and one reported recreational methylphenidate use. The Glasgow"/>
   <result pre="use, one reported prescribed methylphenidate use, and one reported recreational" exact="methylphenidate" post="use. The Glasgow Coma Scale (GCS) is a neurological"/>
   <result pre="toxicology screens and/or patient verbal reports of tetrahydrocannabinol (THC) and" exact="amphetamine" post="use (including methylenedioxy-methamphetamine, otherwise known as MDMA, &quot;molly&quot;, or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5791467/results/search/drugs/results.xml">
   <result pre="in the body, as the decrease in the amount of" exact="progesterone" post="at the end of the luteal phase leads to"/>
   <result pre="by reducing the level of renin and increasing estrogen and" exact="progesterone" post="and thus decreases and improves physical symptoms.[ 7 8"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5820747/results/search/drugs/results.xml">
   <result pre="ailments, so he renounced himself in 1975 to requiem as" exact="metoprolol" post="tartrate and as metoprolol succinate in 1990 to achieve"/>
   <result pre="himself in 1975 to requiem as metoprolol tartrate and as" exact="metoprolol" post="succinate in 1990 to achieve greater prowess (bioavailability). The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5820821/results/search/drugs/results.xml">
   <result pre=": Letters Cinema-like sensory phenomena in a migraine patient on" exact="topiramate" post="Tandon R Verma SK [], rtlib161080@gmail.com ppub: 2018 64"/>
   <result pre="antiepileptic used for migraine prophylaxis. Several side effects may follow" exact="topiramate" post="use such as auditory and visual sensory phenomena.[ 1"/>
   <result pre="sleep. He took one or two analgesics/month and was on" exact="propranolol" post="and antianxiety medications with no relief. During the past"/>
   <result pre="no significant change in headache frequency and intensity, dose of" exact="amitriptyline" post="was increased to 25 mg; and subsequently 25 mg"/>
   <result pre="amitriptyline was increased to 25 mg; and subsequently 25 mg" exact="topiramate" post="daily was added. After 1 month, he experienced headache"/>
   <result pre="being run at fast mode. Due to these sensory phenomena," exact="topiramate" post="was stopped and 10 mg of flunarizine daily was"/>
   <result pre="these sensory phenomena, topiramate was stopped and 10 mg of" exact="flunarizine" post="daily was prescribed. Amitryptyline was, however, continued. His hematological"/>
   <result pre="missed school due to difficulty in concentrating. Two months following" exact="topiramate" post="withdrawal, these so called &quot;cinema-like sensory phenomena&quot; disappeared completely."/>
   <result pre="3] Change in serotonergic activity can cause palinopsia and combining" exact="amitriptyline" post="with topiramate may have lead to this phenomena or"/>
   <result pre="in serotonergic activity can cause palinopsia and combining amitriptyline with" exact="topiramate" post="may have lead to this phenomena or it is"/>
   <result pre="this phenomena or it is possible that cumulative doses of" exact="topiramate" post="after daily administration may have been the possible etiology.["/>
   <result pre="seems to be a need for greater vigilance while prescribing" exact="topiramate" post="for migraine prophylaxis and monitoring patients, especially pediatric and"/>
   <result pre="E Gilliam F Kuzniecky R Acute psychotic symptoms induced by" exact="topiramate" post="Seizure 1999 8 235 7 10452922 2 Jurgens TP"/>
   <result pre="Stork JH May A &quot;Alice in Wonderland syndrome&quot; associated with" exact="topiramate" post="for migraine prevention J Neurol Neurosurg Psychiatry 2011 82"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5966347/results/search/drugs/results.xml">
   <result pre="C Arterial spin-labeled MRI study of migraine attacks treated with" exact="rizatriptan" post="J Headache Pain 2010 11 255 258 10.1007/s10194-010-0215-2 20411294"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC5996544/results/search/drugs/results.xml">
   <result pre="recurrence rates in postmenopausal women by about 30% compared with" exact="tamoxifen" post="while treatments differ. Unfortunately, nearly half of women taking"/>
   <result pre="in clinical practice are the third generation aromatase inhibitors (exemestane," exact="anastrozole" post="and letrozole). AIs improve outcomes in the adjuvant treatment"/>
   <result pre="postmenopausal women with hormone receptor positive (HR+) BC compared with" exact="tamoxifen" post="decreasing the risk of recurrence (20–36%) and decreasing 10-year"/>
   <result pre="radiotherapy. Retrospective analyses indicate prescription-controlled adherence rates of 80% for" exact="tamoxifen" post="and 69% for anastrozole [ 9]. The worst figures"/>
   <result pre="prescription-controlled adherence rates of 80% for tamoxifen and 69% for" exact="anastrozole" post="[ 9]. The worst figures are found in those"/>
   <result pre="cases was higher in those patients who were treated with" exact="exemestane" post="(2,8%) than in those who taking TMX as hormonal"/>
   <result pre="CTS were reported in 2,6% of the participant in the" exact="anastrozole" post="arm, compared with 0.7% in the tamoxifen arm, although"/>
   <result pre="participant in the anastrozole arm, compared with 0.7% in the" exact="tamoxifen" post="arm, although the symptoms were mild or moderate in"/>
   <result pre="strength and they found that a short course of low-dose" exact="prednisone" post="showed promising potential as an effective treatment [ 19]."/>
   <result pre="height, body mass index, waist perimeter and hip perimeter) and" exact="tamoxifen" post="and AIs treatment duration. Table 1 summarises the patients"/>
   <result pre="hormone therapy regimen administered, that is, if they started with" exact="tamoxifen" post="before switching to AIs. In addition to analyzing the"/>
   <result pre="this arthralgia is actually more likely in women switching from" exact="tamoxifen" post="to an AI compared with women starting with AI"/>
   <result pre="AIA AI- induced arthralgia AIs Aromatase Inhibitors ATAC Arimidex and" exact="tamoxifen" post="alone or in combination BADIX Backache Disability Index BAI"/>
   <result pre="R Ingle J Aihara T et al. Aromatase inhibitors versus" exact="tamoxifen" post="in early breast cancer: patient-level meta-analysis of the randomised"/>
   <result pre="symptoms in postmenopausal women with early breast cancer treated with" exact="exemestane" post="or tamoxifen after 2–3 years of tamoxifen: a retrospective"/>
   <result pre="postmenopausal women with early breast cancer treated with exemestane or" exact="tamoxifen" post="after 2–3 years of tamoxifen: a retrospective analysis of"/>
   <result pre="F Bassignana A Miglietta A Antiproliferative effects of COX-2 inhibitor" exact="celecoxib" post="on human breast cancer cell lines Mol Cell Biochem"/>
   <result pre="M Shimada K Yokohata K et al. Short-term and low-dose" exact="prednisolone" post="administration reduces aromatase inhibitor-induced arthralgia in patients with breast"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6025213/results/search/drugs/results.xml">
   <result pre="tightly regulated by local changing levels of neuromodulators such as" exact="adenosine" post="[ 82–84]. Alternatively, the sleep–wake cycle during the day"/>
   <result pre="sleep can be strongly induced by local increased levels of" exact="adenosine" post="in the basal forebrain through its adenosine A1 receptor"/>
   <result pre="increased levels of adenosine in the basal forebrain through its" exact="adenosine" post="A1 receptor and repressed by its antagonist caffeine ["/>
   <result pre="[ 82, 85], the mechanism of how the concentration of" exact="adenosine" post="is regulated in the brain remains elusive. Intriguingly, adenosine"/>
   <result pre="of adenosine is regulated in the brain remains elusive. Intriguingly," exact="adenosine" post="and three of its main precursors (ATP, AMP, and"/>
   <result pre="premature to conclude that local intracellular and extracellular levels of" exact="adenosine" post="and xanthine derivatives may also exhibit 12-hour rhythms in"/>
   <result pre="2B). Contrary to the discriminatory nature of forskolin and tunicamycin," exact="dexamethasone" post="and glucose depletion can synchronize both the circadian and"/>
   <result pre="Fig. 3B). More importantly, whereas siRNA-mediated depletion of Bmal1 abolishes" exact="dexamethasone" post="and glucose depletion–synchronized circadian Per2 expression, it does not"/>
   <result pre="3C). In contrast, ablation of Xbp1 has no effects on" exact="dexamethasone" post="and glucose depletion–synchronized circadian gene expression [ 3] ("/>
   <result pre="and 2C) [ 3], it may be desirable to administer" exact="mercaptopurine" post="(and other drugs targeting de novo purine and pyrimidine"/>
   <result pre="RW Control and function of the homeostatic sleep response by" exact="adenosine" post="A1 receptors. J Neurosci. 2009; 29( 5): 1267– 1276."/>
   <result pre="Huang ZL , Zhang Z , Qu WM Roles of" exact="adenosine" post="and its receptors in sleep–wake regulation. Int Rev Neurobiol."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6031898/results/search/drugs/results.xml">
   <result pre="found to improve cognitive deficits and impulse control problems in" exact="methamphetamine" post="use disorder (MUD). However, there is limited research regarding"/>
   <result pre="rehabilitation centers in Shanghai. The CCAT was designed by combine" exact="methamphetamine" post="use-related picture stimuli with cognitive training with the aim"/>
   <result pre="Trial Registration ClinicalTrials.gov NCT03318081; https://clinicaltrials.gov/ct2/show/NCT03318081 (Archived by WebCite at https://clinicaltrials.gov/ct2/show/NCT03318081)" exact="methamphetamine" post="methamphetamine use disorder cognitive function impulse control risk decision"/>
   <result pre="Registration ClinicalTrials.gov NCT03318081; https://clinicaltrials.gov/ct2/show/NCT03318081 (Archived by WebCite at https://clinicaltrials.gov/ct2/show/NCT03318081) methamphetamine" exact="methamphetamine" post="use disorder cognitive function impulse control risk decision making"/>
   <result pre="are the second most widely abused illicit drugs worldwide, with" exact="methamphetamine" post="being one of the most abused amphetamine-type stimulant drugs,"/>
   <result pre="caused major public health consequences all over the world. Chronic" exact="methamphetamine" post="use has been associated with abnormalities in brain function"/>
   <result pre="paradox situation in which individuals often desperately continue to consume" exact="methamphetamine" post="despite being fully aware of the negative consequences. According"/>
   <result pre="dual-systems perspective of addiction, two unbalanced information processing mechanisms underlying" exact="methamphetamine" post="use disorder (MUD) patients’ behaviors might address this paradox"/>
   <result pre="the word on the right, while ignoring the interference of" exact="methamphetamine" post="pictures and words as quickly as possible ( Figure"/>
   <result pre="trials to help participants get familiar with the training, and" exact="methamphetamine" post="cues were not presented during practice. During the real"/>
   <result pre="treatment, (5) right handedness, and (6) no current use of" exact="methamphetamine" post="or any other substances (except nicotine) for at least"/>
   <result pre="one trained psychiatrist to collect the individual’s sociodemographic characteristics and" exact="methamphetamine" post="use histories. Cognitive Function Cognitive function was assessed using"/>
   <result pre="higher impulsiveness. Methamphetamine Stroop Task A Chinese version of the" exact="methamphetamine" post="addiction Stroop task was applied to measure the methamphetamine-related"/>
   <result pre="terms of mean age, education, marriage, onset age of first" exact="methamphetamine" post="use, abstinence time, duration of methamphetamine use, dose, and"/>
   <result pre="onset age of first methamphetamine use, abstinence time, duration of" exact="methamphetamine" post="use, dose, and frequency. Effect of Computerized Cognitive Addiction"/>
   <result pre="mean (SD) 4.30 (1.17) 4.10 (1.18) 0.224 .64 Duration of" exact="methamphetamine" post="use (year), mean (SD) 6.02 (3.72) 7.00 (2.73) 0.891"/>
   <result pre="mean (SD) 6.02 (3.72) 7.00 (2.73) 0.891 .35 Dose of" exact="methamphetamine" post="use (g/day), mean (SD) 0.60 (0.31) 0.66 (0.39) 0.294"/>
   <result pre="mean (SD) 0.60 (0.31) 0.66 (0.39) 0.294 .59 Frequency of" exact="methamphetamine" post="use, n (%) 2.4 .56 Everyday 14 (70%) 10"/>
   <result pre="police officers, and social workers who participated and helped recruit" exact="methamphetamine" post="use disorder patients during this study. We also appreciate"/>
   <result pre="Task IGT Iowa Gambling Task ISL International Shopping List MUD" exact="methamphetamine" post="use disorder SUD substance use disorder References 1 Robbins"/>
   <result pre="R Fassbender C Structural, functional and spectroscopic MRI studies of" exact="methamphetamine" post="addiction Curr Top Behav Neurosci 2012 11 321 364"/>
   <result pre="3 London ED Kohno M Morales AM Ballard ME Chronic" exact="methamphetamine" post="abuse and corticostriatal deficits revealed by neuroimaging Brain Res"/>
   <result pre="controlled trial of the effects of working memory training in" exact="methadone" post="maintenance patients Drug Alcohol Depend 2015 11 01 156"/>
   <result pre="Effects of length of abstinence on decision-making and craving in" exact="methamphetamine" post="abusers PLoS One 2013 7 8 7 e68791 10.1371/journal.pone.0068791"/>
   <result pre="the effect of working memory training on impulse control in" exact="methamphetamine" post="users Psychopharmacology (Berl) 2017 6 234 12 1911 1921"/>
   <result pre="K Zhao M The cognitive impairments and psychological wellbeing of" exact="methamphetamine" post="dependent patients compared with health controls Prog Neuropsychopharmacol Biol"/>
   <result pre="AJ Fitzpatrick RE Lubman DI Verdejo-Garcia A Working memory predicts" exact="methamphetamine" post="hair concentration over the course of treatment: moderating effect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6045462/results/search/drugs/results.xml">
   <result pre="fMRI, functional magnetic resonance imaging HE, hepatic encephalopathy IAP, intracarotid" exact="amobarbital" post="procedure ICA, independent component analysis IES, intracutaneous epidermal electrical"/>
   <result pre="coherence has been observed in Parkinsonian patients during withdrawal of" exact="levodopa" post="treatment ( Salenius et al., 2002), and abnormal EEG–EMG"/>
   <result pre="with the unilateral results of the Wada test (with intracarotid" exact="amobarbital" post="procedure, IAP) that has traditionally been used to preoperatively"/>
   <result pre="verbal memory ( Milner et al., 1962). The effects of" exact="amobarbital" post="are short-lasting but long enough for quick testing of"/>
   <result pre="Differential modulation of STN-cortical and cortico-muscular coherence by movement and" exact="levodopa" post="in Parkinson's disease Neuroimage 68 2013 203 213 23247184"/>
   <result pre="Kakigi R. Evaluation of nociceptive Aδ- and C-fiber dysfunction with" exact="lidocaine" post="using intraepidermal electrical stimulation Clin Neurophysiol 125 2014 1870"/>
   <result pre="drive to muscle in Parkinson's disease and its improvement with" exact="levodopa" post="Brain 125 2002 491 500 11872607 Salenius S. Hari"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6089040/results/search/drugs/results.xml">
   <result pre="the embryo was exited. In the control group, who received" exact="oxytocin" post="for induction of childbirth and received only routine care"/>
   <result pre="of endorphin, which can be the cause of increase in" exact="oxytocin" post="from posterior pituitary, which leads to this outcome and"/>
   <result pre="by reducing adrenalin and neuradrenaline levels and increasing endorphins and" exact="oxytocin" post="decreases mother's stress and leads to regular uterine contractions,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6111600/results/search/drugs/results.xml">
   <result pre="can cause an endogenous opioid response that is blunted by" exact="naloxone" post="in a dose dependent fashion [ 120]. The unity"/>
   <result pre="had recommended hydroxyurea. The family was considering the addition of" exact="hydroxyurea" post="but had some concerns about side effects. The initial"/>
   <result pre="her pain in general, including the potential benefits of adding" exact="hydroxyurea" post="as recommended by her hematologist. After development of rapport,"/>
   <result pre="Olness K. MacDonald J.T. Uden D.L. Comparison of self-hypnosis and" exact="propranolol" post="in the treatment of juvenile classic migraine Pediatrics 1987"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6213542/results/search/drugs/results.xml">
   <result pre="cells, production and release of inflammatory cytokines, chemokines, proteases, and" exact="nitric oxide" post="that induce the production of proapoptotic lipid ceramide ["/>
   <result pre="or placebo. After 26 weeks of treatment, patients in the" exact="laronidase" post="group showed improved forced vital capacity and walking distance,"/>
   <result pre="S. et al. MPS VI Study Group. The effect of" exact="galsulfase" post="enzyme replacement therapy on the growth of patients with"/>
   <result pre="al. Safety and physiological effects of two different doses of" exact="elosulfase alfa" post="in patients with morquio a syndrome: A randomized, double-blind,"/>
   <result pre="Berger K.I. Jester A. Treadwell M. et al. Impact of" exact="elosulfase alfa" post="in patients with morquio A syndrome who have limited"/>
   <result pre="AR b-glucuronidase DS/HS/C6S 1 + MPS IX Hyaluronidase deficiency AR" exact="hyaluronidase" post="deficiency hyaluronidase none None (2 Families described) ± ijms-19-03063-t002_Table"/>
   <result pre="DS/HS/C6S 1 + MPS IX Hyaluronidase deficiency AR hyaluronidase deficiency" exact="hyaluronidase" post="none None (2 Families described) ± ijms-19-03063-t002_Table 2 Table"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6300897/results/search/drugs/results.xml">
   <result pre="used in cardiology [2]. The European Consensus of 2015 defines" exact="propranolol" post="as the first line therapy for IHs, especially during"/>
   <result pre="tolerability, reserving a secondary or obsolete role to steroids, interferon," exact="vincristine" post="and surgery. The therapeutic dose ranges from 2 mg/kg/day"/>
   <result pre="clinical experience of the least 10 years demonstrate that oral" exact="propranolol" post="is successfully used in the treatment of IHs. Recent"/>
   <result pre="of IHs. Recent scientific literature proves that the use of" exact="propranolol" post="during the first months of life do not compromise"/>
   <result pre="Oranges, M. Cutrone, P. Dalmonte. Safety and effectiveness of oral" exact="propranolol" post="for infantile hemangiomas started before 5 weeks and after"/>
   <result pre="Torrelo A. Study of cognitive function in children treated with" exact="propranolol" post="for infantile hemangioma. Pediatr Dermatol. 2017; 34:554-558. A22 Depression"/>
   <result pre="RAD positive cases or score 5 children using 50 mg." exact="amoxicillin" post="in two daily doses for 6 days [3]. Other"/>
   <result pre="(0-14 years old) and an increase in the ratio of" exact="amoxicillin" post="to amoxicillin-clavulanate acid prescriptions (i.e. ratio of first choice"/>
   <result pre="Temporal trend in total antibiotic prescription rate and ratio of" exact="amoxicillin" post="to amoxicillin-clavulanic acid in children, 2005-2017 A37 Elaborating the"/>
   <result pre="2017, the fixed-dose combination of sofosbuvir/ledipasvir and the combination of" exact="sofosbuvir" post="with ribavirin have been approved by the European Medicines"/>
   <result pre="fixed-dose combination of sofosbuvir/ledipasvir and the combination of sofosbuvir with" exact="ribavirin" post="have been approved by the European Medicines Agency for"/>
   <result pre="children are available for sofosbuvir/ledipasvir in children aged 6-17, for" exact="sofosbuvir" post="and ribavirin for children older than 12 years, for"/>
   <result pre="available for sofosbuvir/ledipasvir in children aged 6-17, for sofosbuvir and" exact="ribavirin" post="for children older than 12 years, for the combination"/>
   <result pre="combination of ombitasvir/paritaprevir/ritonavir with or without dasabuvir, with or without" exact="ribavirin" post="for children older than 12 years with hepatitis C"/>
   <result pre="genotype 1 or 4 infection, and for the combination of" exact="sofosbuvir" post="with daclatasvir for children with hepatitis C virus genotype"/>
   <result pre="or 4 infection, and for the combination of sofosbuvir with" exact="daclatasvir" post="for children with hepatitis C virus genotype 4 infection"/>
   <result pre="Resti M. Kinetic of virologic response to pegylated interferon and" exact="ribavirin" post="in children with chronic hepatitis C predicts the effect"/>
   <result pre="prevent late-onset sepsis by any agent in preterm neonates, whereas" exact="fluconazole" post="and (to a lesser extent) nystatin can prevent invasive"/>
   <result pre="in preterm neonates, whereas fluconazole and (to a lesser extent)" exact="nystatin" post="can prevent invasive systemic fungal infections. Finally, specific measures"/>
   <result pre="with deficiency of selected micronutrients such as vitamin A, and" exact="folic acid." post="Historically, celiac disease has been associated with many micronutrient"/>
   <result pre="opinion recommends checking for vitamin D, vitamin A, zinc, copper," exact="folic acid," post="and ferritin [10]. Routine measuring of fat-soluble vitamins levels"/>
   <result pre="patient’s medical history, to test anti-thyroid antibodies (anti-tireoperoxidase and anti-" exact="thyroglobulin" post="antibodies) and to do a thyroid ultrasound. We have"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6336730/results/search/drugs/results.xml">
   <result pre="and tinnitus for 3 years. The patient had been taking" exact="silodosin" post="4 mg a day for benign prostate hyperplasia. The"/>
   <result pre="responsible lesion. The patient was placed on 48 mg of" exact="betahistine" post="and 80 mg of Ginko Biloba per day. The"/>
   <result pre="changes during the intercourse are known to be mediated by" exact="oxytocin" post="( 21). In humans, the plasma oxytocin level rises"/>
   <result pre="be mediated by oxytocin ( 21). In humans, the plasma" exact="oxytocin" post="level rises during sexual arousal with a greater increase"/>
   <result pre="arousal with a greater increase during the orgasm. Administration of" exact="naloxone" post="that blocks the periorgasmic oxytocin release decreases the arousal"/>
   <result pre="during the orgasm. Administration of naloxone that blocks the periorgasmic" exact="oxytocin" post="release decreases the arousal and orgasm ( 22). Along"/>
   <result pre="be explained by the hormonal changes, especially the rise of" exact="oxytocin" post="during the coitus and orgasm. Indeed, two of our"/>
   <result pre="ICP hypothesis as the mechanism of coital dizziness/vertigo. Otherwise, as" exact="oxytocin" post="increases cerebral blood flow by vasoconstrictory effect on small"/>
   <result pre="Dixen J Davidson JM . Relationships among cardiovascular, muscular, and" exact="oxytocin" post="responses during human sexual activity . Arch Sex Behav."/>
   <result pre="MR Checkley SA Seckl JR Lightman SL . Naloxone inhibits" exact="oxytocin" post="release at orgasm in man. J Clin Endocrinol Metab."/>
   <result pre="profile of in vivo cerebral blood flow changes following intranasal" exact="oxytocin" post="in humans . Biol Psychiatry ( 2016) 79: 693–"/>
   <result pre="et al. . Elevated cerebrospinal fluid and blood concentrations of" exact="oxytocin" post="following its intranasal administration in humans . Sci Rep."/>
   <result pre="Stolz-Born G Widder B Born J . Vascular effects of" exact="oxytocin" post="on human middle cerebral artery determined by transcranial Doppler"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6361827/results/search/drugs/results.xml">
   <result pre="V Barzegar M Rezamand A Feiz AH Electrophysiological consequences of" exact="vincristine" post="contained chemotherapy in children: a cohort study . J"/>
   <result pre="Tanner L . Gait patterns in children with cancer and" exact="vincristine" post="neuropathy. Pediatr Phys Ther. ( 2016) 28: 16– 22."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6400876/results/search/drugs/results.xml">
   <result pre="via its corticostriatal projection, possibly depending on the level of" exact="dopamine" post="receptor activation (or lack of) in the ventral tegmental"/>
   <result pre="output to the PAG [ 45]. As with opioid receptors," exact="dopamine" post="D2-like receptor activation could attenuate the inhibitory action of"/>
   <result pre="to the PAG [ 46, 47]. Microinjection of a non-selective" exact="dopamine" post="receptor agonist, apomorphine, or the dopamine D2 receptor (D2R)"/>
   <result pre="Microinjection of a non-selective dopamine receptor agonist, apomorphine, or the" exact="dopamine" post="D2 receptor (D2R) agonist, quinpirole, into the VLO attenuates"/>
   <result pre="of D2R in the PFC [ 48]. Endogenous release of" exact="dopamine" post="in the rat PFC, induced by high-frequency stimulation of"/>
   <result pre="and this effect is reversed by the opioid receptor antagonist" exact="naloxone" post="[ 44]. In another study, the VLO is found"/>
   <result pre="of chronic pain, possibly as a result of changes in" exact="dopamine" post="and opioid systems that play a role in endogenous"/>
   <result pre="in the midbrain [ 17]. Close appositions are found between" exact="dopamine" post="fibers and GABAergic interneurons in the ACC [ 82]."/>
   <result pre="GABAergic interneurons in the ACC [ 82]. In addition, the" exact="dopamine" post="D2/D3 receptor availability in the ventrolateral PFC has been"/>
   <result pre="correlate with recalled efficacy of placebo, suggesting a role of" exact="dopamine" post="in pain processing [ 83]. In animals, high-frequency stimulation"/>
   <result pre="impairs the long-lasting suppression evoked by high-frequency stimulation, suggesting that" exact="dopamine" post="may modify PFC nociceptive responses via the D2R ["/>
   <result pre="IL-1β, TNF-α, and 8-OH-dG) in the PFC[ 127]. Daily intrathecal" exact="minocycline" post="treatment to reduce microglial activation starting from POD0 for"/>
   <result pre="regions, with disease progression [ 206]. A reduction in brain" exact="dopamine" post="signaling due to compensatory downregulation of dopamine receptors could"/>
   <result pre="reduction in brain dopamine signaling due to compensatory downregulation of" exact="dopamine" post="receptors could also occur as a result of addiction."/>
   <result pre="and could lead to increased corticostriatal input. The release of" exact="dopamine" post="via the VTA-projection is a key part of the"/>
   <result pre="show depressed intracranial-self stimulation and extracellular levels of nucleus accumbens" exact="dopamine" post="[ 210]. It has been suggested that changes in"/>
   <result pre="Based on this possibility, we postulate that one function of" exact="dopamine" post="D2 receptors in the nucleus accumbens is to counteract"/>
   <result pre="(2) depending on chronic neuroinflammatory processes, and the level of" exact="dopamine" post="receptor activation (or lack of) in the VTA-nucleus accumbens"/>
   <result pre="gyrus, DLPFC, and precentral gyrus [ 248]. In another study," exact="naloxone" post="injection significantly decreased the analgesic effects of M1 stimulation,"/>
   <result pre="M1 or DLPFC rTMS are also decreased by ketamine. Since" exact="ketamine" post="is an inhibitor of NMDA receptors, this suggests that"/>
   <result pre="inhibitor antidepressants including duloxetine, tricyclic antidepressants such as amitriptyline, capsaicin," exact="lidocaine" post="patches, tramadol, botulinum toxin, and opioids. Rectal pain induces"/>
   <result pre="cortex, but only during stress [ 265]. In another study," exact="duloxetine" post="treatment is associated with a significant reduction in brain"/>
   <result pre="pain scores during treatment with milnacipran, a selective serotonin and" exact="norepinephrine" post="reuptake inhibitor (SNRI), in fibromyalgia patients are correlated with"/>
   <result pre="of neuroinflammation [ 268]. Treatment of rats with tapentadol, a" exact="norepinephrine" post="reuptake inhibitor with μ-opioid receptor agonistic activity, has recently"/>
   <result pre="severe pain, which results in a dose-dependent increase in cortical" exact="dopamine" post="and norepinephrine levels with a mean maximum increase of"/>
   <result pre="which results in a dose-dependent increase in cortical dopamine and" exact="norepinephrine" post="levels with a mean maximum increase of 600 and"/>
   <result pre="Izawa Y Abe H Kawakami Y Amygdala-prefrontal pathways and the" exact="dopamine" post="system affect nociceptive responses in the prefrontal cortex BMC"/>
   <result pre="Huo FQ Du JQ Tang JS D2-like but not D1-like" exact="dopamine" post="receptors are involved in the ventrolateral orbital cortex-induced antinociception:"/>
   <result pre="FQ Tang JS Qu CL Chen T The role of" exact="dopamine" post="receptors in ventrolateral orbital cortex-evoked anti-nociception in a rat"/>
   <result pre="49. Sogabe S Yagasaki Y Onozawa K Kawakami Y Mesocortical" exact="dopamine" post="system modulates mechanical nociceptive responses recorded in the rat"/>
   <result pre="al. Placebo analgesia: self-report measures and preliminary evidence of cortical" exact="dopamine" post="release associated with placebo response Neuroimage Clin 2016 10"/>
   <result pre="et al. A selective alpha2 B adrenoceptor agonist (A-1262543) and" exact="duloxetine" post="modulate nociceptive neurones in the medial prefrontal cortex, but"/>
   <result pre="traits determine the differential neuroinflammatory responses and analgesic effect of" exact="minocycline" post="in chronic neuropathic pain Brain Behav Immun 2016 58"/>
   <result pre="Jr Banks ML Negus SS Pain-related depression of the mesolimbic" exact="dopamine" post="system in rats: expression, blockade by analgesics, and role"/>
   <result pre="Soriano-Mas C Deus J Ortiz H et al. Effects of" exact="duloxetine" post="treatment on brain response to painful stimulation in major"/>
   <result pre="268. Burke NN Finn DP Roche M Chronic administration of" exact="amitriptyline" post="differentially alters neuropathic pain-related behaviour in the presence and"/>
   <result pre="G Irappanavar S Ponnamaneni R Manoharan A Mechanistic evaluation of" exact="tapentadol" post="in reducing the pain perception using in-vivo brain and"/>
   <result pre="Lee SW Lee S Cho IH et al. Effects of" exact="tianeptine" post="on symptoms of fibromyalgia via BDNF signaling in a"/>
   <result pre="prefrontal cortical calcium independent phospholipase A(2) in antidepressant-like effect of" exact="maprotiline" post="Int J Neuropsychopharmacol 2012 15 8 1087 1098 10.1017/S1461145711001234"/>
   <result pre="prefrontal cortical calcium-independent phospholipase A2 in antinociceptive effect of the" exact="norepinephrine" post="reuptake inhibitor antidepresssant maprotiline Neuroscience 2017 340 91 100"/>
   <result pre="A2 in antinociceptive effect of the norepinephrine reuptake inhibitor antidepresssant" exact="maprotiline" post="Neuroscience 2017 340 91 100 10.1016/j.neuroscience.2016.10.037 27789386 273. Li"/>
   <result pre="contribute to depression-like phenotype after spared nerve injury: improvement by" exact="ketamine" post="Sci Rep 2017 7 1 3124 10.1038/s41598-017-03590-3 28600519 305."/>
   <result pre="Manhaes A Schmidt S Attentional performance may help to identify" exact="duloxetine" post="responders in chronic pain fibromyalgia patients Eur J Pain"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6406666/results/search/drugs/results.xml">
   <result pre="treatments have been proposed, especially strategies involving drugs that regulate" exact="dopamine" post="metabolism or benzodiazepines treatment [ 14, 15, 16, 17]."/>
   <result pre="Kurihara T. Ishii M. Kawana F. et al. Effect of" exact="clonazepam" post="and clonidine on primary sleep bruxism: A double-blind, crossover,"/>
   <result pre="Ishii M. Kawana F. et al. Effect of clonazepam and" exact="clonidine" post="on primary sleep bruxism: A double-blind, crossover, placebocontrolled J."/>
   <result pre="17. Raigrodski A.J. Mohamed S.E. Gardiner D.M. The effect of" exact="amitriptyline" post="on pain intensity and perception of stress in bruxers"/>
   <result pre="Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: A comparison with" exact="methylphenidate" post="Appl. Psychophysiol. Biofeedback 2003 28 1 12 10.1023/A:1022353731579 12737092"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6406753/results/search/drugs/results.xml">
   <result pre="Pharmacological interventions in this setting often include analgesics such as" exact="acetaminophen" post="and nonsteroidal agents, gabapentinoids, clonidine, tricyclic antidepressants, and where"/>
   <result pre="Olness K. MacDonald J.T. Uden D.L. Comparison of self-hypnosis and" exact="propranolol" post="in the treatment of juvenile classic migraine Pediatrics 1987"/>
   <result pre="19743552 115. Chavan S.S. Tracey K.J. Regulating innate immunity with" exact="dopamine" post="and electroacupuncture Nat. Med. 2014 20 239 241 10.1038/nm.3501"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6443660/results/search/drugs/results.xml">
   <result pre="in response to pain-related words 20 . In addition, increased" exact="dopamine" post="release was detected in the NAcc from the vental"/>
   <result pre="well 23, 27 . Felice et al. 28 found that" exact="sumatriptan" post="and CGRP 8–37 treatment selectively elicited relief of ongoing"/>
   <result pre="relief of ongoing cephalic but not non-cephalic pain, stimulated the" exact="dopamine" post="efflux in NAcc and elicited conditioned place preference in"/>
   <result pre="10.1016/j.pain.2011.01.026 21377797 21. Matsumoto M Hikosaka O Two types of" exact="dopamine" post="neuron distinctly convey positive and negative motivational signals Nature"/>
   <result pre="of 6-hydroxydopamine-induced aphagia: implications for arousal and anhedonia hypotheses of" exact="dopamine" post="function Behav. Neurosci. 1989 103 36 45 10.1037/0735-7044.103.1.36 2493791"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6499187/results/search/drugs/results.xml">
   <result pre="tDCS has the potential to be addictive. Because the neurotransmitter" exact="dopamine" post="is involved in both the reward-related processes associated with"/>
   <result pre="2008). There is some limited evidence associating tDCS with altered" exact="dopamine" post="levels (e.g., Fonteneau et al., 2018), but it is"/>
   <result pre="dopaminergic effect 4 appears to be more aligned with indirect" exact="dopamine" post="concentrations 5 than with drugs that directly increase dopamine"/>
   <result pre="indirect dopamine concentrations 5 than with drugs that directly increase" exact="dopamine" post="levels in the reward system 6 , so the"/>
   <result pre="reward system 6 , so the effect of tDCS on" exact="dopamine" post="levels appears subtle. No issues with addiction have hitherto"/>
   <result pre="present paper). 4 Indicated by a 14–34% decrease in the" exact="dopamine" post="antagonist [ 11C]raclopride ( Fonteneau et al., 2018). 5"/>
   <result pre="music consumption ( Suzuki et al., 2008) can indirectly increase" exact="dopamine" post="levels by approximately 50–100%. 6 Such as cocaine and"/>
   <result pre="as cocaine and amphetamine, which have been found to stimulate" exact="dopamine" post="in the nucleus accumbens by up to 1000%, respectively"/>
   <result pre="A. ( 1988). Drugs abused by humans preferentially increase synaptic" exact="dopamine" post="concentrations in the mesolimbic system of freely moving rats."/>
   <result pre="et al. ( 2018). Frontal transcranial direct current stimulation induces" exact="dopamine" post="release in the ventral striatum in human. Cereb. Cortex"/>
   <result pre="Aviation). Hattori S. Naoi M. Nishino H. ( 1994). Striatal" exact="dopamine" post="turnover during treadmill running in the rat: relation to"/>
   <result pre="Lingford-Hughes A. Erritzoe D. Stokes P. R. ( 2015). The" exact="dopamine" post="theory of addiction: 40 years of highs and lows."/>
   <result pre="Zhu W. Telang F. et al. ( 2009). Effects of" exact="modafinil" post="on dopamine and dopamine transporters in the male human"/>
   <result pre="Telang F. et al. ( 2009). Effects of modafinil on" exact="dopamine" post="and dopamine transporters in the male human brain: clinical"/>
   <result pre="et al. ( 2009). Effects of modafinil on dopamine and" exact="dopamine" post="transporters in the male human brain: clinical implications. JAMA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6521793/results/search/drugs/results.xml">
   <result pre="his symptoms. His eye pressure normalized with the use of" exact="bimatoprost" post="and dorzolamide/timolol eye drops. However, over the course of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6558685/results/search/drugs/results.xml">
   <result pre="Fisher A de Vita G Melani C et al. Low" exact="testosterone" post="is associated with an increased risk of MACE lethality"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6632133/results/search/drugs/results.xml">
   <result pre="went to 10 pharmacies in 1 day to get an" exact="oxycodone" post="prescription. They told me that they only order a"/>
   <result pre="their usual dose of opioids. At times, a shortage of" exact="hydromorphone" post="was cited as a reason for reducing the dosage"/>
   <result pre="it is beyond cruel.&quot; Participants suspected during the shortage of" exact="hydromorphone" post="that the hospital staff was reserving the drug for"/>
   <result pre="For example, ED staff advised that they do not have" exact="hydromorphone" post="in the ED; however, when the patient with SCD"/>
   <result pre="the ED; however, when the patient with SCD was hospitalized," exact="hydromorphone" post="was available. Heightened Stigma and Focus on Pain Participants"/>
   <result pre="overall difficulties maintaining opioid therapy. A participant stated, &quot;Yes, the" exact="hydrocodone" post="pills. Because once CVS got their first prescription there’s"/>
   <result pre="One participant stated, &quot;They had me on 180 milligrams of" exact="oxycodone" post="and 30 milligrams of methadone. That was my pain"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6722762/results/search/drugs/results.xml">
   <result pre="methods of adjusting saddle height [ 22], the effects of" exact="tramadol" post="on physical performance [ 23] or heat acclimation ["/>
   <result pre="after a program involving IC, strength training and placebo or" exact="liraglutide" post="[ 15] and after IC exercise at home. Interestingly,"/>
   <result pre="the SBP. Specifically, the combination of IC, strength training and" exact="liraglutide" post="was effective to reduce SBP but not DBP ["/>
   <result pre="reduction of 3.1% (2.2kg), (b) the combination of IC and" exact="liraglutide" post="[ 15], and (c) the combination of IC and"/>
   <result pre="PrM: premenopausal group; PoM: postmenopausal group; Pl: placebo group; Li:" exact="liraglutide" post="group. medicina-55-00452-t004_Table 4 Table 4 ( a) Effects of"/>
   <result pre="cycling; ST: strength training; NS: nonsignificant; Pl: placebo group; Li:" exact="liraglutide" post="group; D: diet group; CG: control group; PT: physical"/>
   <result pre="CG: control group; ST: strength training; Pl: placebo group; Li:" exact="liraglutide" post="group; D: diet; PT: physical training; p-value: p-value within"/>
   <result pre="PrM: premenopausal group; PoM: postmenopausal group; Pl: placebo group; Li:" exact="liraglutide" post="group; BP: BodyPump ® ; BB: BodyBalance ® ;"/>
   <result pre="IC: indoor cycling; ST: strength training; Pl: placebo group; Li:" exact="liraglutide" post="group; NS: nonsignificant; BP: BodyPump ® ; BB: BodyBalance"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6787535/results/search/drugs/results.xml">
   <result pre="6 Very preliminary clinical work also suggests some efficacy of" exact="acetylsalicylic acid" post="in schizophrenia. 7   Epidemiological data show that patients"/>
   <result pre="placebo for sulindac, piroxicam, acetaminophen, naproxen, nabumetone, ketoprofen, diclofenac, or" exact="acetylsalicylic acid." post="9 The prescription of NSAIDs cannot be recommended for"/>
   <result pre="for either prevention or treatment of AD.  Bumetanide  The diuretic" exact="bumetanide" post="decreases intraneuronal chloride concentration and thereby facilitates γ-aminobutyric acid"/>
   <result pre="facilitates γ-aminobutyric acid (GABA) inhibition. In animal models of ASD," exact="bumetanide" post="restores intraneuronal chloride levels, enhances GABAergic inhibition, and attenuates"/>
   <result pre="inhibition, and attenuates behavioral symptoms. In a phase II trial," exact="bumetanide" post="reduced the severity of ASD in children and adolescents."/>
   <result pre="double-blind study. 12   Clonidine and other α-blockers  The antihypertensive" exact="clonidine" post="is a central α-2 agonist that also acts through"/>
   <result pre="in PTSD. 17   Gabapentin and other anticonvulsants  The antiepileptics" exact="valproic acid," post="lamotrigine, and carbamazepine have a recognized role in psychiatry"/>
   <result pre="Gabapentin and other anticonvulsants  The antiepileptics valproic acid, lamotrigine, and" exact="carbamazepine" post="have a recognized role in psychiatry that will not"/>
   <result pre="several anxiety disorders including social anxiety. 18 Its close compound" exact="pregabalin" post="has been registered in the United States for use"/>
   <result pre="receptor, which have also long been prescribed as sleeping pills;" exact="diphenhydramine" post="and several other antihistamines have been registered in many"/>
   <result pre="the side effect profile. The more recent H1-blockers such as" exact="cetirizine" post="or loratadine have not been studied as sleeping pills,"/>
   <result pre="effect profile. The more recent H1-blockers such as cetirizine or" exact="loratadine" post="have not been studied as sleeping pills, although cetirizine"/>
   <result pre="or loratadine have not been studied as sleeping pills, although" exact="cetirizine" post="induces some sedation. Pitolisant, an antagonist to the H3"/>
   <result pre="of post-surgery pain. Several randomized controlled trials (RCTs) of intravenous" exact="ketamine" post="provide findings of efficacy in treatment-resistant depression, bipolar depression,"/>
   <result pre="AD. 23   Minocycline and other antibiotics  Minocycline is a" exact="tetracycline" post="bacteriostatic antibiotic. Apart from its antibacterial properties, minocycline has"/>
   <result pre="is a tetracycline bacteriostatic antibiotic. Apart from its antibacterial properties," exact="minocycline" post="has anti-inflammatory, antiapoptotic, and neuroprotective effects. 24 Minocycline might"/>
   <result pre="of Il-6 or brain glutathione and a better response to" exact="minocycline" post="is supposed. The clinical effects of adjunctive minocycline on"/>
   <result pre="response to minocycline is supposed. The clinical effects of adjunctive" exact="minocycline" post="on the negative symptoms of schizophrenia are controversial, 28"/>
   <result pre=", 32 The progression of AD might be slowed with" exact="rifampicin" post="associated with doxycycline or rifampicin alone. 33 , 34"/>
   <result pre="progression of AD might be slowed with rifampicin associated with" exact="doxycycline" post="or rifampicin alone. 33 , 34 These results were"/>
   <result pre="AD might be slowed with rifampicin associated with doxycycline or" exact="rifampicin" post="alone. 33 , 34 These results were not confirmed"/>
   <result pre="for its mucolytic effects and as antidote in cases of" exact="acetaminophen" post="overdose by providing a precursor for the glutathione synthetase"/>
   <result pre="42   Pramipexole and other antiparkinsonian drugs  Pramipexole is a" exact="dopamine" post="D2 and D3 receptor agonist indicated in Parkinson disease"/>
   <result pre="of manic or hypomanic switch is also very low and" exact="pramipexole" post="is quoted as an option for bipolar depression in"/>
   <result pre="to L-dopa, while nowadays delusion would be a contraindication to" exact="dopamine" post="agonists. 46   Propranolol and other β-blockers  These cardiovascular"/>
   <result pre=", 48 Aside from cardiovascular indications, migraine, and essential tremor," exact="propranolol" post="might be useful in panic attacks. 49 Also, a"/>
   <result pre="panic attacks. 49 Also, a meta-analysis showed no difference between" exact="propranolol" post="and benzodiazepines on anxiety, panic attack frequency, and avoidance"/>
   <result pre="although equivalence was not proven. 50 Several studies showed that" exact="propranolol" post="decreased apprehension before diagnostic tests or dental interventions and"/>
   <result pre="the benefit of no sedation. Since β-blockers inhibit memory consolidation," exact="propranolol" post="has been studied in PTSD prevention. 51 - 53"/>
   <result pre="after a trauma are ongoing. A recent RCT concluded that" exact="propranolol" post="associated with brief memory reactivation had significant results compared"/>
   <result pre="2 evidence while there already is level 1 evidence for" exact="ketamine" post="perfusion which was still considered as experimental in some"/>
   <result pre="in number and in quality. It is the case of" exact="gabapentin" post="which is listed as first-line treatment in anxiety symptoms"/>
   <result pre="bipolar patients, despite only level 3 evidence. 61 The β-blocker" exact="propranolol" post="is not recommended in anxiety guidelines, because available data"/>
   <result pre="is intrinsically limited by availability of data. The example of" exact="lithium" post="as a first choice in bipolar disorder is illustrative"/>
   <result pre="will be important to establish how much NSAIDs, rifampicin, or" exact="doxycycline" post="really protect from AD or slow its evolution. The"/>
   <result pre="very few data available except rare but encouraging results for" exact="propranolol" post="and hydrocortisone, which administered shortly after a trauma, favorably"/>
   <result pre="NAC Amino acid Mucous secretions in broncho-pulmonary disorders, antidote for" exact="paracetamol" post="overdose Unipolar and bipolar depression,  schizophrenia As third-line adjunctive"/>
   <result pre="Shortened onset of action of antidepressants in major depression using" exact="acetylsalicylic acid" post="augmentation: a pilot open-label study. Int Clin Psychopharmacol. 2006"/>
   <result pre="Lemonnier E, Villeneuve N, Sonie S, et al. Effects of" exact="bumetanide" post="on neurobehavioral function in children and adolescents with autism"/>
   <result pre="23441623 25 Rosenblat JD, McIntyre RS. Efficacy and tolerability of" exact="minocycline" post="for depression: a systematic review and meta-analysis of clinical"/>
   <result pre="TK, Misaki M, et al. Treatment of bipolar depression with" exact="minocycline" post="and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase"/>
   <result pre="Huryk KM, Mao X, et al. A pilot study of" exact="minocycline" post="for the treatment of bipolar depression: effects on cortical"/>
   <result pre="B, Suckling J, Barnes TRE, et al. The benefit of" exact="minocycline" post="on negative symptoms of schizophrenia in patients with recent-onset"/>
   <result pre="S, Riwkes S, et al. A double-blind, randomized study of" exact="minocycline" post="for the treatment of negative and cognitive symptoms in"/>
   <result pre="30 Xiang YQ, Zheng W, Wang SB, et al. Adjunctive" exact="minocycline" post="for schizophrenia: a meta-analysis of randomized controlled trials. Eur"/>
   <result pre="B, Hanoglu L, Ozansov M, et al. Therapeutic role of" exact="rifampicin" post="in Alzheimer’s disease. Psychiatry Clin Neurosci. 2018 72 3"/>
   <result pre="DW, Smieja M, et al. A randomized, controlled trial of" exact="doxycycline" post="and rifampin for patients with Alzheimer’s disease. J Am"/>
   <result pre="T, Morimoto K, Sasaki Y, et al. Preventive effect of" exact="rifampicin" post="on Alzheimer disease needs at least 450 mg daily"/>
   <result pre="Study group. A multicenter, blinded, randomized, factorial controlled trial of" exact="doxycycline" post="and rifampin for treatment of Alzheimer’s disease: The DARAD"/>
   <result pre="T, Morimoto K, Sasaki Y, et al. Preventive effect of" exact="rifampicin" post="on Alzheimer disease needs at least 450 mg daily"/>
   <result pre="Friedman MJ, Hauri PJ, McHugo GJ. A controlled study of" exact="alprazolam" post="and propranolol in panic-disordered and agoraphobic outpatients. J Clin"/>
   <result pre="Hauri PJ, McHugo GJ. A controlled study of alprazolam and" exact="propranolol" post="in panic-disordered and agoraphobic outpatients. J Clin Psychopharmacol. 1991"/>
   <result pre="H, Robertson K, Nader K, Pitman RK. Effect of post-retrieval" exact="propranolol" post="on psychophysiologic responding during subsequent script-driver traumatic imagery in"/>
   <result pre="Tremblay J, Pitman RK. Reduction of PTSD symptoms with pre-reactivation" exact="propranolol" post="therapy : a randomized controlled trial. Am J Psychiatry."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6827519/results/search/drugs/results.xml">
   <result pre="limited to only two small studies exploring two pharmacological interventions:" exact="midodrine" post="and beta-blockers. 14, 15 Ross and colleagues (2014) 14"/>
   <result pre="and beta-blockers. 14, 15 Ross and colleagues (2014) 14 surmised" exact="midodrine" post="hydrochloride may be an effective treatment for POTS in"/>
   <result pre="improved heart rate control. For pediatric patients, propranolol, metoprolol, and" exact="labetalol" post="have been used. 8 Midodrine is an alpha-1 adrenergic"/>
   <result pre="hypertension. Midodrine can also be used as dual therapy with" exact="fludrocortisone" post="in patients with POTS to improve their symptoms, particularly"/>
   <result pre="more severe POTS symptoms, greater perceived symptom disability, lower supine" exact="norepinephrine" post="levels, and greater likelihood of blood pressure abnormality during"/>
   <result pre="A double-blind placebo-controlled cross-over study of the vascular effects of" exact="midodrine" post="in neuropathic compared with hyperadrenergic postural tachycardia syndrome ."/>
   <result pre="Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with" exact="midodrine" post="and β‐blockers . Pacing Clin Electrophysiol . 2009; 32("/>
   <result pre=", Williams GH , Levine BD . Exercise training versus" exact="propranolol" post="in the treatment of the postural orthostatic tachycardia syndrome"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6839138/results/search/drugs/results.xml">
   <result pre="and other organic pathologies were discarded. Pharmacotherapy: Flunarizine, rizatriptan, and" exact="dexketoprofen" post="trometamol. At the age of 16 years (in 2007), she"/>
   <result pre="be correlated with acute posterior coronary syndrome. Treatment: Withdrawal of" exact="valproic acid." post="The patient was discharged with problems in ambulation (ambulation"/>
   <result pre="genetic cause of ataxia was discarded. Symptomatic drug treatment with" exact="ibuprofen" post="and rizatriptan was prescribed, and the patient was referred"/>
   <result pre="of ataxia was discarded. Symptomatic drug treatment with ibuprofen and" exact="rizatriptan" post="was prescribed, and the patient was referred to physical"/>
   <result pre="continue etiological diagnosis, because the patient used many medications, including" exact="valproic acid," post="which are controlled and present adverse effects at the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6873267/results/search/drugs/results.xml">
   <result pre="dealing with acute and severe pain episodes such as taking" exact="ibuprofen" post="or a warm Epsom salt bath. Table 2. Treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6914898/results/search/drugs/results.xml">
   <result pre="a pharmacological intervention. The pharmacological interventions included Celebrex, Vioxx, and/or" exact="paracetamol" post="[ 75], fluoxetine [ 81], ibuprofen [ 82], metoprolol"/>
   <result pre="The pharmacological interventions included Celebrex, Vioxx, and/or paracetamol [ 75]," exact="fluoxetine" post="[ 81], ibuprofen [ 82], metoprolol [ 78], sodium"/>
   <result pre="included Celebrex, Vioxx, and/or paracetamol [ 75], fluoxetine [ 81]," exact="ibuprofen" post="[ 82], metoprolol [ 78], sodium diclofenac [ 40],"/>
   <result pre="and/or paracetamol [ 75], fluoxetine [ 81], ibuprofen [ 82]," exact="metoprolol" post="[ 78], sodium diclofenac [ 40], or sodium valproate"/>
   <result pre="fluoxetine [ 81], ibuprofen [ 82], metoprolol [ 78], sodium" exact="diclofenac" post="[ 40], or sodium valproate [ 77], or local"/>
   <result pre="82], metoprolol [ 78], sodium diclofenac [ 40], or sodium" exact="valproate" post="[ 77], or local injections of botulin toxin ["/>
   <result pre="[ 77], or local injections of botulin toxin [ 77]," exact="lidocaine" post="[ 79], or dibucaine [ 80]. Five trials showed"/>
   <result pre="studies reported no difference between the effects of acupuncture and" exact="lidocaine" post="injections on trigger points (myofascial pain) after 3 weeks"/>
   <result pre="headaches (trigger points) (8 weeks) or the administration of sodium" exact="valproate" post="(12 weeks) compared to real acupuncture at 1 month"/>
   <result pre="treatment compared to physiotherapy alone [ 32] and physiotherapy plus" exact="diclofenac" post="[ 68], respectively. 3.4.7. Acupuncture versus Relaxation Two trials"/>
   <result pre="A. et al. Effectiveness and tolerability of acupuncture compared with" exact="metoprolol" post="in migraine prophylaxis Headache: The Journal of Head and"/>
   <result pre="H. Park C. H. Yoon H. J. Acupuncture needling versus" exact="lidocaine" post="injection of trigger points in myofascial pain syndrome in"/>
   <result pre="randomized clinical trial of fibromyalgia treatment with acupuncture compared with" exact="fluoxetine" post="Iranian Red Crescent Medical Journal 2012 14 10 631"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6918555/results/search/drugs/results.xml">
   <result pre="current body of evidence, including safety issues. In this perspective," exact="omalizumab" post="-an anti-IgE monoclonal antibody-, alone or combined with oral"/>
   <result pre="Dawson P, et al. A randomized, double-blind, placebo-controlled study of" exact="omalizumab" post="combined with oral immunotherapy for the treatment of cow's"/>
   <result pre="Mennini M, Pecora V, Fierro V, et al. Impact of" exact="omalizumab" post="on food allergy in patients treated for asthma: a"/>
   <result pre="trial in sJIA, MAS was observed in some patients receiving" exact="tocilizumab" post="[2-3]. High serum levels of IL-18 have been observed"/>
   <result pre="aggregation test showed severe defect in response to ADP, collagen," exact="epinephrine" post="and reduced to ristocetin. Further evaluation showed total GpIIb"/>
   <result pre="syndrome and pulmonary disorders, spleen sequestration and splenectomy, transfusion and" exact="hydroxyurea" post="therapy were some of the most relevant issues addressed"/>
   <result pre="at high risk of this life-threatening complication [5] and on" exact="hydroxyurea" post="therapy in SCD children [6]. Acknowledgements We thank SITE"/>
   <result pre="indicators: the total antibiotic prescription rate and the ratio of" exact="amoxicillin" post="versus amoxicillin-clavulanic acid. Throughout the project, papers both in"/>
   <result pre="children), along with a relative growth of the use of" exact="amoxicillin" post="(the ratio of amoxicillin to amoxicillin-clavulanic acid increased from"/>
   <result pre="relative growth of the use of amoxicillin (the ratio of" exact="amoxicillin" post="to amoxicillin-clavulanic acid increased from 0.6 to 1.3 in"/>
   <result pre="(quite higher than the one in Emilia-Romagna), and ratio of" exact="amoxicillin" post="to amoxicillin-clavulanic acid 0.3 (much lower than the one"/>
   <result pre="antibiotic prophylaxis; the promising results reported with the CXCR4 antagonist" exact="plerixafor" post="[8] paved the way to the future treatment of"/>
   <result pre="(43%) no germ was isolated. The most used antibiotics were" exact="ceftriaxone" post="(36 %), rifampicin (36 %), meropenem (29 %), linezolid"/>
   <result pre="was isolated. The most used antibiotics were ceftriaxone (36 %)," exact="rifampicin" post="(36 %), meropenem (29 %), linezolid (21%), amoxicillin (14%)"/>
   <result pre="most used antibiotics were ceftriaxone (36 %), rifampicin (36 %)," exact="meropenem" post="(29 %), linezolid (21%), amoxicillin (14%) and vancomycin (14"/>
   <result pre="were ceftriaxone (36 %), rifampicin (36 %), meropenem (29 %)," exact="linezolid" post="(21%), amoxicillin (14%) and vancomycin (14 %). Ciprofloxacin was"/>
   <result pre="(36 %), rifampicin (36 %), meropenem (29 %), linezolid (21%)," exact="amoxicillin" post="(14%) and vancomycin (14 %). Ciprofloxacin was largely used"/>
   <result pre="(36 %), meropenem (29 %), linezolid (21%), amoxicillin (14%) and" exact="vancomycin" post="(14 %). Ciprofloxacin was largely used (57 %), mainly"/>
   <result pre="for children with severe allergic asthma. Binding to free IgE," exact="omalizumab" post="reduces cell-bound IgE, down-regulates IgE receptors and prevents the"/>
   <result pre="release of pro-inflammatory mediators [2]. The efficacy and safety of" exact="omalizumab" post="have been established by several randomized controlled trials specifically"/>
   <result pre="randomized controlled trials specifically conducted in pediatric patients [3]. Overall," exact="omalizumab" post="was effective in reducing the rate of asthma exacerbations,"/>
   <result pre="subjects [3]. A large amount of safety data showed that" exact="omalizumab" post="is generally well-tolerated. The main side effects reported were"/>
   <result pre="support an increased risk of malignancy in patients treated with" exact="omalizumab" post="[3]. Other biologic therapies have provided new evidence of"/>
   <result pre="R, Marseglia A, Ciprandi G. The discovery and development of" exact="omalizumab" post="for the treatment of asthma. Expert Opin Drug Discov."/>
   <result pre="first line-steroid-sparing agent, whilst anti-tumor necrosis factor-α (anti-TNFα) agents, as" exact="adalimumab" post="and infliximab are currently used as second line agents,"/>
   <result pre="agent, whilst anti-tumor necrosis factor-α (anti-TNFα) agents, as adalimumab and" exact="infliximab" post="are currently used as second line agents, in case"/>
   <result pre="has been shown a higher probability of maintaining remission on" exact="adalimumab" post="than infliximab during the time of treatment, and a"/>
   <result pre="shown a higher probability of maintaining remission on adalimumab than" exact="infliximab" post="during the time of treatment, and a better efficacy"/>
   <result pre="the first anti-TNFα agent failed, there is evidence that increasing" exact="adalimumab" post="dose and/or administration or switching to a second anti-TNFα"/>
   <result pre="emerging treatment for uveitis and cystoid macular oedema. Rituximab and" exact="canakinumab" post="are progressively showing an emerging role in chronic resistant"/>
   <result pre="Emmi G, et al. Safety profile of the interleukin-1 inhibitors" exact="anakinra" post="and canakinumab in real-life clinical practice: a nationwide multicenter"/>
   <result pre="et al. Safety profile of the interleukin-1 inhibitors anakinra and" exact="canakinumab" post="in real-life clinical practice: a nationwide multicenter retrospective observational"/>
   <result pre="Corsello G. Early treatment of systemic juvenile idiopathic arthritis with" exact="canakinumab" post="and complete remission after 2 years of treatment suspension:"/>
   <result pre="In the last years increasing evidence supports the use of" exact="anakinra" post="in the treatment of MAS associated with sJIA. Recently,"/>
   <result pre="in the management of rheumatic diseases. Since the introduction of" exact="methotrexate" post="in the early ‘90s, the treatment of JIA was"/>
   <result pre="assessed at the arrival, at 1 and 2 hours after" exact="paracetamol" post="(20 mg/kg orally or 15 mg/kg IV) or ibuprofen"/>
   <result pre="after paracetamol (20 mg/kg orally or 15 mg/kg IV) or" exact="ibuprofen" post="(10mg/kg orally) administration according to OMS guidelines and pain"/>
   <result pre="effective in TTH at 2 hours after administration compared to" exact="paracetamol" post="(OR 6.00). Paracetamol administered both orally (OR 2.00) and"/>
   <result pre="IV (OR 2.50) is more effective in mixed headaches than" exact="ibuprofen" post="(OR 1.75). Ibuprofen (OR 5.50) and paracetamol administered IV"/>
   <result pre="mixed headaches than ibuprofen (OR 1.75). Ibuprofen (OR 5.50) and" exact="paracetamol" post="administered IV (OR 5.50) are more effective than paracetamol"/>
   <result pre="and paracetamol administered IV (OR 5.50) are more effective than" exact="paracetamol" post="administered orally (OR 1.50). Conclusion It may need easier"/>
   <result pre="Ibuprofen maybe more effective in the migraine and TTH than" exact="paracetamol" post="administered orally, but it needs more studies to confirm"/>
   <result pre="in 6 out of 56 emergency departments in Lombardy region" exact="amoxicillin" post="was prescribed to more than 50% of children treated"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6923767/results/search/drugs/results.xml">
   <result pre="573– 82. 10.1038/nrneurol.2010.127 20820195 74. Wackym PA Ultrastructural organization of" exact="calcitonin" post="gene-related peptide immunoreactive efferent axons and terminals in the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="music/PMC6939407/results/search/drugs/results.xml">
   <result pre="disorder, attention deficit hyperactivity disorder and other psychiatric diagnoses, pharmacology," exact="melatonin" post="and solely or primarily biofeedback were excluded, as were"/>
   <result pre="arms To determine the benefits of CBT when combined with" exact="amitriptyline" post="vs headache education plus amitriptyline on pain, disability and"/>
   <result pre="of CBT when combined with amitriptyline vs headache education plus" exact="amitriptyline" post="on pain, disability and credibility Chronic migraine by ICHD-II"/>
   <result pre="sessions over 8 weeks and 2 booster sessions; 1mg/kg/day of" exact="amitriptyline" post="T2: Headache Education (HE) 10 sessions; 1mg/kg/day of amitriptyline"/>
   <result pre="of amitriptyline T2: Headache Education (HE) 10 sessions; 1mg/kg/day of" exact="amitriptyline" post="66% in the CBT group had a headache reduction"/>
   <result pre="d Palermo 2016 47 x c/x d Notes: * aPlus" exact="amitriptyline" post="in both groups. bSpecialised headache treatment in both groups."/>
   <result pre="al 51 and Kroner et al 45 used CBT plus" exact="amitriptyline" post="as the primary intervention. Kroner et al 45 collected"/>
   <result pre=", Kashikar-Zuck SM , et al. Cognitive behavioral therapy plus" exact="amitriptyline" post="for children and adolescents with chronic migraine reduces headache"/>
   <result pre=", Allen JR , et al. Cognitive behavioral therapy plus" exact="amitriptyline" post="for chronic migraine in children and adolescents: a randomized"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
